<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68764</article-id><article-id pub-id-type="doi">10.7554/eLife.68764</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Ecology</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-231889"><name><surname>Smith</surname><given-names>David RM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7330-4262</contrib-id><email>david.smith@pasteur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-233732"><name><surname>Temime</surname><given-names>Laura</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8850-5403</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-120147"><name><surname>Opatowski</surname><given-names>Lulla</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE)</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team</institution><addr-line><named-content content-type="city">Montigny-Le-Bretonneux</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution>PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Knight</surname><given-names>Gwenan M</given-names></name><role>Reviewing Editor</role><aff><institution>London School of Hygiene and Tropical Medicine</institution><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Senior Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e68764</elocation-id><history><date date-type="received" iso-8601-date="2021-03-26"><day>26</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-31"><day>31</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Smith et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Smith et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68764-v2.pdf"/><abstract><p>The human microbiome can protect against colonization with pathogenic antibiotic-resistant bacteria (ARB), but its impacts on the spread of antibiotic resistance are poorly understood. We propose a mathematical modeling framework for ARB epidemiology formalizing within-host ARB-microbiome competition, and impacts of antibiotic consumption on microbiome function. Applied to the healthcare setting, we demonstrate a trade-off whereby antibiotics simultaneously clear bacterial pathogens and increase host susceptibility to their colonization, and compare this framework with a traditional strain-based approach. At the population level, microbiome interactions drive ARB incidence, but not resistance rates, reflecting distinct epidemiological relevance of different forces of competition. Simulating a range of public health interventions (contact precautions, antibiotic stewardship, microbiome recovery therapy) and pathogens (<italic>Clostridioides difficile</italic>, methicillin-resistant <italic>Staphylococcus aureus</italic>, multidrug-resistant Enterobacteriaceae) highlights how species-specific within-host ecological interactions drive intervention efficacy. We find limited impact of contact precautions for Enterobacteriaceae prevention, and a promising role for microbiome-targeted interventions to limit ARB spread.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>S. aureus</italic></kwd><kwd>K. pneumoniae</kwd><kwd>C. difficile</kwd><kwd>microbiota</kwd><kwd>within-host interactions</kwd><kwd>antibiotics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>SPHINX-17-CE36-0008-01</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David RM</given-names></name><name><surname>Temime</surname><given-names>Laura</given-names></name><name><surname>Opatowski</surname><given-names>Lulla</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>164263</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David RM</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-10-LABX62-IBEID</award-id><principal-award-recipient><name><surname>Opatowski</surname><given-names>Lulla</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel mathematical modeling framework for antibiotic-resistant bacteria combining within-host microbiome-pathogen interactions with population-level pathogen epidemiology, demonstrating how antibiotic consumption and ecological competition come together to drive the spread of resistance.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Bacteria are fundamental drivers of human health and disease. On one hand, bacterial pathogens are leading causes of global infectious disease burden, with antibiotic-resistant and healthcare-associated infections posing significant risks to patient safety and public health (<xref ref-type="bibr" rid="bib30">Cassini et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Cassini et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Friedman et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Naylor et al., 2018</xref>). On the other, the bacterial microbiome – the trillions of individual bacteria that collectively inhabit the human body – provides support to development and homeostasis, facilitates core physiological processes like digestion, and protects against diseases ranging from colitis to cancer (<xref ref-type="bibr" rid="bib8">Bäckhed et al., 2005</xref>; <xref ref-type="bibr" rid="bib75">Kamada et al., 2013b</xref>; <xref ref-type="bibr" rid="bib94">Lynch and Pedersen, 2016</xref>; <xref ref-type="bibr" rid="bib127">Round and Mazmanian, 2009</xref>; <xref ref-type="bibr" rid="bib128">Roy and Trinchieri, 2017</xref>). The microbiome can also protect against colonization with infectious bacterial pathogens, a phenomenon known as colonization resistance, limiting their capacities to establish colonies, grow, persist, and transmit (<xref ref-type="bibr" rid="bib15">Bäumler and Sperandio, 2016</xref>; <xref ref-type="bibr" rid="bib27">Buffie and Pamer, 2013</xref>). This is perhaps best exemplified by the canonical <italic>Clostridioides difficile</italic>: growth within the intestine is inhibited by secondary metabolites of commensal gut bacteria, protecting colonized hosts from disease and limiting propagation of the infectious spores that drive between-host transmission (<xref ref-type="bibr" rid="bib74">Kamada et al., 2013a</xref>; <xref ref-type="bibr" rid="bib114">Pamer, 2016</xref>). The human microbiome is purported to play a defensive role against a range of bacterial pathogens, but the mechanistic nature and epidemiological consequences of within-host microbiome-pathogen interactions are poorly understood.</p><p>This relationship between microbiome ecology and bacterial epidemiology is important in the context of widespread antibiotic use and global dissemination of high-risk pathogenic antibiotic-resistant bacteria (ARB). When prescribed appropriately, antibiotics target particular bacterial pathogens, but co-colonizing microbiota are also exposed (<xref ref-type="bibr" rid="bib145">Tedijanto et al., 2018</xref>). This can unintentionally destabilize healthy microbial communities, resulting in dysbiosis, a state of population dynamic disequilibrium (<xref ref-type="bibr" rid="bib18">Bhalodi et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Coyte et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Dethlefsen and Relman, 2011</xref>). Microbiome dysbiosis is associated with reduced abundance and diversity of commensal bacteria, impaired host immune responses, and loss of colonization resistance, altogether increasing host susceptibility to ARB colonization (<xref ref-type="bibr" rid="bib80">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib139">Sorbara and Pamer, 2019</xref>; <xref ref-type="bibr" rid="bib156">Zhang et al., 2015</xref>). Antibiotic-induced dysbiosis may further result in elevated expression of antibiotic resistance genes, increased rates of horizontal transfer of such genes, and ecological release, whereby subdominant ARB are released from competition via clearance of drug-sensitive bacteria, growing out into dominant colonies (<xref ref-type="bibr" rid="bib48">Doan et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Letten et al., 2021</xref>; <xref ref-type="bibr" rid="bib129">Ruppé et al., 2019</xref>; <xref ref-type="bibr" rid="bib141">Stecher et al., 2013</xref>). These associations may be particularly relevant for healthcare settings, where antibiotic use is widespread, and where microbiome dysbiosis is increasingly recognized as a key driver of ARB colonization and infection (<xref ref-type="bibr" rid="bib10">Baggs et al., 2018</xref>; <xref ref-type="bibr" rid="bib120">Prescott et al., 2015</xref>; <xref ref-type="bibr" rid="bib124">Ravi et al., 2019</xref>). From a clinical perspective, this motivates a need for public health interventions that minimize or reverse harm to patient microbiota, from antibiotic stewardship, to fecal microbiota transplantation, to microbiome protective therapies. (<xref ref-type="bibr" rid="bib44">de Gunzburg et al., 2018</xref>; <xref ref-type="bibr" rid="bib125">Relman and Lipsitch, 2018</xref>).</p><p>In the face of uncertainty, mathematical modeling is a useful tool to analyze epidemiological dynamics of antibiotic resistance and evaluate control measures (<xref ref-type="bibr" rid="bib68">Heesterbeek et al., 2015</xref>; <xref ref-type="bibr" rid="bib112">Opatowski et al., 2011</xref>). However, an incomplete understanding of key eco-evolutionary principles is highlighted as a limitation to using modeling to predict future trends and inform decision-making (<xref ref-type="bibr" rid="bib19">Birkegård et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Knight et al., 2019</xref>). Disruption of the host microbiome is a long-standing theory explaining how antibiotics select for the spread of resistance at both the individual and population levels (<xref ref-type="bibr" rid="bib90">Lipsitch and Samore, 2002</xref>), but most epidemiological models consider just one species of bacteria at a time, under the traditional assumption that antibiotic selection for resistance results from intraspecific competition between co-circulating strains (<xref ref-type="bibr" rid="bib21">Blanquart, 2019</xref>; <xref ref-type="bibr" rid="bib123">Ramsay et al., 2018</xref>; <xref ref-type="bibr" rid="bib140">Spicknall et al., 2013</xref>). This simple framework has been particularly useful for bacteria like <italic>Streptococcus pneumoniae</italic> and <italic>Staphylococcus aureus</italic>, in which different strains – sometimes conceptualized as drug-sensitive vs. drug-resistant, or community-associated vs. healthcare-associated – are believed to be in close ecological competition (<xref ref-type="bibr" rid="bib21">Blanquart, 2019</xref>; <xref ref-type="bibr" rid="bib49">Domenech de Cellès et al., 2011</xref>; <xref ref-type="bibr" rid="bib76">Kardaś-Słoma et al., 2011</xref>; <xref ref-type="bibr" rid="bib121">Pressley et al., 2010</xref>; <xref ref-type="bibr" rid="bib151">van Kleef et al., 2013</xref>).</p><p>Accounting for other forms of complexity in epidemiological models – from treatment intensity, to age-assortative contact behavior, to hospital referral networks, to animal-human interactions, to genetic linkage between resistance and non-resistance genes – has helped to unravel the many, disparate forces that contribute to drive the spread of resistance (<xref ref-type="bibr" rid="bib20">Blanquart et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Cobey et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Colijn and Cohen, 2015</xref>; <xref ref-type="bibr" rid="bib50">Donker et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Lehtinen et al., 2017</xref>; <xref ref-type="bibr" rid="bib149">van Bunnik and Woolhouse, 2017</xref>). Nevertheless, within-host bacterial competition remains a key mechanism of selection for antibiotic resistance dissemination, and an active area of research at the forefront of resistance modeling (<xref ref-type="bibr" rid="bib90">Lipsitch and Samore, 2002</xref>; <xref ref-type="bibr" rid="bib108">Mulberry et al., 2020</xref>; <xref ref-type="bibr" rid="bib140">Spicknall et al., 2013</xref>). For instance, the ‘mixed-carriage’ model by Davies et al. demonstrates how intraspecific competition results in negative frequency-dependent selection for either of two competing strains, and provides a satisfying mechanistic explanation for widespread strain coexistence at the population level (<xref ref-type="bibr" rid="bib41">Davies et al., 2019</xref>). However, contemporary work has stopped short of evaluating consequences of between-species competition on resistance epidemiology. Yet for many ARB, including emerging high-priority multidrug-resistant bacteria like extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae, interactions with the host microbiome may be important mediators of nosocomial colonization dynamics (<xref ref-type="bibr" rid="bib80">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Lerminiaux and Cameron, 2019</xref>; <xref ref-type="bibr" rid="bib118">Pilmis et al., 2020</xref>).</p><p>Here, we use mathematical modeling to evaluate how microbiome ecology and antibiotic consumption combine to drive the spread and control of antibiotic-resistant bacteria in the healthcare setting. This is presented in two parts. First, we propose a modeling framework for ARB colonization dynamics, accounting for different within-host ecological interactions – including intraspecific pathogen strain competition, interspecific microbiome-pathogen competition, and horizontal gene transfer (HGT) – in the context of antibiotic treatment. Synthesizing these into a final model, we show how different combinations of ecological interactions drive antibiotic selection for the spread of resistance, with heterogeneous impacts on classic epidemiological indicators. Second, using parameter estimates from the literature, we apply this framework to simulate the nosocomial epidemiology of four high-risk ARB: <italic>C. difficile</italic>, methicillin-resistant <italic>S. aureus</italic> (MRSA), ESBL-producing <italic>Escherichia coli</italic> (ESBL-EC) and carbapenemase-producing <italic>Klebsiella pneumoniae</italic> (CP-KP). Expert elicitation interviews were conducted to characterize the clinical relevance of microbiome dysbiosis for each species, and to qualify and quantify interaction coefficients with uncertainty. By simulating a range of different public health interventions, we demonstrate the theoretical importance of microbiome-pathogen interactions as mediators of ARB epidemiology, and determining factors in the control of resistance dissemination.</p></sec><sec id="s2"><title>Model and results</title><sec id="s2-1"><title>Part 1: A modeling framework for antibiotic resistance epidemiology in healthcare settings</title><p>We propose a series of five models describing colonization dynamics of an antibiotic-resistant bacterial <italic>pathogen</italic>, denoted P<sup>R</sup>, among hospital inpatients in an acute care setting. Each model accounts for different within-host ecological interactions between P<sup>R</sup> and other bacteria. Models are described using systems of ordinary differential equations (ODEs), and are evaluated deterministically using numerical integration. Across models, three primary epidemiological outcomes are calculated at steady-state equilibrium: P<sup>R</sup> prevalence (the proportion of patients colonized), P<sup>R</sup> incidence (the daily rate of colonization acquisition within the hospital), and the pathogen resistance rate (the proportion of patients colonized with the focal antibiotic-resistant strain P<sup>R</sup> relative to a competing drug-sensitive strain P<sup>S</sup>). We also derive and evaluate the basic reproduction number <italic>R</italic><sub>0</sub> for P<sup>R</sup>, an indicator of pathogen epidemicity representing the average number of patients expected to acquire a novel pathogen from an initial index patient. See Materials and methods for technical details, and the supplementary appendix for the complete modeling framework and assumptions (Appendix <xref ref-type="disp-formula" rid="equ9">Equation A1</xref>).</p><sec id="s2-1-1"><title>A simple transmission model for bacterial colonization</title><p>We start with a Susceptible-Colonized transmission model (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) representing a population of N hospital patients as either susceptible to colonization (S) or colonized (C<sup>R</sup>) by P<sup>R</sup>, the focal strain or species:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>μ</mml:mi><mml:mo>−</mml:mo><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mo>×</mml:mo><mml:mi>f</mml:mi><mml:mo>×</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Comparison of models describing bacterial colonization dynamics in healthcare settings: in contrast to predictions from a model with no ecological competition (A, D, G), models including strain competition (B, E, H) or microbiome competition (C, F, I) can explain how antibiotics select for the epidemiological spread of antibiotic-resistant bacteria.</title><p>For all models, ODEs are integrated numerically using the same parameter values representing a generic nosocomial pathogen P<sup>R</sup> (see <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). (<bold>A,B,C</bold>) Compartmental model diagrams representing corresponding ODE systems from the main text (<bold>A</bold>: <xref ref-type="disp-formula" rid="equ19">Equation 1</xref>; <bold>B</bold>: <xref ref-type="disp-formula" rid="equ3">Equation 3</xref>; <bold>C</bold>: <xref ref-type="disp-formula" rid="equ4">Equation 4</xref>). (<bold>D,E,F</bold>) Pathogen colonization prevalence as a function of antibiotic exposure prevalence (<inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>), assuming partial antibiotic resistance (<italic>r<sub>R</sub></italic> = 0.8). For (<bold>E</bold>) P<sup>S</sup> and P<sup>R</sup> circulate simultaneously, assuming strain-specific differences in antibiotic resistance (<italic>r<sub>S</sub></italic> = 0, <italic>r<sub>R</sub></italic> = 0.8), natural clearance (γ<sub>S</sub> = 0.03 day<sup>−1</sup>, γ<sub>R</sub> = 0.06 day<sup>−1</sup>) and transmission (λ<sub>S</sub> = β × C<sup>S</sup>/N, λ<sub>R</sub> = β × C<sup>R</sup>/N). For (<bold>F</bold>), epidemiological dynamics are evaluated independently for each interaction and superimposed (ε = colonization resistance; η = resource competition; ϕ = ecological release); shaded intervals represent outcomes across the range of values considered for each interaction (see <xref ref-type="fig" rid="fig2">Figure 2</xref>); and antibiotics are assumed to induce dysbiosis after 1 day (θ<sub>m</sub> = 1 day<sup>−1</sup>), from which microbiome stability recovers after 7 days (δ = 1/7 day<sup>−1</sup>). Dashed vertical arrows denote the levels of antibiotic use that maximize P<sup>R</sup> prevalence (the sum of colonized compartments C<sup>R</sup>). (<bold>G,H,I</bold>) Numerical evaluation of the basic reproduction number (<italic>R</italic><sub>0</sub>) of P<sup>R</sup> as a function of <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> and <italic>r<sub>R</sub></italic>. White contour lines indicate <italic>R</italic><sub>0</sub> = 1, above which a single colonized patient admitted to a naïve hospital population is expected to trigger an outbreak. For I, all three microbiome-pathogen interactions are applied simultaneously using baseline values (ε = 0.5; η = 0.5; ϕ = 5).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig1-v2.tif"/></fig><p>This model is adapted from classic colonization models of antibiotic-resistant bacteria (<xref ref-type="bibr" rid="bib7">Austin et al., 1997</xref>), includes no ecological interactions with non-focal bacteria, and reflects a suite of common assumptions relevant to the healthcare setting, including: (i) a symmetric rate of patient admission and discharge μ, holding N constant; (ii) a proportion of patients colonized upon admission <italic>f</italic>, reflecting pathogen prevalence in the community; (iii) a dynamic rate of colonization acquisition λ<sub>R</sub>=β×C<sup>R</sup>/N, for host-to-host transmission; (iv) a static rate of acquisition α<sub>R</sub>, for endogenous routes of acquisition; (v) a rate of natural clearance γ<sub>R</sub>; and (vi) a rate of effective antibiotic treatment σ<sub>R</sub>. Note that all state variables are functions of time <italic>t</italic>, though this is omitted from ODEs for brevity.</p><p>Efficacy of antibiotic treatment is assumed to depend both on the distribution of antibiotics consumed in the hospital and on the intrinsic antibiotic resistance profile of P<sup>R</sup>. We express this as<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula>where <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> is the hospital population’s antibiotic exposure prevalence (the proportion of patients exposed to antibiotics at any <italic>t</italic>), θ<sub>C</sub> is the antibiotic-induced clearance rate (the rate at which effective antibiotics clear pathogen colonization), and <italic>r<sub>R</sub></italic> is the antibiotic resistance level (the proportion of antibiotics that are ineffective against P<sup>R</sup>). Modeling the latter as a continuous proportion reflects that bacteria are not necessarily fully drug-sensitive (<italic>r<sub>R</sub></italic> = 0) nor -resistant (<italic>r<sub>R</sub></italic> = 1), but can range in their sensitivity to different antibiotics (0 ≤ <italic>r<sub>R</sub></italic> ≤ 1). The resistance level <italic>r<sub>R</sub></italic> is thus a model input interpreted as an overall measure of the pathogen’s innate degree of resistance to the particular antibiotics to which it is exposed.</p><p>Following models build upon these assumptions, representing the same pathogen P<sup>R</sup>, but altering its ecological interactions with other bacteria from one model to the next. Models were evaluated over the same generic parameter space, to isolate impacts of model structure on epidemiological outcomes in the context of antibiotic use (see parameters in <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>).</p></sec><sec id="s2-1-2"><title>Antibiotic selection for resistance: the role of strain competition</title><p>Antibiotic consumption selects for the epidemiological spread of antibiotic-resistant bacteria (<xref ref-type="bibr" rid="bib32">Chatterjee et al., 2018</xref>). To explain this mechanistically, a classic modeling assumption is that selection results from intraspecific competition between two or more drug-sensitive strains P<sup>S</sup> and drug-resistant strains P<sup>R</sup> (<xref ref-type="bibr" rid="bib140">Spicknall et al., 2013</xref>). The reasoning goes: strains of the same species occupy the same ecological niche, so colonization with one strain inhibits colonization with another. In turn, antibiotics that preferentially clear P<sup>S</sup> render the within-host niche available to potential colonization with co-circulating P<sup>R</sup>, indirectly favouring P<sup>R</sup> spread through the host population. A simple two-strain ‘exclusive colonization’ model (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) can be written as:<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>where patients can be colonized (C<sup>S</sup>, C<sup>R</sup>) by either strain (P<sup>S</sup>, P<sup>R</sup>). Subscripts <italic>S</italic> and <italic>R</italic> denote strain-specific rates, accounting for ecological differences between strains (e.g. antibiotic resistance levels, fitness costs of resistance; see Appendix <xref ref-type="disp-formula" rid="equ3 equ4 equ5 equ6 equ7">Equations 3–7</xref>). Strains are labeled as sensitive or resistant, but here this is interpreted as relative (<italic>r<sub>S</sub></italic> &lt; <italic>r<sub>R</sub></italic>). For simplicity, patient demography (admission and discharge) is given as Δ<sub>j</sub> for each compartment <italic>j</italic>.</p><p>Unlike the single-strain Susceptible-Colonized model (<xref ref-type="fig" rid="fig1">Figure 1D and G</xref>), the strain competition model can explain how antibiotic consumption selects for the spread of resistance (<xref ref-type="fig" rid="fig1">Figures 1E,H</xref>). When P<sup>R</sup> is resistant to all antibiotics (<italic>r<sub>R</sub></italic> = 1), its prevalence increases monotonically with increasing antibiotic exposure (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>). When resistance is partial – when P<sup>R</sup> is still cleared by antibiotics, but at a lower rate than P<sup>S</sup> (<italic>r<sub>S</sub></italic> &lt; <italic>r<sub>R</sub> &lt;</italic> 1) – selection for resistance can peak at intermediate antibiotic exposure, owing to a trade-off in how antibiotics both clear and facilitate P<sup>R</sup>. As such, <italic>R</italic><sub>0</sub> for P<sup>R</sup> tends to increase with antibiotic use when P<sup>R</sup> is highly resistant to antibiotics (high <italic>r<sub>R</sub></italic>), but decrease when still largely sensitive (low <italic>r<sub>R</sub></italic>).</p><p>Most contemporary antibiotic resistance models are variants of this typology (<xref ref-type="bibr" rid="bib21">Blanquart, 2019</xref>; <xref ref-type="bibr" rid="bib140">Spicknall et al., 2013</xref>), but intraspecific strain competition is not the only mechanism by which antibiotic consumption can drive ARB spread (<xref ref-type="bibr" rid="bib90">Lipsitch and Samore, 2002</xref>), and may have limited relevance for certain species, settings, timescales and epidemiological indicators.</p></sec><sec id="s2-1-3"><title>Antibiotic selection for resistance: the role of microbiome competition</title><p>Antibiotic-induced microbiome dysbiosis is an alternative mechanism by which antibiotics may select for the spread of resistance. We propose a model in which (i) bacterial pathogens and commensal microbiota compete ecologically within the host, and (ii) antibiotic-induced dysbiosis disrupts these interactions, predisposing hosts to pathogen colonization. We consider three competitive within-host microbiome-pathogen interactions and conceptualize how they affect pathogen epidemiology (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="bibr" rid="bib26">Buffie et al., 2015</xref>; <xref ref-type="bibr" rid="bib70">Hooper et al., 2003</xref>; <xref ref-type="bibr" rid="bib74">Kamada et al., 2013a</xref>). First, a stable microbiome can act as a barrier preventing introduced pathogens from establishing colonies. We modeled this <italic>colonization resistance</italic> (ε) as a reduced rate of pathogen transmission (β) to hosts with stable microbiota, β<sub>ε</sub> = (1 – ε) × β. Second, co-colonizing bacteria can compete for space, nutrients and other limited resources within the host. In this case, antibiotics that reduce the density of potential competitors may favour pathogen persistence. We modeled this <italic>resource competition</italic> (η) as a reduced rate of pathogen clearance (γ) among hosts undergoing dysbiosis, γ<sub>η</sub> = (1 – η) × γ. Lastly, microbiome dysbiosis can favor the emergence or outgrowth of subdominant pathogen colonies, and this <italic>ecological release</italic> (ϕ) was modeled as an increased rate of endogenous pathogen acquisition (α) upon dysbiosis, α<sub>ϕ</sub> = ϕ × α.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Illustration of within-host ecological interactions between the host microbiome (blue) and a transmissible bacterial pathogen P<sup>R</sup> (yellow), and their impact on P<sup>R</sup>’s vital epidemiological parameters β (transmission rate), γ (clearance rate) and α (endogenous acquisition rate).</title><p>To illustrate the latter: sub-dominant, non-transmissible P<sup>R</sup> colonies inhibited by microbiota are represented by small cartoon pathogens, which can grow into dominant, transmissible colonies (large cartoon pathogens) via endogenous acquisition. Microbiome-pathogen interactions are assumed to differ between hosts with a stable microbiome at population dynamic equilibrium (left) and hosts experiencing antibiotic-induced microbiome dysbiosis (right). Interaction coefficients can be interpreted as terms explaining variation in host susceptibility to pathogen colonization, as depending on their recent history of antibiotic exposure. For interaction coefficient parameter values, broad intervals are assumed for the baseline analysis.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig2-v2.tif"/></fig><p>We integrate the microbiome, these three interactions, and antibiotic-induced microbiome dysbiosis into <xref ref-type="disp-formula" rid="equ19">Equation 1</xref>. The resulting ‘microbiome competition model’ (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) is given by<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>describing colonization (C<sup>R</sup>) with a single pathogen strain (P<sup>R</sup>) across two host types: patients with a microbiome at dynamic equilibrium (subscript <italic>e</italic>) and those undergoing dysbiosis (subscript <italic>d</italic>). Antibiotics induce dysbiosis at a rate σ<sub>m</sub> given by<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula>such that microbiome dysbiosis depends on both antibiotic exposure prevalence (<inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>) and the rate at which antibiotic exposure causes dysbiosis (θ<sub>m</sub>). Accordingly, the same level of antibiotic exposure (<inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>) can have asymmetric effects on microbiome stability (via θ<sub>m</sub>) and P<sup>R</sup> colonization (via (1 – <italic>r<sub>R</sub></italic>) × θ<sub>c</sub>, as in <xref ref-type="disp-formula" rid="equ2">Equation 2</xref>). Dysbiosis can result in long-term changes to microbiome composition, but ecological function and population dynamic stability tend to recover in the days or weeks following antibiotic therapy (<xref ref-type="bibr" rid="bib91">Lozupone et al., 2012</xref>), represented here by microbiome recovery rate δ.</p><p>Included microbiome-pathogen interactions predict in different ways how antibiotic consumption selects for the epidemiological spread of antibiotic-resistant bacterial pathogens (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Like strain competition, microbiome competition underlies a trade-off in antibiotic selection: P<sup>R</sup> prevalence and <italic>R</italic><sub>0</sub> increase monotonically with antibiotic exposure when P<sup>R</sup> is completely antibiotic-resistant (<italic>r<sub>R</sub></italic> = 1) (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>), but can peak at intermediate antibiotic exposure when resistance is partial (0 &lt; <italic>r<sub>R</sub></italic> &lt; 1) because antibiotics simultaneously clear pathogen colonization and induce greater host susceptibility through dysbiosis (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). This trade-off is more pronounced when multiple interactions are combined: when microbiota simultaneously limit multiple colonization processes (transmission, emergence, persistence), patients with stable microbiota are more protected from P<sup>R</sup> colonization, but antibiotic use is predicted to have greater epidemiological costs, selecting more strongly for P<sup>R</sup> spread (<xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>).</p></sec><sec id="s2-1-4"><title>Antibiotic selection for resistance: combining strain and microbiome competition</title><p>Strain competition and microbiome competition are not mutually exclusive: when combined in a two-strain ‘microbiome-strain competition’ model, different strains of the same pathogen species compete for hosts whose microbiota and history of antibiotic consumption influence susceptibility to colonization. We assume that microbiome-pathogen interactions are species- and not strain-specific, that is that ε, η and ϕ apply equally to P<sup>S</sup> and P<sup>R</sup>. This is given by:<disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Introducing a drug-sensitive strain P<sup>S</sup> to the microbiome model dampens <italic>R</italic><sub>0</sub> of the focal strain P<sup>R</sup>, because fewer patients are susceptible to colonization when the competing strain co-circulates in the population (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3</xref>). However, antibiotic use makes way for P<sup>R</sup> not only through preferential clearance of P<sup>S</sup>, but remaining P<sup>R</sup> also benefit from increased host susceptibility to colonization when antibiotics cause dysbiosis. Accordingly, antibiotics that both disrupt host microbiota and clear drug-sensitive pathogen strains tend to select more strongly for the spread of resistant strains than antibiotics that only target one or the other (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Overall, antibiotics with stronger impacts on pathogen clearance (higher θ<sub>C</sub>) lead to increased resistance rates, while consequences for P<sup>R</sup> colonization prevalence are modest and depend on potential interactions with the microbiome. Conversely, antibiotics with stronger impacts on microbiome stability (higher θ<sub>m</sub>) lead to higher prevalence, with only modest effects on resistance rates. Further, impacts of antibiotic treatment on resistance rates are greater when P<sup>R</sup> resists a greater share of antibiotics (higher <italic>r<sub>R</sub></italic>), while impacts on prevalence are greater when microbiome-pathogen interactions are stronger (higher ε, η, ϕ) (<xref ref-type="fig" rid="app1fig4">Appendix 1—figure 4</xref>). Different microbiome-pathogen interactions also underlie distinct dynamic responses to theoretical public health interventions. For the same generic pathogen P<sup>R</sup>, antibiotic stewardship interventions generally, but do not always prevent colonization, with predictions depending on the ecological interactions in effect (e.g. strain competition, microbiome competition), the impact of the intervention (e.g. reduced microbiome disruption, reduced overall prescribing), and the epidemiological outcome considered (e.g. colonization prevalence, resistance rate) (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Strain competition and microbiome competition as simultaneous forces of antibiotic selection, with asymmetric impacts on epidemiological indicators.</title><p>In a mixed microbiome-strain competition model (<xref ref-type="disp-formula" rid="equ6">Equation 6</xref>), colonization prevalence of P<sup>R</sup> (C<sup>R</sup>; circle size) and the pathogen’s resistance rate (C<sup>R</sup>/(C<sup>S</sup> + C<sup>R</sup>); color) depend on the relative rates at which antibiotics disrupt microbiota (θ<sub>m</sub>) and clear pathogen colonization (θ<sub>c</sub>). Antibiotics with a stronger effect on pathogen clearance (higher θ<sub>c</sub>) increase the resistance rate, while antibiotics with a stronger effect on microbiota (higher θ<sub>m</sub>) increase prevalence.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig3-v2.tif"/></fig></sec><sec id="s2-1-5"><title>Antibiotic selection for resistance: introducing interspecific horizontal gene transfer</title><p>Horizontal transfer of resistance-encoding genes may also contribute to hospital resistance dynamics (<xref ref-type="bibr" rid="bib57">Evans et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Lerminiaux and Cameron, 2019</xref>). We extend our model to include interspecific HGT, conceptualized as two-way within-host transfer of a focal resistance gene, either from a resistant pathogen strain P<sup>R</sup> to co-colonizing microbiota, or from resistance-bearing microbiota to a co-colonizing drug-sensitive pathogen strain P<sup>S</sup>. (See final model and assumptions, Appendix <xref ref-type="disp-formula" rid="equ9">Equations A1–A11</xref>). Overall, an increasing rate of within-host HGT (χ) is found to drive increasing P<sup>R</sup> prevalence (C<sup>R</sup>), regardless of other microbiome-pathogen interactions (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Under our modeling assumptions, HGT-driven gains in C<sup>R</sup> result from symmetric declines in C<sup>S</sup>, such that HGT’s potential impact depends on the presence of both sufficient resistance donors and sufficient recipients. This results in non-linear feedbacks between HGT and other processes that drive strain prevalence (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref>). For instance, impacts of HGT on C<sup>R</sup> are greatest at intermediate antibiotic exposure (<inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>). This is linked to another antibiotic selection trade-off: higher <inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> affords a selective advantage to P<sup>R</sup> relative to P<sup>S</sup>, increasing the potential impact of HGT on C<sup>R</sup>; but higher <inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> also reduces the pool of recipient C<sup>S</sup>, ultimately limiting HGT’s ability to drive C<sup>R</sup>.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Impacts of horizontal gene transfer (HGT) on antibiotic selection for resistance.</title><p>Allowing a resistance gene to transfer horizontally increases prevalence (top row) of the strain P<sup>R</sup> that bears the gene, as well as its resistance rate (bottom row). The relative impact of HGT depends on the gene’s rate of transfer (χ, line type), antibiotic exposure prevalence (<inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, x-axis), competitive interactions between pathogen strains and host microbiota (colors), the level of resistance conferred by the gene (<italic>r<sub>R</sub></italic>, columns), and any other parameters that drive the dynamics of donor and recipient strains. We assume that χ<sub>d</sub>/χ<sub>e</sub> = 10, such that the low HGT rate corresponds to {χ<sub>e</sub>=0.01 day<sup>−1</sup>, χ<sub>d</sub>=0.1 day<sup>−1</sup>} and the high rate to {χ<sub>e</sub>=0.1 day<sup>−1</sup>, χ<sub>d</sub>=1 day<sup>−1</sup>}. Impacts of HGT on colonization incidence are shown in <xref ref-type="fig" rid="app1fig6">Appendix 1—figure 6</xref>. Alternative HGT assumptions are explored in <xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7A</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig4-v2.tif"/></fig></sec></sec><sec id="s2-2"><title>Part 2: Model application to high-risk nosocomial pathogens</title><p>We applied this modeling framework to simulate colonization dynamics of four nosocomial pathogens in the hospital setting: <italic>C. difficile</italic>, methicillin-resistant <italic>S. aureus</italic> (MRSA), extended-spectrum beta-lactamase-producing <italic>E. coli</italic> (ESBL-EC), and carbapenemase-producing <italic>K. pneumoniae</italic> (CP-KP). Data from the literature were used to parameterize the model to each pathogen (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5</xref>, <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>–<xref ref-type="table" rid="app1table6">6</xref>). Literature estimates for microbiome-pathogen interaction coefficients are scarce, and the species-specific relevance of different within-host interactions (intraspecific strain competition, microbiome competition, HGT) in the hospital environment are not well-defined. To characterize ecological interactions for each species and inform model structure, we conducted interviews with a panel of subject-matter experts in medical microbiology and antibiotic resistance epidemiology (details in Materials and methods). Based on their beliefs, all pathogens were assumed to compete with microbiota; MRSA, ESBL-EC and CP-KP were further assumed to compete intra-specifically with non-focal strains, for simplicity characterized as methicillin-sensitive <italic>S. aureus</italic> (MSSA), <italic>E. coli</italic> (EC), and <italic>K. pneumoniae</italic> (KP); and both ESBL resistance and carbapenem resistance were assumed to be borne by plasmids capable of horizontal transfer between patient microbiota and, respectively, EC and KP (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). To quantify species-specific strengths of microbiome-pathogen interactions, within-host ecological parameters were translated into clinical parameters (<xref ref-type="table" rid="app1table7">Appendix 1—table 7</xref>), and experts were asked to quantify these using standardized expert elicitation methodology (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="app1fig8">Appendix 1—figures 8</xref>–<xref ref-type="fig" rid="app1fig10">10</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Characterizing the species-specific ecology of four selected antibiotic-resistant bacterial pathogens in the hospital setting.</title><p>(<bold>A</bold>) Model structure: the within-host ecological interactions assumed for each pathogen, based on expert elicitation. (<bold>B</bold>) Simulation inputs: 95% distributions for selected model parameters drawn stochastically over 10,000 runs (all parameter distributions in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>–<xref ref-type="table" rid="app1table6">6</xref>). (<bold>C</bold>) The distribution of antibiotic classes consumed in French hospitals in 2016 (<xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>), shaded by their assumed impact on intestinal microbiome dysbiosis. Inset: the cumulative impact of each antibiotic class (given as ATC codes, see <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref> for corresponding names) on dysbiosis (<italic>a<sub>j</sub></italic> × <italic>e<sup>-k</sup></italic>, see <xref ref-type="disp-formula" rid="equ7">Equation 7</xref>); circle size represents each class’s contribution to exposure prevalence (<italic>a<sub>j</sub></italic>). (<bold>D</bold>) Antibiograms for each pathogen strain and antibiotic class, adapted from the Therapeutics Education Collaboration (<xref ref-type="bibr" rid="bib101">McCormack and Lalji, 2015</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig5-v2.tif"/></fig><p>Colonization dynamics for each ARB were modeled against a common backdrop of antibiotic consumption. This was parameterized at the level of antibiotic class, using national data from French hospitals in 2016 (<xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref>; <xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>). Using data from the literature, antibiotic classes were assumed to vary in their impact on microbiome dysbiosis (very low, low, medium, or high rate of inducing dysbiosis) and on each pathogen strain (classified as sensitive, intermediate, or resistant) (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>; <xref ref-type="bibr" rid="bib10">Baggs et al., 2018</xref>; <xref ref-type="bibr" rid="bib25">Brown et al., 2013</xref>; <xref ref-type="bibr" rid="bib101">McCormack and Lalji, 2015</xref>). For each of 10,000 Monte Carlo simulations, in which parameter values were sampled randomly from their respective probability distributions, epidemiological outcomes were evaluated at population dynamic equilibrium. For all outcomes, we compare results from simulations that include microbiome-pathogen interactions and dysbiosis (‘microbiome simulations’) and those that exclude them (‘single-species simulations’). Multivariate sensitivity analyses were also conducted, using partial rank correlation coefficients (PRCCs) to evaluate impacts of parameter uncertainty on model outcomes (details in Methods).</p><sec id="s2-2-1"><title>Species-specific hospital colonization dynamics</title><p>Across simulations, <italic>C. difficile</italic> was the most prevalent pathogen (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), MRSA had the highest resistance rate (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), and ESBL-EC had the highest rate of incidence within the hospital (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). CP-KP had the lowest prevalence, resistance rate and incidence, but was the pathogen most favoured by the hospital environment, its prevalence increasing by approximately 5.4-fold (95% uncertainty interval: 2.1–10.9) among hospital patients relative to baseline prevalence in the community (<xref ref-type="fig" rid="app1fig12">Appendix 1—figure 12A</xref>). For pathogens subject to intraspecific strain competition, resistance rates in the hospital also tended to exceed rates in the community (<xref ref-type="fig" rid="app1fig12">Appendix 1—figure 12B</xref>). Patient-to-patient transmission was the primary route of MRSA acquisition, while endogenous acquisition was the primary route for the enteric pathogens <italic>C. difficile</italic>, ESBL-EC and CP-KP (<xref ref-type="fig" rid="app1fig13">Appendix 1—figure 13</xref>). HGT played a potentially important but highly uncertain role for ESBL-EC and CP-KP, accounting for 8.7% (&lt;0.01–49.7%) and 2.1% (&lt;0.01–22.8%) of acquisition events, respectively. In multivariate sensitivity analysis, community prevalence (<italic>f<sub>C</sub></italic> for <italic>C. difficile</italic>, <italic>f<sub>R</sub></italic> for others) and rates of endogenous acquisition (α<sub>R</sub>) had overall the strongest positive impacts (highest PRCCs) on hospital colonization prevalence across ARB, while rates of hospital admission/discharge (μ) and microbiome recovery (δ) had the strongest negative impacts (lowest PRCCs; <xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14A</xref>). For resistance rates, parameters with the strongest positive impacts (highest PRCCs) were community prevalence (<italic>f<sub>R</sub></italic>), the rate of endogenous acquisition (α<sub>R</sub>) and the rate of antibiotic-induced pathogen clearance (θ<sub>C</sub>). Parameters with the strongest negative impacts (lowest PRCCs) were rates of hospital admission/discharge (μ) and endogenous acquisition of competing drug-sensitive strains (α<sub>S</sub>) (<xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14B</xref>). Across ARB, prevalence estimates, but not resistance rates, were generally sensitive to microbiome parameters.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Baseline steady-state pathogen colonization outcomes.</title><p>(<bold>A</bold>) Colonization prevalence, the percentage of patients colonized with the focal strain. Dashed lines (model inputs) represent assumed community prevalence, that is the proportion of patients already colonized upon hospital admission (see <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref>–<xref ref-type="table" rid="app1table6">6</xref>). Solid lines represent simulated prevalence within the hospital, as resulting from both importation from the community and within-hospital epidemiology. (<bold>B</bold>) Resistance rates, the proportion of <italic>S. aureus</italic> carriers bearing methicillin-resistant strains, <italic>E. coli</italic> carriers bearing ESBL-producing strains, and <italic>K. pneumoniae</italic> carriers bearing carbapenemase-producing strains. As in panel A, dashed lines (model inputs) represent assumed community resistance rates, and solid lines represent simulated resistance rates within the hospital. (<bold>C</bold>) Pathogen incidence (daily rate of within-hospital colonization acquisition), stratified by route of acquisition. Points (in panels A and B) and bar height (panel C) represent medians, and error bars represent 95% uncertainty intervals across 10,000 Monte Carlo simulations. For comparison, the same information for single-species simulations excluding the microbiome is presented in <xref ref-type="fig" rid="app1fig11">Appendix 1—figure 11</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig6-v2.tif"/></fig></sec><sec id="s2-2-2"><title>Microbiome ecology underlies epidemiological responses to public health interventions</title><p>We simulated three types of public health intervention, each across three levels of intervention compliance: (i) contact precautions, which reduced transmission rates of all strains by 20%, 35%, or 50%; (ii) antibiotic stewardship interventions, which reduced or modified hospital antibiotic consumption patterns by 20%, 35%, or 50%; and (iii) a theoretical ‘microbiome recovery therapy’ intervention that facilitates recovery from dysbiosis. We assumed a mean 2 day delay to microbiome recovery, and compliance levels corresponding to use among 10%, 30%, or 50% of antibiotic-exposed patients (see Materials and methods). Intervention efficacy was evaluated using: reduction in colonization incidence, 1 – IRR (where IRR is the incidence rate ratio of post-intervention to pre-intervention incidence); and reduction in the resistance rate, 1 – RRR (where RRR is the resistance rate ratio, the ratio of the post-intervention to pre-intervention resistance rate).</p><p>Efficacies of simulated interventions varied considerably by pathogen and type of intervention (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Contact precautions were highly effective for reducing MRSA incidence, of intermediate efficacy for <italic>C. difficile</italic>, and minimally effective for ESBL-EC and CP-KP. Contact precautions had comparatively little impact on resistance rates, with a median 2–4% reduction across simulations and compliance levels for MRSA, 0–2% for CP-KP and negligible impact for ESBL-EC (<xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>). These interventions were overall less effective in microbiome simulations, which tended to limit the role of between-host transmission (via colonization resistance) and favor the role of endogenous acquisition (via ecological release) in the hospital environment when compared to single-species simulations (<xref ref-type="fig" rid="app1fig13">Appendix 1—figure 13</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The microbiome drives pathogen-specific responses to simulated public health interventions (left panels, contact precautions; middle, antibiotic stewardship; right, microbiome recovery therapy).</title><p>Top panels show results from simulations using classical ‘single-species models’ that only account for the focal pathogen species (including intraspecific strain competition for MRSA, ESBL-EC and CP-KP); bottom panels show simulation results when models also include microbiome-pathogen interactions and antibiotic-induced microbiome dysbiosis. For each intervention, three levels of intervention compliance (shading) are simulated. For antibiotic stewardship, simulation results are pooled across three different types of stewardship (see <xref ref-type="fig" rid="app1fig17">Appendix 1—figure 17</xref>). Points correspond to medians, and bars to 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-fig7-v2.tif"/></fig><p>Antibiotic stewardship interventions led to substantial reductions in nosocomial incidence for all pathogens, but only when the microbiome was taken into account (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Unlike contact precautions, which only reduced incidence via transmission, stewardship reduced incidence through all acquisition routes, including HGT (<xref ref-type="fig" rid="app1fig16">Appendix 1—figure 16</xref>). Overall efficacy estimates and species-specific responses were similar across three types of stewardship considered (<xref ref-type="fig" rid="app1fig17">Appendix 1—figure 17</xref>). Pooling these together under intermediate compliance, colonization incidence was reduced by a median 20% for CP-KP, 18% for C. difficile, 15% for ESBL-EC, and 10% for MRSA. Single-species simulations excluding microbiome competition predicted negligible efficacy of all stewardship interventions for reducing incidence, and non-efficacy for <italic>C. difficile</italic>. Stewardship interventions also had a substantial impact on resistance rates, with overall greater reductions for CP-KP than MRSA and ESBL-EC, and similar outcomes across microbiome and single-species simulations (<xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>).</p><p>Lastly, microbiome recovery therapy was potentially highly effective for limiting pathogen incidence, but efficacy varied greatly across different levels of intervention compliance (<xref ref-type="fig" rid="fig7">Figure 7</xref>). This intervention was most effective against <italic>C. difficile</italic>, of similar efficacy against ESBL-EC and CP-KP, and comparatively least effective against MRSA. Across pathogens, microbiome recovery therapy reduced incidence through all acquisition routes,(<xref ref-type="fig" rid="app1fig16">Appendix 1—figure 16</xref>) but had no clear impact on resistance rates (<xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>).</p></sec></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Antibiotics are essential medicines for the treatment and prevention of bacterial infections, but their use selects for the spread of pathogenic antibiotic-resistant bacteria (ARB), and can inadvertently disrupt the host microbiome and its associated immune function (<xref ref-type="bibr" rid="bib27">Buffie and Pamer, 2013</xref>; <xref ref-type="bibr" rid="bib32">Chatterjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kim et al., 2017</xref>). Within-host ecological interactions between co-colonizing bacteria can have important consequences for their colonization dynamics, which likely extend to influence the epidemiology of human pathogens in clinical settings. Yet microbiome ecology remains largely absent from the epidemiological modeling of antibiotic resistance (<xref ref-type="bibr" rid="bib6">Assab et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Birkegård et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Blanquart, 2019</xref>; <xref ref-type="bibr" rid="bib111">Niewiadomska et al., 2019</xref>), suggesting a need to better understand within-host competition between ARB and the host microbiome, its potential epidemiological consequences, and more broadly how antibiotics exert selection pressure on resistant bacteria (<xref ref-type="bibr" rid="bib82">Knight et al., 2019</xref>). We present a modeling framework that includes within-host ecological costs of antibiotic use in the form of microbiome dysbiosis, incorporating a leading hypothesis for antibiotic selection into classical models of resistance epidemiology (<xref ref-type="bibr" rid="bib7">Austin et al., 1997</xref>; <xref ref-type="bibr" rid="bib90">Lipsitch and Samore, 2002</xref>). We formalize three examples of microbiome-pathogen competition potentially affected by dysbiosis, and show how they, either separately or in combination with other forces of selection, help explain how antibiotic use drives the spread of ARB in healthcare settings. We use probabilistic simulations to apply this framework across a panel of characteristic nosocomial pathogens and compare results to a traditional strain-based framework, demonstrating utility of a microbiome-oriented approach for modeling antibiotic resistance epidemiology and associated interventions.</p><p>MRSA, <italic>C. difficile</italic> and ESBL-producing Enterobacteriaceae are leading causes of antibiotic-resistant and healthcare-associated infection, while carbapenemase-producing Enterobacteriaceae represent emerging threats of particular concern due to limited therapeutic options for effective treatment of invasive infection (<xref ref-type="bibr" rid="bib30">Cassini et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Jernigan et al., 2020</xref>; <xref ref-type="bibr" rid="bib105">Miller et al., 2011</xref>; <xref ref-type="bibr" rid="bib126">Rodríguez-Baño et al., 2018</xref>). Antibiotic stewardship is a core component of public health efforts to limit the emergence and spread of these ARB in clinical settings (<xref ref-type="bibr" rid="bib16">Baur et al., 2017</xref>), and an important focus of antibiotic resistance modeling (<xref ref-type="bibr" rid="bib111">Niewiadomska et al., 2019</xref>). Different antibiotics vary in which organisms they intrinsically target, as well as pharmacodynamic factors like route of administration (e.g. oral vs. systemic), clearance mechanism (e.g. biliary vs. renal excretion) and site of absorption (e.g. small vs. large intestine). These differences affect the degree to which bacteria in different host niches are exposed to and cleared by different antibiotics, and are increasingly well described (<xref ref-type="bibr" rid="bib18">Bhalodi et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib156">Zhang et al., 2015</xref>). Our findings suggest that asymmetric impacts of different antibiotics on competing commensal and pathogenic bacteria can drive antibiotic-driven selection for these high-risk ARB, with important consequences for resistance dynamics and stewardship efficacy.</p><p>Findings also suggest promise for interventions that effectively restore microbiome stability and associated colonization resistance as a means to control ARB spread. Fecal microbiota transplantation is already used to treat recurrent <italic>C. difficile</italic> infection, and is under investigation for multidrug-resistant Enterobacteriaceae decolonization (<xref ref-type="bibr" rid="bib39">Davido et al., 2019a</xref>; <xref ref-type="bibr" rid="bib77">Kassam et al., 2013</xref>; <xref ref-type="bibr" rid="bib130">Saha et al., 2019</xref>). However, its appropriateness for dysbiosis recovery in the absence of other clinical indications is unclear. Transplantation requires rigorous donor screening and close longitudinal follow-up, and cases of donor stool contaminated with toxicogenic and multidrug-resistant bacteria highlight non-negligible risks (<xref ref-type="bibr" rid="bib66">Gupta et al., 2021</xref>; <xref ref-type="bibr" rid="bib155">Zellmer et al., 2021</xref>). Alternative microbiome protective therapies now exist, like DAV132, a novel activated-charcoal product currently undergoing clinical trials. When co-administered with antibiotics by the oral route, DAV132 has been shown to absorb antibiotic residues in the colon and preserve the richness and composition of intestinal microbiota, while maintaining systemic antibiotic exposure (<xref ref-type="bibr" rid="bib44">de Gunzburg et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">de Gunzburg et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Pinquier et al., 2021</xref>). Modeling has been used previously to evaluate impacts of such microbiome-oriented interventions at the within-host level (<xref ref-type="bibr" rid="bib64">Guittar et al., 2021</xref>; <xref ref-type="bibr" rid="bib65">Guk et al., 2021</xref>), but knock-on impacts on ARB transmission dynamics and epidemiological burden are unknown. Our simulations were limited to a select few ARB, but our framework and findings likely have relevance for other bacteria known to interact with the microbiome, including vancomycin-resistant Enterococci and other multidrug-resistant Enterobacteriaceae (<xref ref-type="bibr" rid="bib40">Davido et al., 2019b</xref>; <xref ref-type="bibr" rid="bib141">Stecher et al., 2013</xref>). and could be further extended to explore impacts of the microbiome on resistance dynamics and intervention efficacy beyond healthcare settings.</p><p>Our simulations predicted colonization dynamics broadly consistent with previous findings from the literature. Input from the community was the main driver of hospital prevalence, and both prevalence and resistance rates tended to increase in the hospital relative to the community, as estimated in previous modeling studies (<xref ref-type="bibr" rid="bib81">Knight et al., 2018</xref>; <xref ref-type="bibr" rid="bib95">MacFadden et al., 2019</xref>). Findings reflected an important role for between-host nosocomial transmission for MRSA, as observed clinically (<xref ref-type="bibr" rid="bib78">Khader et al., 2019</xref>; <xref ref-type="bibr" rid="bib109">Nadimpalli et al., 2020</xref>), and a comparatively important role for endogenous acquisition for enteric ARB, as estimated elsewhere (<xref ref-type="bibr" rid="bib22">Bootsma et al., 2007</xref>; <xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref>). Our estimates of intervention efficacy were more consistent with previous findings from the literature when microbiome interactions were taken into account. Contact precautions were effective for reducing incidence of MRSA and to a lesser extent <italic>C. difficile</italic>, but had limited impact against Enterobacteriaceae, consistent with clinical trials and modeling estimates. (<xref ref-type="bibr" rid="bib79">Khader et al., 2021</xref>; <xref ref-type="bibr" rid="bib92">Luangasanatip et al., 2015</xref>; <xref ref-type="bibr" rid="bib97">Maechler et al., 2020</xref>). By contrast, simulated antibiotic stewardship interventions were broadly effective for reducing incidence across all included ARB. This is consistent with findings from a meta-analysis of clinical trials evaluating the efficacy of hospital antibiotic stewardship interventions for reducing incidence of ARB colonization and infection (<xref ref-type="bibr" rid="bib16">Baur et al., 2017</xref>), which we updated to exclude studies co-implementing stewardship with alternative interventions (<xref ref-type="fig" rid="app1fig18">Appendix 1—figure 18</xref>). In comparison to our findings, estimates from the meta-analysis were associated with greater uncertainty across more heterogeneous interventions, but predicted the same rank order of efficacy across included ARB, and similar mean efficacy for <italic>C. difficile</italic> (19% from n=seven studies, vs. 18% under intermediate compliance in our simulations), ESBL-EC (18% from n=four studies, vs. 15%) and MRSA (12% from n=10 studies, vs. 10%), but higher efficacy for CP-KP (54% from n=one study, vs. 20%).</p><p>When excluding microbiome interactions, simulations predicted negligible efficacy of antibiotic stewardship interventions for controlling ARB incidence. Previous models have predicted efficacy using predominantly strain-based approaches, but often focus on resistance rates as the primary outcome, and in many cases assume that patient-to-patient transmission is the only route of colonization acquisition (<xref ref-type="bibr" rid="bib111">Niewiadomska et al., 2019</xref>). Here, microbiome competition was found to have a large impact on incidence but comparatively little impact on resistance rates – both for the theoretical pathogen evaluated in Part 1 (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref>) and for the four ARB simulated in Part 2 (<xref ref-type="fig" rid="app1fig12">Appendix 1—figures 12</xref> and <xref ref-type="fig" rid="app1fig14">14</xref>) – underlying why stewardship interventions were of similar efficacy for reducing resistance rates across single-species and microbiome simulations (<xref ref-type="fig" rid="app1fig15">Appendix 1—figure 15</xref>). This reflects the importance of different forces of antibiotic selection for different epidemiological outcomes: while strain-based competition explains relative ecological dynamics of co-circulating strains, microbiome interactions may be better suited to explain how increasing antibiotic use favours ARB incidence, and how antibiotic stewardship and microbiome recovery interventions can help prevent colonization acquisition.</p><p>Under strain competition, pathogen colonization is limited by closely related strains sharing an ecological niche, with the same approximate epidemiological profile and transmission characteristics. Competition against ARB is assumed to depend on the epidemic spread of competing strains, and removal of drug-sensitive strains releases antibiotic selection for resistance. By contrast, microbiome population structure is inherently stable, depending less on the epidemiological transmission of particular taxa, and more on host factors like diet, maternal inheritance, genetics, and antibiotic exposure (<xref ref-type="bibr" rid="bib24">Brito and Alm, 2016</xref>). Despite great inter-individual diversity in microbiome composition, there is functional redundancy from one host to the next, such that colonization resistance and other forms of microbiome competition are shared across healthy hosts colonized with different taxa (<xref ref-type="bibr" rid="bib13">Bashan et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Kim et al., 2017</xref>). For these reasons, microbiome stability is modeled as a host trait reflecting the functional ecology of the microbiome in different population dynamic states, as opposed to a more traditional bacterial colonization process governed by rates of acquisition and clearance. This is clearly an oversimplification of real microbiome dynamics and complexity (<xref ref-type="bibr" rid="bib69">Hooks and O’Malley, 2017</xref>), but is a useful approximation for the needs of epidemiological modeling, particularly in the absence of data, and reflects the universality of both human microbiome function and of the ecological impacts that antibiotics have on microbiome stability (<xref ref-type="bibr" rid="bib13">Bashan et al., 2016</xref>).</p><p>Previous studies have modeled antibiotic exposure as a risk factor for ARB colonization, which can be interpreted as indirectly accounting for microbiome dysbiosis. In transmission models of <italic>C. difficile</italic>, ESBL-EC and <italic>Pseudomonas aeruginosa</italic>, among others, patients undergoing antibiotic therapy are assumed to be at greater risk of colonization and/or infection (<xref ref-type="bibr" rid="bib60">Gingras et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Hurford et al., 2012</xref>; <xref ref-type="bibr" rid="bib95">MacFadden et al., 2019</xref>). An alternative approach has been to use antibiotic exposure as a coefficient on epidemiological parameters (e.g. transmission, endogenous acquisition), allowing ARB colonization rates to scale with antibiotic use (<xref ref-type="bibr" rid="bib81">Knight et al., 2018</xref>). These strategies reflect widespread recognition that antibiotic use favours ARB acquisition, through erosion of colonization resistance or other supposed mechanisms, and independent of potential competition with other strains. The present work formalizes examples of the microbiome-pathogen interactions that underlie these assumptions, demonstrating their relevance to various epidemiological outcomes, distinguishing them from strain-based selection, and providing a framework for their application.</p><p>This study has a number of limitations. First, hospitals and healthcare settings are heterogeneous environments with non-random contact patterns and relatively small population sizes. Stochastic, individual-based models accounting for these factors reproduce more realistic nosocomial transmission dynamics than deterministic ODE simulations, allowing for local extinction events, super-spreaders, and other inherently random epidemiological phenomena. Nonetheless, our goal was to study how ecological mechanisms impact average epidemiological outcomes in the context of different model assumptions and parameter uncertainty, and in this context, ODE modeling was the more appropriate tool, particularly for widely endemic ARB like <italic>C. difficile</italic>, MRSA and ESBL-EC. Still, further insights could certainly be gained by accounting for additional complexity and stochastic heterogeneity in future work, from within-host spatial organization (<xref ref-type="bibr" rid="bib55">Estrela et al., 2015</xref>), to patient and staff contact behavior (<xref ref-type="bibr" rid="bib53">Duval et al., 2019</xref>), to inter-institutional or inter-ward meta-population dynamics (<xref ref-type="bibr" rid="bib133">Shapiro et al., 2020</xref>). These distinctions may be particularly important for rare or non-endemic ARB (e.g. CP-KP in some regions). Second, our evaluation of strain competition was limited to exclusive colonization, a widely used approach (an estimated 12% of published strain competition models allow co-colonization or -infection) (<xref ref-type="bibr" rid="bib111">Niewiadomska et al., 2019</xref>). Yet alternative models predict unique impacts on resistance dynamics (<xref ref-type="bibr" rid="bib140">Spicknall et al., 2013</xref>), and explicit consideration of higher resolution within-host population dynamics has been shown to better reproduce empirical findings in previous work (<xref ref-type="bibr" rid="bib41">Davies et al., 2019</xref>). Further, our exclusive colonization approach precluded assessment of intraspecific HGT, which may have different impacts on resistance dynamics than interspecific HGT.</p><p>Third, Monte Carlo simulations were limited by the availability of species-specific model parameters from the literature, in some instances necessitating use of previous modeling results, approximations, or estimates from small studies in specific locations, making the generalizability of results unclear. For instance, Khader et al. estimated a four-fold difference in MRSA transmission rates between hospitals and nursing homes (<xref ref-type="bibr" rid="bib78">Khader et al., 2019</xref>). Such differences could have a substantial impact on dynamics and estimated intervention efficacy, with higher transmission rates favouring use of contact precautions, and higher rates of endogenous acquisition favouring antibiotic stewardship (in the context of a high ecological release coefficient). Uncertainty in endogenous acquisition rates may be particularly important: in multivariate sensitivity analyses, this parameter emerged as a key driver of both colonization prevalence and resistance rates across ARB (<xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14</xref>). Further, data used to estimate class-specific rates of microbiome dysbiosis are specific to the gut; class-specific data for dysbiosis of the skin, the preferred niche of <italic>S. aureus</italic>, were not available. This may over-estimate impacts of dysbiosis on MRSA colonization dynamics.</p><p>Finally, the nature of microbiome-pathogen interactions and their epidemiological consequences remain poorly understood and largely unquantified. We show in theory why these interactions matter at the population level, but empirical data were unavailable to inform their parameterization. Instead, we translated microbiome-pathogen competition coefficients into clinical parameters, designed a structured expert elicitation protocol, and conducted interviews allowing subject-matter experts to quantify their beliefs. Although these estimates are subject to substantial bias and uncertainty, they facilitated species-specific characterization of the epidemiological impact of microbiome dysbiosis, and represent useful proxy measures in the absence of clinical data. More broadly, our characterizations of microbiome-pathogen interactions are conceptual, and were mapped mechanistically to particular colonization processes (transmission, clearance, endogenous acquisition), but we note that in other contexts terms like <italic>colonization resistance, resource competition</italic> and <italic>ecological release</italic> may map to specific biochemical processes that could affect epidemiological parameters in different ways.</p><p>Despite data limitations, epidemiological conclusions from Monte Carlo simulations were largely consistent with empirical findings (discussed above), suggesting that final parameter distributions were reasonable approximations. Uncertainty in parameter inputs translated to uncertainty in model outputs, reflecting the knowledge gaps underlying our simulations (<xref ref-type="fig" rid="app1fig14">Appendix 1—figure 14</xref>). This is exemplified by HGT and its highly uncertain role in driving colonization incidence; to date, HGT modeling has largely been limited to within-host dynamics, and impacts on epidemiological dynamics are only just beginning to come to light (<xref ref-type="bibr" rid="bib57">Evans et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Leclerc et al., 2019</xref>; <xref ref-type="bibr" rid="bib87">Lerminiaux and Cameron, 2019</xref>). Increasing availability and synthesis of high-quality within-host microbiological data will help to further characterize epidemiological impacts of microbiome-pathogen interactions. Studies are needed that describe ecological impacts of antibiotic exposure on microbiome population structure across control and treatment groups, with longitudinal follow-up evaluating subsequent nosocomial ARB colonization risk. In the absence of clinical data, insights from experiments and within-host models nonetheless suggest that antibiotic disruption of microbiome-pathogen competition is a key driver of selection for resistance (<xref ref-type="bibr" rid="bib14">Baumgartner et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Estrela and Brown, 2018</xref>; <xref ref-type="bibr" rid="bib113">O’Brien et al., 2021</xref>; <xref ref-type="bibr" rid="bib134">Shaw et al., 2019</xref>; <xref ref-type="bibr" rid="bib142">Stein et al., 2013</xref>; <xref ref-type="bibr" rid="bib147">Tepekule et al., 2019</xref>). The present work highlights the importance of extending these within-host concepts to the population level. Links between within- and between-host dynamics have been widely studied in various contexts, including the theory underlying the evolution of parasite life history and antimicrobial resistance (<xref ref-type="bibr" rid="bib42">Day et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Greischar et al., 2019</xref>; <xref ref-type="bibr" rid="bib158">zur Wiesch et al., 2011</xref>), but remain largely absent from clinical models of antibiotic resistance (<xref ref-type="bibr" rid="bib21">Blanquart, 2019</xref>). A clear extension of the present work is to explicitly account for simultaneous within- and between-host processes using nested models (<xref ref-type="bibr" rid="bib19">Birkegård et al., 2018</xref>; <xref ref-type="bibr" rid="bib111">Niewiadomska et al., 2019</xref>). However, such models do not necessarily provide more epidemiological clarity, especially when data are lacking and simple heuristic parameters can capture epidemiological consequences of within-host processes (<xref ref-type="bibr" rid="bib61">Gog et al., 2015</xref>; <xref ref-type="bibr" rid="bib104">Mideo et al., 2008</xref>).</p><p>In conclusion, we have proposed a mathematical modeling framework for the epidemiology of antibiotic-resistant bacteria that accounts for their potential interactions with the host microbiome. This model simplifies into accessible epidemiological parameters what are in reality highly complex ecological systems, comprising a staggering diversity of microbes and interactions among them. We demonstrate that accounting for at least some of this ecological complexity may help to explain how antibiotics select for the epidemiological spread of resistance, how antibiotic stewardship works to reduce pathogen colonization incidence, and how interventions favouring healthy microbiome function may help to mitigate the epidemiological burden of antibiotic resistance.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mathematical models of bacterial colonization</title><p>We evaluated ODE systems describing colonization dynamics of bacterial pathogens in the healthcare setting. The final model, comprising pathogen colonization (<xref ref-type="disp-formula" rid="equ19">Equation 1</xref>), intraspecific strain competition (<xref ref-type="disp-formula" rid="equ3">Equation 3</xref>), microbiome-pathogen competition (<xref ref-type="disp-formula" rid="equ4">Equation 4</xref>), and horizontal gene transfer (HGT), is given alongside all assumptions in the supplementary appendix (Appendix <xref ref-type="disp-formula" rid="equ9">Equation A1</xref>). ODEs were integrated numerically to calculate steady-state epidemiological outcomes for nosocomial P<sup>R</sup> colonization: colonization prevalence (the sum of all compartments C<sup>R</sup>), colonization incidence (the daily rate of C<sup>R</sup> acquisition), and the resistance rate (C<sup>R</sup>/(C<sup>S</sup> + C<sup>R</sup>)). (See Appendix 1 for technical details, and R and Mathematica files available online at <ext-link ext-link-type="uri" xlink:href="https://github.com/drmsmith/microbiomeR">https://github.com/drmsmith/microbiomeR</ext-link> [<xref ref-type="bibr" rid="bib138">Smith, 2021</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b9466325c11d19e7bc3962c2c4b913dd88d701b8;origin=https://github.com/drmsmith/microbiomeR;visit=swh:1:snp:111f1edd0d2dbcdc7509e028d86125d72f7d7650;anchor=swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f">swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f</ext-link>].) For each model, outcomes were evaluated over the same parameter space representing a generic pathogen P<sup>R</sup> (parameters in <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>), while varying specific parameters through univariate and bivariate analysis to assess their impacts on dynamic equilibria in the context of different modeling assumptions. We focused on impacts of the patient population’s antibiotic exposure prevalence (<inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>), rates of antibiotic-induced pathogen clearance (θ<sub>c</sub>) and microbiome dysbiosis (θ<sub>m</sub>), the focal pathogen’s intrinsic antibiotic resistance level (<italic>r<sub>R</sub></italic>), and mediating impacts of microbiome-pathogen competition (ε, η, ϕ) and horizontal gene transfer (χ<sub>e</sub>, χ<sub>d</sub>).</p></sec><sec id="s4-2"><title>Monte Carlo simulations over parameter distributions</title><p>We applied the final model to simulate epidemiological dynamics of four high-risk nosocomial pathogens, varying the within-host ecological interactions in effect for each (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). For MRSA, ESBL-EC and CP-KP, the focal pathogen was taken as the ‘drug-resistant’ strain P<sup>R</sup>, while the ‘drug-sensitive’ strain P<sup>S</sup> was taken to represent all other co-circulating strains of the same species. We simulated colonization dynamics using these model characterizations and accounted for parameter uncertainty using Monte Carlo methods. Specifically, 10,000 unique parameter vectors Ω were created by drawing random values for each parameter from its respective probability distribution (parameters in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>–<xref ref-type="table" rid="app1table6">6</xref>). For each Ω, epidemiological outcomes (prevalence, incidence, resistance rate) were calculated as above. Final outcome distributions were reported as the median and 95% uncertainty interval, that is the 50th (2.5th–97.5th) percentiles across all simulations.</p></sec><sec id="s4-3"><title>Parameterizing models for application to specific nosocomial pathogens</title><p>Models were parameterized using estimates from the literature, prioritizing clinical studies from the French hospital setting where available. We used expert elicitation to inform model structure and quantify parameter values for microbiome-pathogen interactions. This involved development of a protocol and questionnaire (provided separately), designed using established expert elicitation methodologies for quantitative estimation of unknown parameter values (<xref ref-type="bibr" rid="bib73">Johnson et al., 2010</xref>). To facilitate more reliable parameter interpretation, microbiome-pathogen coefficients were translated into clinical parameters, for example relative risks of pathogen colonization among hospital patients undergoing dysbiosis relative to those with stable microbiota (<xref ref-type="table" rid="app1table7">Appendix 1—table 7</xref>). Expert estimates were quantified with uncertainty using the MATCH Uncertainty Elicitation Tool (<xref ref-type="bibr" rid="bib107">Morris et al., 2014</xref>), and final parameter distributions were generated by pooling their individual distributions while maintaining estimated species rank order (<xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref>–<xref ref-type="fig" rid="app1fig10">10</xref>).</p></sec><sec id="s4-4"><title>Characterizing ecological impacts of antibiotic consumption</title><p>Antibiotic exposure prevalence was quantified at the level of antibiotic class using nationally representative antibiotic consumption data from French hospitals in 2016 (<xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>). A study from American hospitals in 2006–2012 was used to further stratify antibiotics with ATC code J01F into J01FA and J01FF, J01X into J01XA and J01XD, and J01DD+DE into J01DD and J01DE (<xref ref-type="bibr" rid="bib9">Baggs et al., 2016</xref>). Final antibiotic consumption data are presented in <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref>. To simulate class-specific rates of microbiome dysbiosis, we used a four-point log-linear scale of intestinal microbiome disruption from <xref ref-type="bibr" rid="bib25">Brown et al., 2013</xref>. For interpretation, we present classes as inducing dysbiosis at a high, medium, low, or very low rate. This scale was supplemented with data for additional antibiotic classes from <xref ref-type="bibr" rid="bib10">Baggs et al., 2018</xref>. Applied to our model, the rate that antibiotic treatment induces dysbiosis (σ<sub>m</sub>) is given by<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where <italic>a<sub>k</sub></italic> is the proportion of antibiotics consumed of each group <italic>k</italic>, and where the most ecologically disruptive group (k=0) causes dysbiosis a mean 12 hr after antibiotic exposure (θ<sub>m</sub> = 2 day<sup>−1</sup>), with classes in less disruptive groups (k=1,2,3) causing dysbiosis at successively slower rates (<xref ref-type="fig" rid="fig5">Figure 5C</xref>).</p><p>To characterize class-specific effects on pathogen clearance, characteristic antibiograms for all strains were adapted from an online compendium from the Therapeutics Education Collaboration (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; <xref ref-type="bibr" rid="bib101">McCormack and Lalji, 2015</xref>). Each strain <italic>i</italic> was classified as sensitive (<italic>r<sub>i,j</sub></italic> = 0), of intermediate sensitivity (0 &lt; <italic>r<sub>i,j</sub></italic> &lt; 1), or resistant (<italic>r<sub>i,j</sub></italic> = 1) to each antibiotic class <italic>j</italic>. Overall, the rate that antibiotic treatment clears each strain is given by:<disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>18</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>across the included classes. Under these assumptions, MRSA was resistant to the greatest proportion of antibiotics consumed in hospital (median <italic>r<sub>R</sub></italic> = 94.5%), followed by <italic>C. difficile</italic> (94.3%), CP-KP (91.7%) and ESBL-EC (84.8%); competing ‘drug-sensitive’ strains bore considerably less resistance median <italic>r<sub>S</sub></italic> = 33.0% for MSSA and 23.0% for both <italic>E. coli</italic> and <italic>K. pneumoniae</italic>.</p></sec><sec id="s4-5"><title>Sensitivity analyses</title><p>Two distinct sensitivity analyses were conducted. First, to evaluate the impact of microbiome competition on model outcomes, a second lot of ‘single-species simulations’ was run after removing microbiome-pathogen interactions from all Ω (ε = 0, η = 0, ϕ = 1, χ = 0). Second, the impact of parameter uncertainty on model outcomes was evaluated. For each pathogen, model parameter values were re-sampled from their distributions (<xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>–<xref ref-type="table" rid="app1table6">6</xref>) using Latin Hypercube Sampling over 10,000 iterations, epidemiological outcomes were re-calculated at population dynamic equilibrium, and partial rank correlation coefficients were calculated between each parameter and the pathogen’s (i) colonization prevalence and (ii) resistance rate (using the R package <italic>pse</italic>) (<xref ref-type="bibr" rid="bib31">Chalom and Prado, 2013</xref>; <xref ref-type="bibr" rid="bib99">Marino et al., 2008</xref>).</p></sec><sec id="s4-6"><title>Public health interventions</title><p>Three public health interventions were incorporated into the final model (see Appendix <xref ref-type="disp-formula" rid="equ20 equ21 equ22 equ23">Equations A12–A15</xref>). First, contact precautions were assumed to represent physical or behavioral barriers that block opportunities for transmission, reducing transmission rates by the same fraction τ<sub>ipc</sub> across all pathogens relative to baseline. Second, antibiotic stewardship programmes were assumed to alter antibiotic consumption patterns in the hospital. Two main types were considered: antibiotic reduction, which limits overall antibiotic prescribing by a fraction τ<sub>asp</sub>, and antibiotic restriction, which adjusts the distribution of antibiotic classes consumed in the hospital by the same fraction. We considered two types of restriction, the first favouring classically narrow-spectrum antibiotics (e.g. macrolides) over broad-spectrum (e.g. quinolones), and the second favouring antibiotics that cause dysbiosis at very low or low rates (k={3,2}) over those causing dysbiosis at medium or high rates (k={1,0}) (see <xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref> for antibiotic classification). Third, microbiome recovery therapy was assumed to trigger recovery at rate 0.5 day<sup>−1</sup> and was apportioned to the fraction τ<sub>pbt</sub> of patients. Overall, different values assumed for intervention parameters (τ<sub>ipc</sub>, τ<sub>asp</sub>, τ<sub>pbt</sub>) are interpreted as different levels of compliance to the respective interventions. Intervention efficacy was evaluated using the IRR and RRR (defined in Model and Results). Outcomes were matched across Monte Carlo simulations, such that IRRs and RRRs were calculated for each intervention and compliance level for each Ω. The distribution of outcomes is expressed as the median and 95% uncertainty interval.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We express our gratitude to the subject-matter experts who participated in our expert elicitation exercise: Antoine Andremont, Christian Brun-Buisson, Aurélien Dinh, Stephan Harbarth, Jean-Louis Herrmann, Solen Kernéis, Alban Le Monnier, Benoît Pilmis, Etienne Ruppé and Paul-Louis Woerther. The work was supported directly by internal resources from the French National Institute for Health and Medical Research, the Institut Pasteur, the Conservatoire National des Arts et Métiers, and the University of Versailles–Saint-Quentin-en-Yvelines / University of Paris-Saclay. This study received funding from the French Government’s ‘Investissement d’Avenir’ program, Laboratoire d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (Grant ANR-10-LABX-62- IBEID). DS is supported by a Canadian Institutes of Health Research Doctoral Foreign Study Award (Funding Reference Number 164263) and all authors are supported by the French government through its National Research Agency project SPHINX-17-CE36-0008-01.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Funding acquisition, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Expert elicitation protocol.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-68764-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-68764-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Model equations and parameter values are provided in the manuscript, as well as in supporting R files and a Mathematica notebook available online at <ext-link ext-link-type="uri" xlink:href="https://github.com/drmsmith/microbiomeR">https://github.com/drmsmith/microbiomeR</ext-link> (copy archived at<ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f">https://archive.softwareheritage.org/swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f</ext-link>).</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbara</surname> <given-names>S</given-names></name><name><surname>Cazanave</surname> <given-names>C</given-names></name><name><surname>Dubée</surname> <given-names>V</given-names></name><name><surname>D’humières</surname> <given-names>C</given-names></name><name><surname>Jauréguiberry</surname> <given-names>S</given-names></name><name><surname>Kernéis</surname> <given-names>S</given-names></name><name><surname>Lefort</surname> <given-names>A</given-names></name><name><surname>Lepeule</surname> <given-names>R</given-names></name><name><surname>Pilmis</surname> <given-names>B</given-names></name><name><surname>Nguyen</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Classement pragmatique des antibiotiques en fonction de leur spectre et de leur impact écologique à des fins éducatives : résultats d’une enquête Delphi pour le jeu éducatif « Dawaa »</article-title><source>Médecine Et Maladies Infectieuses</source><volume>50</volume><elocation-id>S60</elocation-id><pub-id pub-id-type="doi">10.1016/j.medmal.2020.06.115</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Agence nationale de sécurité du médicament et des produits de santé</collab></person-group><year iso-8601-date="2017">2017</year><source>La Consommation D’antibiotiques en France en 2016 – Rapport De l’ANSM</source><ext-link ext-link-type="uri" xlink:href="http://www.ordre.pharmacien.fr/Communications/Les-actualites/La-consommation-d-antibiotiques-en-France-en-2016-rapport-de-l-ANSM">http://www.ordre.pharmacien.fr/Communications/Les-actualites/La-consommation-d-antibiotiques-en-France-en-2016-rapport-de-l-ANSM</ext-link></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfandari</surname> <given-names>S</given-names></name><name><surname>Robert</surname> <given-names>J</given-names></name><name><surname>Péan</surname> <given-names>Y</given-names></name><name><surname>Rabaud</surname> <given-names>C</given-names></name><name><surname>Bedos</surname> <given-names>JP</given-names></name><name><surname>Varon</surname> <given-names>E</given-names></name><name><surname>Lepape</surname> <given-names>A</given-names></name><name><surname>Bru</surname> <given-names>JP</given-names></name><name><surname>Gauzit</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antibiotic use and good practice in 314 french hospitals: the 2010 SPA2 prevalence study</article-title><source>Médecine Et Maladies Infectieuses</source><volume>45</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2015.10.001</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archambaud</surname> <given-names>C</given-names></name><name><surname>Derré-Bobillot</surname> <given-names>A</given-names></name><name><surname>Lapaque</surname> <given-names>N</given-names></name><name><surname>Rigottier-Gois</surname> <given-names>L</given-names></name><name><surname>Serror</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>8926</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-45441-3</pub-id><pub-id pub-id-type="pmid">31222056</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arda</surname> <given-names>B</given-names></name><name><surname>Sipahi</surname> <given-names>OR</given-names></name><name><surname>Yamazhan</surname> <given-names>T</given-names></name><name><surname>Tasbakan</surname> <given-names>M</given-names></name><name><surname>Pullukcu</surname> <given-names>H</given-names></name><name><surname>Tunger</surname> <given-names>A</given-names></name><name><surname>Buke</surname> <given-names>C</given-names></name><name><surname>Ulusoy</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance</article-title><source>Journal of Infection</source><volume>55</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2007.02.014</pub-id><pub-id pub-id-type="pmid">17512598</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assab</surname> <given-names>R</given-names></name><name><surname>Nekkab</surname> <given-names>N</given-names></name><name><surname>Crépey</surname> <given-names>P</given-names></name><name><surname>Astagneau</surname> <given-names>P</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Opatowski</surname> <given-names>L</given-names></name><name><surname>Temime</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mathematical models of infection transmission in healthcare settings: recent advances from the use of network structured data</article-title><source>Current Opinion in Infectious Diseases</source><volume>30</volume><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000390</pub-id><pub-id pub-id-type="pmid">28570284</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname> <given-names>DJ</given-names></name><name><surname>Kakehashi</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The transmission dynamics of antibiotic-resistant Bacteria: the relationship between resistance in commensal organisms and antibiotic consumption</article-title><source>Proceedings of the Royal Society of London. Series B: Biological Sciences</source><volume>264</volume><fpage>1629</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1098/rspb.1997.0227</pub-id><pub-id pub-id-type="pmid">9404026</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckhed</surname> <given-names>F</given-names></name><name><surname>Ley</surname> <given-names>RE</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name><name><surname>Peterson</surname> <given-names>DA</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Host-bacterial mutualism in the human intestine</article-title><source>Science</source><volume>307</volume><fpage>1915</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.1126/science.1104816</pub-id><pub-id pub-id-type="pmid">15790844</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggs</surname> <given-names>J</given-names></name><name><surname>Fridkin</surname> <given-names>SK</given-names></name><name><surname>Pollack</surname> <given-names>LA</given-names></name><name><surname>Srinivasan</surname> <given-names>A</given-names></name><name><surname>Jernigan</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012</article-title><source>JAMA Internal Medicine</source><volume>176</volume><fpage>1639</fpage><lpage>1648</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2016.5651</pub-id><pub-id pub-id-type="pmid">27653796</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggs</surname> <given-names>J</given-names></name><name><surname>Jernigan</surname> <given-names>JA</given-names></name><name><surname>Halpin</surname> <given-names>AL</given-names></name><name><surname>Epstein</surname> <given-names>L</given-names></name><name><surname>Hatfield</surname> <given-names>KM</given-names></name><name><surname>McDonald</surname> <given-names>LC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Risk of subsequent Sepsis within 90 days after a hospital stay by type of antibiotic exposure</article-title><source>Clinical Infectious Diseases</source><volume>66</volume><fpage>1004</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1093/cid/cix947</pub-id><pub-id pub-id-type="pmid">29136126</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Yoseph</surname> <given-names>H</given-names></name><name><surname>Hussein</surname> <given-names>K</given-names></name><name><surname>Braun</surname> <given-names>E</given-names></name><name><surname>Paul</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>71</volume><fpage>2729</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1093/jac/dkw221</pub-id><pub-id pub-id-type="pmid">27317444</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbut</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Prevalence and pathogenicity of Clostridium difficile in hospitalized patients</article-title><source>Archives of Internal Medicine</source><volume>156</volume><elocation-id>1449</elocation-id><pub-id pub-id-type="doi">10.1001/archinte.1996.00440120107012</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashan</surname> <given-names>A</given-names></name><name><surname>Gibson</surname> <given-names>TE</given-names></name><name><surname>Friedman</surname> <given-names>J</given-names></name><name><surname>Carey</surname> <given-names>VJ</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name><name><surname>Hohmann</surname> <given-names>EL</given-names></name><name><surname>Liu</surname> <given-names>YY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Universality of human microbial dynamics</article-title><source>Nature</source><volume>534</volume><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/nature18301</pub-id><pub-id pub-id-type="pmid">27279224</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname> <given-names>M</given-names></name><name><surname>Bayer</surname> <given-names>F</given-names></name><name><surname>Pfrunder-Cardozo</surname> <given-names>KR</given-names></name><name><surname>Buckling</surname> <given-names>A</given-names></name><name><surname>Hall</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Resident microbial communities inhibit growth and antibiotic-resistance evolution of <italic>Escherichia coli</italic> in human gut microbiome samples</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000465</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000465</pub-id><pub-id pub-id-type="pmid">32310938</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäumler</surname> <given-names>AJ</given-names></name><name><surname>Sperandio</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interactions between the Microbiota and pathogenic Bacteria in the gut</article-title><source>Nature</source><volume>535</volume><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/nature18849</pub-id><pub-id pub-id-type="pmid">27383983</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baur</surname> <given-names>D</given-names></name><name><surname>Gladstone</surname> <given-names>BP</given-names></name><name><surname>Burkert</surname> <given-names>F</given-names></name><name><surname>Carrara</surname> <given-names>E</given-names></name><name><surname>Foschi</surname> <given-names>F</given-names></name><name><surname>Döbele</surname> <given-names>S</given-names></name><name><surname>Tacconelli</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant Bacteria and Clostridium difficile infection: a systematic review and meta-analysis</article-title><source>The Lancet Infectious Diseases</source><volume>17</volume><fpage>990</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30325-0</pub-id><pub-id pub-id-type="pmid">28629876</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernier</surname> <given-names>A</given-names></name><name><surname>Delarocque-Astagneau</surname> <given-names>E</given-names></name><name><surname>Ligier</surname> <given-names>C</given-names></name><name><surname>Vibet</surname> <given-names>M-A</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Watier</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>58</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1128/AAC.01813-13</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhalodi</surname> <given-names>AA</given-names></name><name><surname>van Engelen</surname> <given-names>TSR</given-names></name><name><surname>Virk</surname> <given-names>HS</given-names></name><name><surname>Wiersinga</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impact of antimicrobial therapy on the gut microbiome</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>74</volume><fpage>i6</fpage><lpage>i15</lpage><pub-id pub-id-type="doi">10.1093/jac/dky530</pub-id><pub-id pub-id-type="pmid">30690540</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkegård</surname> <given-names>AC</given-names></name><name><surname>Halasa</surname> <given-names>T</given-names></name><name><surname>Toft</surname> <given-names>N</given-names></name><name><surname>Folkesson</surname> <given-names>A</given-names></name><name><surname>Græsbøll</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Send more data: a systematic review of mathematical models of antimicrobial resistance</article-title><source>Antimicrobial Resistance &amp; Infection Control</source><volume>7</volume><elocation-id>117</elocation-id><pub-id pub-id-type="doi">10.1186/s13756-018-0406-1</pub-id><pub-id pub-id-type="pmid">30288257</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanquart</surname> <given-names>F</given-names></name><name><surname>Lehtinen</surname> <given-names>S</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Fraser</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The evolution of antibiotic resistance in a structured host population</article-title><source>Journal of the Royal Society Interface</source><volume>15</volume><elocation-id>20180040</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2018.0040</pub-id><pub-id pub-id-type="pmid">29925579</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanquart</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolutionary epidemiology models to predict the dynamics of antibiotic resistance</article-title><source>Evolutionary Applications</source><volume>12</volume><fpage>365</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1111/eva.12753</pub-id><pub-id pub-id-type="pmid">30828361</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bootsma</surname> <given-names>MC</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Nijssen</surname> <given-names>S</given-names></name><name><surname>Fluit</surname> <given-names>AC</given-names></name><name><surname>Diekmann</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An algorithm to estimate the importance of bacterial acquisition routes in hospital settings</article-title><source>American Journal of Epidemiology</source><volume>166</volume><fpage>841</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1093/aje/kwm149</pub-id><pub-id pub-id-type="pmid">17644823</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borde</surname> <given-names>JP</given-names></name><name><surname>Litterst</surname> <given-names>S</given-names></name><name><surname>Ruhnke</surname> <given-names>M</given-names></name><name><surname>Feik</surname> <given-names>R</given-names></name><name><surname>Hübner</surname> <given-names>J</given-names></name><name><surname>deWith</surname> <given-names>K</given-names></name><name><surname>Kaier</surname> <given-names>K</given-names></name><name><surname>Kern</surname> <given-names>WV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany</article-title><source>Infection</source><volume>43</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s15010-014-0693-2</pub-id><pub-id pub-id-type="pmid">25344419</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname> <given-names>IL</given-names></name><name><surname>Alm</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tracking strains in the microbiome: insights from metagenomics and models</article-title><source>Frontiers in Microbiology</source><volume>7</volume><elocation-id>712</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.00712</pub-id><pub-id pub-id-type="pmid">27242733</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>KA</given-names></name><name><surname>Khanafer</surname> <given-names>N</given-names></name><name><surname>Daneman</surname> <given-names>N</given-names></name><name><surname>Fisman</surname> <given-names>DN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Meta-Analysis of antibiotics and the risk of Community-Associated Clostridium difficile infection</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>2326</fpage><lpage>2332</lpage><pub-id pub-id-type="doi">10.1128/AAC.02176-12</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>McKenney</surname> <given-names>PT</given-names></name><name><surname>Ling</surname> <given-names>L</given-names></name><name><surname>Gobourne</surname> <given-names>A</given-names></name><name><surname>No</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Kinnebrew</surname> <given-names>M</given-names></name><name><surname>Viale</surname> <given-names>A</given-names></name><name><surname>Littmann</surname> <given-names>E</given-names></name><name><surname>van den Brink</surname> <given-names>MR</given-names></name><name><surname>Jenq</surname> <given-names>RR</given-names></name><name><surname>Taur</surname> <given-names>Y</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Cross</surname> <given-names>JR</given-names></name><name><surname>Toussaint</surname> <given-names>NC</given-names></name><name><surname>Xavier</surname> <given-names>JB</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile</article-title><source>Nature</source><volume>517</volume><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/nature13828</pub-id><pub-id pub-id-type="pmid">25337874</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microbiota-mediated colonization resistance against intestinal pathogens</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>790</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nri3535</pub-id><pub-id pub-id-type="pmid">24096337</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdet</surname> <given-names>C</given-names></name><name><surname>Nguyen</surname> <given-names>TT</given-names></name><name><surname>Duval</surname> <given-names>X</given-names></name><name><surname>Ferreira</surname> <given-names>S</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name><name><surname>Guedj</surname> <given-names>J</given-names></name><name><surname>Mentré</surname> <given-names>F</given-names></name><collab>the DAV132-CL-1002 Study Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Impact of antibiotic gut exposure on the temporal changes in microbiome diversity</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00820-19</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassini</surname> <given-names>A</given-names></name><name><surname>Plachouras</surname> <given-names>D</given-names></name><name><surname>Eckmanns</surname> <given-names>T</given-names></name><name><surname>Abu Sin</surname> <given-names>M</given-names></name><name><surname>Blank</surname> <given-names>HP</given-names></name><name><surname>Ducomble</surname> <given-names>T</given-names></name><name><surname>Haller</surname> <given-names>S</given-names></name><name><surname>Harder</surname> <given-names>T</given-names></name><name><surname>Klingeberg</surname> <given-names>A</given-names></name><name><surname>Sixtensson</surname> <given-names>M</given-names></name><name><surname>Velasco</surname> <given-names>E</given-names></name><name><surname>Weiß</surname> <given-names>B</given-names></name><name><surname>Kramarz</surname> <given-names>P</given-names></name><name><surname>Monnet</surname> <given-names>DL</given-names></name><name><surname>Kretzschmar</surname> <given-names>ME</given-names></name><name><surname>Suetens</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Burden of six Healthcare-Associated infections on european population health: estimating Incidence-Based Disability-Adjusted life years through a population Prevalence-Based modelling study</article-title><source>PLOS Medicine</source><volume>13</volume><elocation-id>e1002150</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002150</pub-id><pub-id pub-id-type="pmid">27755545</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassini</surname> <given-names>A</given-names></name><name><surname>Högberg</surname> <given-names>LD</given-names></name><name><surname>Plachouras</surname> <given-names>D</given-names></name><name><surname>Quattrocchi</surname> <given-names>A</given-names></name><name><surname>Hoxha</surname> <given-names>A</given-names></name><name><surname>Simonsen</surname> <given-names>GS</given-names></name><name><surname>Colomb-Cotinat</surname> <given-names>M</given-names></name><name><surname>Kretzschmar</surname> <given-names>ME</given-names></name><name><surname>Devleesschauwer</surname> <given-names>B</given-names></name><name><surname>Cecchini</surname> <given-names>M</given-names></name><name><surname>Ouakrim</surname> <given-names>DA</given-names></name><name><surname>Oliveira</surname> <given-names>TC</given-names></name><name><surname>Struelens</surname> <given-names>MJ</given-names></name><name><surname>Suetens</surname> <given-names>C</given-names></name><name><surname>Monnet</surname> <given-names>DL</given-names></name><collab>Burden of AMR Collaborative Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant Bacteria in the EU and the european economic area in 2015: a population-level modelling analysis</article-title><source>The Lancet Infectious Diseases</source><volume>19</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(18)30605-4</pub-id><pub-id pub-id-type="pmid">30409683</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Chalom</surname> <given-names>A</given-names></name><name><surname>Prado</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Pse: Parameter Space Exploration with Latin Hypercubes</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/pse/pse.pdf">https://cran.r-project.org/web/packages/pse/pse.pdf</ext-link></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>A</given-names></name><name><surname>Modarai</surname> <given-names>M</given-names></name><name><surname>Naylor</surname> <given-names>NR</given-names></name><name><surname>Boyd</surname> <given-names>SE</given-names></name><name><surname>Atun</surname> <given-names>R</given-names></name><name><surname>Barlow</surname> <given-names>J</given-names></name><name><surname>Holmes</surname> <given-names>AH</given-names></name><name><surname>Johnson</surname> <given-names>A</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quantifying drivers of antibiotic resistance in humans: a systematic review</article-title><source>The Lancet Infectious Diseases</source><volume>18</volume><fpage>e368</fpage><lpage>e378</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(18)30296-2</pub-id><pub-id pub-id-type="pmid">30172580</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname> <given-names>Y</given-names></name><name><surname>Shimoda</surname> <given-names>S</given-names></name><name><surname>Yakushiji</surname> <given-names>H</given-names></name><name><surname>Ito</surname> <given-names>Y</given-names></name><name><surname>Miyamoto</surname> <given-names>T</given-names></name><name><surname>Kamimura</surname> <given-names>T</given-names></name><name><surname>Shimono</surname> <given-names>N</given-names></name><name><surname>Akashi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e54190</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0054190</pub-id><pub-id pub-id-type="pmid">23372683</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobey</surname> <given-names>S</given-names></name><name><surname>Baskerville</surname> <given-names>EB</given-names></name><name><surname>Colijn</surname> <given-names>C</given-names></name><name><surname>Hanage</surname> <given-names>W</given-names></name><name><surname>Fraser</surname> <given-names>C</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Host population structure and treatment frequency maintain balancing selection on drug resistance</article-title><source>Journal of the Royal Society Interface</source><volume>14</volume><elocation-id>20170295</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2017.0295</pub-id><pub-id pub-id-type="pmid">28835542</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coello</surname> <given-names>R</given-names></name><name><surname>Glynn</surname> <given-names>JR</given-names></name><name><surname>Gaspar</surname> <given-names>C</given-names></name><name><surname>Picazo</surname> <given-names>JJ</given-names></name><name><surname>Fereres</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Risk factors for developing clinical infection with methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) amongst hospital patients initially only colonized with MRSA</article-title><source>Journal of Hospital Infection</source><volume>37</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/S0195-6701(97)90071-2</pub-id><pub-id pub-id-type="pmid">9321727</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colijn</surname> <given-names>C</given-names></name><name><surname>Cohen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance</article-title><source>eLife</source><volume>4</volume><elocation-id>e10559</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10559</pub-id><pub-id pub-id-type="pmid">26393685</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyte</surname> <given-names>KZ</given-names></name><name><surname>Schluter</surname> <given-names>J</given-names></name><name><surname>Foster</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The ecology of the microbiome: networks, competition, and stability</article-title><source>Science</source><volume>350</volume><fpage>663</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1126/science.aad2602</pub-id><pub-id pub-id-type="pmid">26542567</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cravo Oliveira Hashiguchi</surname> <given-names>T</given-names></name><name><surname>Ait Ouakrim</surname> <given-names>D</given-names></name><name><surname>Padget</surname> <given-names>M</given-names></name><name><surname>Cassini</surname> <given-names>A</given-names></name><name><surname>Cecchini</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study</article-title><source>Eurosurveillance</source><volume>24</volume><elocation-id>1800445</elocation-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2019.24.20.1800445</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davido</surname> <given-names>B</given-names></name><name><surname>Batista</surname> <given-names>R</given-names></name><name><surname>Dinh</surname> <given-names>A</given-names></name><name><surname>de Truchis</surname> <given-names>P</given-names></name><name><surname>Terveer</surname> <given-names>EM</given-names></name><name><surname>Roberts</surname> <given-names>B</given-names></name><name><surname>Kuijper</surname> <given-names>EJ</given-names></name><name><surname>Caballero</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Fifty shades of graft: how to improve the efficacy of faecal Microbiota transplantation for decolonization of antibiotic-resistant Bacteria</article-title><source>International Journal of Antimicrobial Agents</source><volume>53</volume><fpage>553</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2019.03.008</pub-id><pub-id pub-id-type="pmid">30880228</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davido</surname> <given-names>B</given-names></name><name><surname>Batista</surname> <given-names>R</given-names></name><name><surname>Fessi</surname> <given-names>H</given-names></name><name><surname>Michelon</surname> <given-names>H</given-names></name><name><surname>Escaut</surname> <given-names>L</given-names></name><name><surname>Lawrence</surname> <given-names>C</given-names></name><name><surname>Denis</surname> <given-names>M</given-names></name><name><surname>Perronne</surname> <given-names>C</given-names></name><name><surname>Salomon</surname> <given-names>J</given-names></name><name><surname>Dinh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Fecal Microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak</article-title><source>Médecine Et Maladies Infectieuses</source><volume>49</volume><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2018.11.002</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>NG</given-names></name><name><surname>Flasche</surname> <given-names>S</given-names></name><name><surname>Jit</surname> <given-names>M</given-names></name><name><surname>Atkins</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Within-host dynamics shape antibiotic resistance in commensal Bacteria</article-title><source>Nature Ecology &amp; Evolution</source><volume>3</volume><fpage>440</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1038/s41559-018-0786-x</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname> <given-names>T</given-names></name><name><surname>Alizon</surname> <given-names>S</given-names></name><name><surname>Mideo</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Bridging scales in the evolution of infectious disease life histories: theory</article-title><source>Evolution</source><volume>65</volume><fpage>3448</fpage><lpage>3461</lpage><pub-id pub-id-type="doi">10.1111/j.1558-5646.2011.01394.x</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Gunzburg</surname> <given-names>J</given-names></name><name><surname>Ducher</surname> <given-names>A</given-names></name><name><surname>Modess</surname> <given-names>C</given-names></name><name><surname>Wegner</surname> <given-names>D</given-names></name><name><surname>Oswald</surname> <given-names>S</given-names></name><name><surname>Dressman</surname> <given-names>J</given-names></name><name><surname>Augustin</surname> <given-names>V</given-names></name><name><surname>Feger</surname> <given-names>C</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name><name><surname>Weitschies</surname> <given-names>W</given-names></name><name><surname>Siegmund</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Targeted adsorption of molecules in the Colon with the novel adsorbent-based medicinal product, DAV132: a proof of concept study in healthy subjects</article-title><source>The Journal of Clinical Pharmacology</source><volume>55</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/jcph.359</pub-id><pub-id pub-id-type="pmid">25042595</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Gunzburg</surname> <given-names>J</given-names></name><name><surname>Ghozlane</surname> <given-names>A</given-names></name><name><surname>Ducher</surname> <given-names>A</given-names></name><name><surname>Le Chatelier</surname> <given-names>E</given-names></name><name><surname>Duval</surname> <given-names>X</given-names></name><name><surname>Ruppé</surname> <given-names>E</given-names></name><name><surname>Armand-Lefevre</surname> <given-names>L</given-names></name><name><surname>Sablier-Gallis</surname> <given-names>F</given-names></name><name><surname>Burdet</surname> <given-names>C</given-names></name><name><surname>Alavoine</surname> <given-names>L</given-names></name><name><surname>Chachaty</surname> <given-names>E</given-names></name><name><surname>Augustin</surname> <given-names>V</given-names></name><name><surname>Varastet</surname> <given-names>M</given-names></name><name><surname>Levenez</surname> <given-names>F</given-names></name><name><surname>Kennedy</surname> <given-names>S</given-names></name><name><surname>Pons</surname> <given-names>N</given-names></name><name><surname>Mentré</surname> <given-names>F</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protection of the human gut microbiome from antibiotics</article-title><source>The Journal of Infectious Diseases</source><volume>217</volume><fpage>628</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix604</pub-id><pub-id pub-id-type="pmid">29186529</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Wit</surname> <given-names>R</given-names></name><name><surname>Bouvier</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>'Everything is everywhere, but, the environment selects'; what did Baas Becking and Beijerinck really say?</article-title><source>Environmental Microbiology</source><volume>8</volume><fpage>755</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2006.01017.x</pub-id><pub-id pub-id-type="pmid">16584487</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dethlefsen</surname> <given-names>L</given-names></name><name><surname>Relman</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Incomplete recovery and individualized responses of the human distal gut Microbiota to repeated antibiotic perturbation</article-title><source>PNAS</source><volume>108</volume><fpage>4554</fpage><lpage>4561</lpage><pub-id pub-id-type="doi">10.1073/pnas.1000087107</pub-id><pub-id pub-id-type="pmid">20847294</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Ruscio</surname> <given-names>F</given-names></name><name><surname>Guzzetta</surname> <given-names>G</given-names></name><name><surname>Bjørnholt</surname> <given-names>JV</given-names></name><name><surname>Leegaard</surname> <given-names>TM</given-names></name><name><surname>Moen</surname> <given-names>AEF</given-names></name><name><surname>Merler</surname> <given-names>S</given-names></name><name><surname>Freiesleben de Blasio</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country</article-title><source>PNAS</source><volume>116</volume><fpage>14599</fpage><lpage>14605</lpage><pub-id pub-id-type="doi">10.1073/pnas.1900959116</pub-id><pub-id pub-id-type="pmid">31262808</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doan</surname> <given-names>T</given-names></name><name><surname>Hinterwirth</surname> <given-names>A</given-names></name><name><surname>Worden</surname> <given-names>L</given-names></name><name><surname>Arzika</surname> <given-names>AM</given-names></name><name><surname>Maliki</surname> <given-names>R</given-names></name><name><surname>Abdou</surname> <given-names>A</given-names></name><name><surname>Kane</surname> <given-names>S</given-names></name><name><surname>Zhong</surname> <given-names>L</given-names></name><name><surname>Cummings</surname> <given-names>SL</given-names></name><name><surname>Sakar</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Cook</surname> <given-names>C</given-names></name><name><surname>Lebas</surname> <given-names>E</given-names></name><name><surname>Chow</surname> <given-names>ED</given-names></name><name><surname>Nachamkin</surname> <given-names>I</given-names></name><name><surname>Porco</surname> <given-names>TC</given-names></name><name><surname>Keenan</surname> <given-names>JD</given-names></name><name><surname>Lietman</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1370</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0533-0</pub-id><pub-id pub-id-type="pmid">31406349</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domenech de Cellès</surname> <given-names>M</given-names></name><name><surname>Opatowski</surname> <given-names>L</given-names></name><name><surname>Salomon</surname> <given-names>J</given-names></name><name><surname>Varon</surname> <given-names>E</given-names></name><name><surname>Carbon</surname> <given-names>C</given-names></name><name><surname>Boëlle</surname> <given-names>P-Y</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>55</volume><fpage>5255</fpage><lpage>5261</lpage><pub-id pub-id-type="doi">10.1128/AAC.00249-11</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donker</surname> <given-names>T</given-names></name><name><surname>Henderson</surname> <given-names>KL</given-names></name><name><surname>Hopkins</surname> <given-names>KL</given-names></name><name><surname>Dodgson</surname> <given-names>AR</given-names></name><name><surname>Thomas</surname> <given-names>S</given-names></name><name><surname>Crook</surname> <given-names>DW</given-names></name><name><surname>Peto</surname> <given-names>TEA</given-names></name><name><surname>Johnson</surname> <given-names>AP</given-names></name><name><surname>Woodford</surname> <given-names>N</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England</article-title><source>BMC Medicine</source><volume>15</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-017-0844-2</pub-id><pub-id pub-id-type="pmid">28446169</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubrovskaya</surname> <given-names>Y</given-names></name><name><surname>Papadopoulos</surname> <given-names>J</given-names></name><name><surname>Scipione</surname> <given-names>MR</given-names></name><name><surname>Altshuler</surname> <given-names>J</given-names></name><name><surname>Phillips</surname> <given-names>M</given-names></name><name><surname>Mehta</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Antibiotic stewardship for intra-abdominal infections: early impact on antimicrobial use and patient outcomes</article-title><source>Infection Control &amp; Hospital Epidemiology</source><volume>33</volume><fpage>427</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1086/664765</pub-id><pub-id pub-id-type="pmid">22418644</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname> <given-names>DP</given-names></name><name><surname>Olsen</surname> <given-names>MA</given-names></name><name><surname>Dubberke</surname> <given-names>ER</given-names></name><name><surname>Galvani</surname> <given-names>AP</given-names></name><name><surname>Townsend</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Quantifying Transmission of <italic>Clostridium difficile</italic> within and outside Healthcare Settings</article-title><source>Emerging Infectious Diseases</source><volume>22</volume><fpage>608</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.3201/eid2204.150455</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname> <given-names>A</given-names></name><name><surname>Obadia</surname> <given-names>T</given-names></name><name><surname>Boëlle</surname> <given-names>PY</given-names></name><name><surname>Fleury</surname> <given-names>E</given-names></name><name><surname>Herrmann</surname> <given-names>JL</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Temime</surname> <given-names>L</given-names></name><name><surname>Opatowski</surname> <given-names>L</given-names></name><collab>i-Bird Study group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-<italic>E. coli</italic> in healthcare settings</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1006496</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006496</pub-id><pub-id pub-id-type="pmid">31145725</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahimi</surname> <given-names>F</given-names></name><name><surname>Mózes</surname> <given-names>J</given-names></name><name><surname>Monostori</surname> <given-names>J</given-names></name><name><surname>Gorácz</surname> <given-names>O</given-names></name><name><surname>Fésűs</surname> <given-names>A</given-names></name><name><surname>Majoros</surname> <given-names>L</given-names></name><name><surname>Szarka</surname> <given-names>K</given-names></name><name><surname>Kardos</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students</article-title><source>Microbiology and Immunology</source><volume>60</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1111/1348-0421.12373</pub-id><pub-id pub-id-type="pmid">26959958</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrela</surname> <given-names>S</given-names></name><name><surname>Whiteley</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The demographic determinants of human microbiome health</article-title><source>Trends in Microbiology</source><volume>23</volume><fpage>134</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2014.11.005</pub-id><pub-id pub-id-type="pmid">25500524</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrela</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Community interactions and spatial structure shape selection on antibiotic resistant lineages</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1006179</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006179</pub-id><pub-id pub-id-type="pmid">29927925</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>DR</given-names></name><name><surname>Griffith</surname> <given-names>MP</given-names></name><name><surname>Sundermann</surname> <given-names>AJ</given-names></name><name><surname>Shutt</surname> <given-names>KA</given-names></name><name><surname>Saul</surname> <given-names>MI</given-names></name><name><surname>Mustapha</surname> <given-names>MM</given-names></name><name><surname>Marsh</surname> <given-names>JW</given-names></name><name><surname>Cooper</surname> <given-names>VS</given-names></name><name><surname>Harrison</surname> <given-names>LH</given-names></name><name><surname>Van Tyne</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systematic detection of horizontal gene transfer across genera among multidrug-resistant Bacteria in a single hospital</article-title><source>eLife</source><volume>9</volume><elocation-id>e53886</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53886</pub-id><pub-id pub-id-type="pmid">32285801</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>MO</given-names></name><name><surname>Batteiger</surname> <given-names>BE</given-names></name><name><surname>Sorensen</surname> <given-names>SJ</given-names></name><name><surname>Hartstein</surname> <given-names>AI</given-names></name><name><surname>Carr</surname> <given-names>JA</given-names></name><name><surname>McComb</surname> <given-names>JS</given-names></name><name><surname>Clark</surname> <given-names>CD</given-names></name><name><surname>Abel</surname> <given-names>SR</given-names></name><name><surname>Mikuta</surname> <given-names>JM</given-names></name><name><surname>Jones</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program</article-title><source>Clinical Performance and Quality Health Care</source><volume>5</volume><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">10176026</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname> <given-names>ND</given-names></name><name><surname>Temkin</surname> <given-names>E</given-names></name><name><surname>Carmeli</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The negative impact of antibiotic resistance</article-title><source>Clinical Microbiology and Infection</source><volume>22</volume><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2015.12.002</pub-id><pub-id pub-id-type="pmid">26706614</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname> <given-names>G</given-names></name><name><surname>Guertin</surname> <given-names>MH</given-names></name><name><surname>Laprise</surname> <given-names>JF</given-names></name><name><surname>Drolet</surname> <given-names>M</given-names></name><name><surname>Brisson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mathematical modeling of the transmission dynamics of Clostridium difficile infection and colonization in healthcare settings: a systematic review</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0163880</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0163880</pub-id><pub-id pub-id-type="pmid">27690247</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gog</surname> <given-names>JR</given-names></name><name><surname>Pellis</surname> <given-names>L</given-names></name><name><surname>Wood</surname> <given-names>JL</given-names></name><name><surname>McLean</surname> <given-names>AR</given-names></name><name><surname>Arinaminpathy</surname> <given-names>N</given-names></name><name><surname>Lloyd-Smith</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Seven challenges in modeling pathogen dynamics within-host and across scales</article-title><source>Epidemics</source><volume>10</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2014.09.009</pub-id><pub-id pub-id-type="pmid">25843382</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greischar</surname> <given-names>MA</given-names></name><name><surname>Beck‐Johnson</surname> <given-names>LM</given-names></name><name><surname>Mideo</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Partitioning the influence of ecology across scales on parasite evolution</article-title><source>Evolution</source><volume>73</volume><fpage>2175</fpage><lpage>2188</lpage><pub-id pub-id-type="doi">10.1111/evo.13840</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grohs</surname> <given-names>P</given-names></name><name><surname>Kernéis</surname> <given-names>S</given-names></name><name><surname>Sabatier</surname> <given-names>B</given-names></name><name><surname>Lavollay</surname> <given-names>M</given-names></name><name><surname>Carbonnelle</surname> <given-names>E</given-names></name><name><surname>Rostane</surname> <given-names>H</given-names></name><name><surname>Souty</surname> <given-names>C</given-names></name><name><surname>Meyer</surname> <given-names>G</given-names></name><name><surname>Gutmann</surname> <given-names>L</given-names></name><name><surname>Mainardi</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>69</volume><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1093/jac/dkt403</pub-id><pub-id pub-id-type="pmid">24159154</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guittar</surname> <given-names>J</given-names></name><name><surname>Koffel</surname> <given-names>T</given-names></name><name><surname>Shade</surname> <given-names>A</given-names></name><name><surname>Klausmeier</surname> <given-names>CA</given-names></name><name><surname>Litchman</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Resource competition and host feedbacks underlie regime shifts in gut Microbiota</article-title><source>The American Naturalist</source><volume>198</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1086/714527</pub-id><pub-id pub-id-type="pmid">34143726</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guk</surname> <given-names>J</given-names></name><name><surname>Guedj</surname> <given-names>J</given-names></name><name><surname>Burdet</surname> <given-names>C</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name><name><surname>de Gunzburg</surname> <given-names>J</given-names></name><name><surname>Ducher</surname> <given-names>A</given-names></name><name><surname>Mentré</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Modeling the effect of DAV132, a novel Colon-Targeted adsorbent, on fecal concentrations of moxifloxacin and gut Microbiota diversity in healthy volunteers</article-title><source>Clinical Pharmacology &amp; Therapeutics</source><volume>109</volume><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1002/cpt.1977</pub-id><pub-id pub-id-type="pmid">32617960</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Mullish</surname> <given-names>BH</given-names></name><name><surname>Allegretti</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fecal Microbiota transplantation: the evolving risk landscape</article-title><source>American Journal of Gastroenterology</source><volume>116</volume><fpage>647</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.14309/ajg.0000000000001075</pub-id><pub-id pub-id-type="pmid">33982930</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurieva</surname> <given-names>T</given-names></name><name><surname>Dautzenberg</surname> <given-names>MJD</given-names></name><name><surname>Gniadkowski</surname> <given-names>M</given-names></name><name><surname>Derde</surname> <given-names>LPG</given-names></name><name><surname>Bonten</surname> <given-names>MJM</given-names></name><name><surname>Bootsma</surname> <given-names>MCJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The transmissibility of Antibiotic-Resistant Enterobacteriaceae in intensive care units</article-title><source>Clinical Infectious Diseases</source><volume>66</volume><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1093/cid/cix825</pub-id><pub-id pub-id-type="pmid">29020273</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heesterbeek</surname> <given-names>H</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Andreasen</surname> <given-names>V</given-names></name><name><surname>Bansal</surname> <given-names>S</given-names></name><name><surname>De Angelis</surname> <given-names>D</given-names></name><name><surname>Dye</surname> <given-names>C</given-names></name><name><surname>Eames</surname> <given-names>KT</given-names></name><name><surname>Edmunds</surname> <given-names>WJ</given-names></name><name><surname>Frost</surname> <given-names>SD</given-names></name><name><surname>Funk</surname> <given-names>S</given-names></name><name><surname>Hollingsworth</surname> <given-names>TD</given-names></name><name><surname>House</surname> <given-names>T</given-names></name><name><surname>Isham</surname> <given-names>V</given-names></name><name><surname>Klepac</surname> <given-names>P</given-names></name><name><surname>Lessler</surname> <given-names>J</given-names></name><name><surname>Lloyd-Smith</surname> <given-names>JO</given-names></name><name><surname>Metcalf</surname> <given-names>CJ</given-names></name><name><surname>Mollison</surname> <given-names>D</given-names></name><name><surname>Pellis</surname> <given-names>L</given-names></name><name><surname>Pulliam</surname> <given-names>JR</given-names></name><name><surname>Roberts</surname> <given-names>MG</given-names></name><name><surname>Viboud</surname> <given-names>C</given-names></name><collab>Isaac Newton Institute IDD Collaboration</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Modeling infectious disease dynamics in the complex landscape of global health</article-title><source>Science</source><volume>347</volume><elocation-id>aaa4339</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaa4339</pub-id><pub-id pub-id-type="pmid">25766240</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooks</surname> <given-names>KB</given-names></name><name><surname>O’Malley</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dysbiosis and its discontents</article-title><source>mBio</source><volume>8</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01492-17</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname> <given-names>LV</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Hong</surname> <given-names>CV</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Angiogenins: a new class of microbicidal proteins involved in innate immunity</article-title><source>Nature Immunology</source><volume>4</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/ni888</pub-id><pub-id pub-id-type="pmid">12548285</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurford</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>AM</given-names></name><name><surname>Fisman</surname> <given-names>DN</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program</article-title><source>Epidemics</source><volume>4</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2012.12.001</pub-id><pub-id pub-id-type="pmid">23351372</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernigan</surname> <given-names>JA</given-names></name><name><surname>Hatfield</surname> <given-names>KM</given-names></name><name><surname>Wolford</surname> <given-names>H</given-names></name><name><surname>Nelson</surname> <given-names>RE</given-names></name><name><surname>Olubajo</surname> <given-names>B</given-names></name><name><surname>Reddy</surname> <given-names>SC</given-names></name><name><surname>McCarthy</surname> <given-names>N</given-names></name><name><surname>Paul</surname> <given-names>P</given-names></name><name><surname>McDonald</surname> <given-names>LC</given-names></name><name><surname>Kallen</surname> <given-names>A</given-names></name><name><surname>Fiore</surname> <given-names>A</given-names></name><name><surname>Craig</surname> <given-names>M</given-names></name><name><surname>Baggs</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multidrug-Resistant bacterial infections in U.S. hospitalized patients, 2012-2017</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1309</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1914433</pub-id><pub-id pub-id-type="pmid">32242356</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>SR</given-names></name><name><surname>Tomlinson</surname> <given-names>GA</given-names></name><name><surname>Hawker</surname> <given-names>GA</given-names></name><name><surname>Granton</surname> <given-names>JT</given-names></name><name><surname>Grosbein</surname> <given-names>HA</given-names></name><name><surname>Feldman</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A valid and reliable belief elicitation method for bayesian priors</article-title><source>Journal of Clinical Epidemiology</source><volume>63</volume><fpage>370</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2009.08.005</pub-id><pub-id pub-id-type="pmid">19926253</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname> <given-names>N</given-names></name><name><surname>Chen</surname> <given-names>GY</given-names></name><name><surname>Inohara</surname> <given-names>N</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Control of pathogens and pathobionts by the gut Microbiota</article-title><source>Nature Immunology</source><volume>14</volume><fpage>685</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1038/ni.2608</pub-id><pub-id pub-id-type="pmid">23778796</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname> <given-names>N</given-names></name><name><surname>Seo</surname> <given-names>SU</given-names></name><name><surname>Chen</surname> <given-names>GY</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Role of the gut Microbiota in immunity and inflammatory disease</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>321</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/nri3430</pub-id><pub-id pub-id-type="pmid">23618829</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardaś-Słoma</surname> <given-names>L</given-names></name><name><surname>Boëlle</surname> <given-names>PY</given-names></name><name><surname>Opatowski</surname> <given-names>L</given-names></name><name><surname>Brun-Buisson</surname> <given-names>C</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Temime</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Impact of antibiotic exposure patterns on selection of Community-Associated Methicillin-Resistant <italic>Staphylococcus aureus</italic> in hospital settings</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>55</volume><fpage>4888</fpage><lpage>4895</lpage><pub-id pub-id-type="doi">10.1128/AAC.01626-10</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassam</surname> <given-names>Z</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Hunt</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fecal Microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis</article-title><source>American Journal of Gastroenterology</source><volume>108</volume><fpage>500</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1038/ajg.2013.59</pub-id><pub-id pub-id-type="pmid">23511459</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname> <given-names>K</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Toth</surname> <given-names>D</given-names></name><name><surname>Stevens</surname> <given-names>V</given-names></name><name><surname>Samore</surname> <given-names>MH</given-names></name><collab>CDC Modeling Infectious Diseases in Healthcare Program (MInD-Healthcare)</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Variation and trends in transmission dynamics of Methicillin-resistant <italic>Staphylococcus aureus</italic> in veterans affairs hospitals and nursing homes</article-title><source>Epidemics</source><volume>28</volume><elocation-id>100347</elocation-id><pub-id pub-id-type="doi">10.1016/j.epidem.2019.100347</pub-id><pub-id pub-id-type="pmid">31171468</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname> <given-names>K</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Stevens</surname> <given-names>V</given-names></name><name><surname>Visnovsky</surname> <given-names>L</given-names></name><name><surname>Nevers</surname> <given-names>M</given-names></name><name><surname>Toth</surname> <given-names>D</given-names></name><name><surname>Keegan</surname> <given-names>LT</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Rubin</surname> <given-names>M</given-names></name><name><surname>Samore</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Association between contact precautions and transmission of Methicillin-Resistant <italic>Staphylococcus aureus</italic> in veterans affairs hospitals</article-title><source>JAMA Network Open</source><volume>4</volume><elocation-id>e210971</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.0971</pub-id><pub-id pub-id-type="pmid">33720369</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Covington</surname> <given-names>A</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The intestinal Microbiota: antibiotics, colonization resistance, and enteric pathogens</article-title><source>Immunological Reviews</source><volume>279</volume><fpage>90</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1111/imr.12563</pub-id><pub-id pub-id-type="pmid">28856737</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>GM</given-names></name><name><surname>Costelloe</surname> <given-names>C</given-names></name><name><surname>Deeny</surname> <given-names>SR</given-names></name><name><surname>Moore</surname> <given-names>LSP</given-names></name><name><surname>Hopkins</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>AP</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name><name><surname>Holmes</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study</article-title><source>BMC Medicine</source><volume>16</volume><elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-018-1121-8</pub-id><pub-id pub-id-type="pmid">30134939</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>GM</given-names></name><name><surname>Davies</surname> <given-names>NG</given-names></name><name><surname>Colijn</surname> <given-names>C</given-names></name><name><surname>Coll</surname> <given-names>F</given-names></name><name><surname>Donker</surname> <given-names>T</given-names></name><name><surname>Gifford</surname> <given-names>DR</given-names></name><name><surname>Glover</surname> <given-names>RE</given-names></name><name><surname>Jit</surname> <given-names>M</given-names></name><name><surname>Klemm</surname> <given-names>E</given-names></name><name><surname>Lehtinen</surname> <given-names>S</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Llewelyn</surname> <given-names>MJ</given-names></name><name><surname>Mateus</surname> <given-names>ALP</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name><name><surname>Sharland</surname> <given-names>M</given-names></name><name><surname>Stekel</surname> <given-names>D</given-names></name><name><surname>Yakob</surname> <given-names>L</given-names></name><name><surname>Atkins</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mathematical modelling for antibiotic resistance control policy: do we know enough?</article-title><source>BMC Infectious Diseases</source><volume>19</volume><elocation-id>1011</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-019-4630-y</pub-id><pub-id pub-id-type="pmid">31783803</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouyos</surname> <given-names>R</given-names></name><name><surname>Klein</surname> <given-names>E</given-names></name><name><surname>Grenfell</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hospital-community interactions foster coexistence between methicillin-resistant strains of <italic>Staphylococcus aureus</italic></article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003134</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003134</pub-id><pub-id pub-id-type="pmid">23468619</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname> <given-names>F</given-names></name><name><surname>Lelièvre</surname> <given-names>H</given-names></name><name><surname>Cornu</surname> <given-names>M</given-names></name><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Carret</surname> <given-names>G</given-names></name><name><surname>Etienne</surname> <given-names>J</given-names></name><name><surname>Flandrois</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in french hospitals</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>47</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1093/jac/47.3.277</pub-id><pub-id pub-id-type="pmid">11222560</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leclerc</surname> <given-names>QJ</given-names></name><name><surname>Lindsay</surname> <given-names>JA</given-names></name><name><surname>Knight</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mathematical modelling to study the horizontal transfer of antimicrobial resistance genes in Bacteria: current state of the field and recommendations</article-title><source>Journal of the Royal Society Interface</source><volume>16</volume><elocation-id>20190260</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2019.0260</pub-id><pub-id pub-id-type="pmid">31409239</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehtinen</surname> <given-names>S</given-names></name><name><surname>Blanquart</surname> <given-names>F</given-names></name><name><surname>Croucher</surname> <given-names>NJ</given-names></name><name><surname>Turner</surname> <given-names>P</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Fraser</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage</article-title><source>PNAS</source><volume>114</volume><fpage>1075</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617849114</pub-id><pub-id pub-id-type="pmid">28096340</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerminiaux</surname> <given-names>NA</given-names></name><name><surname>Cameron</surname> <given-names>ADS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Horizontal transfer of antibiotic resistance genes in clinical environments</article-title><source>Canadian Journal of Microbiology</source><volume>65</volume><fpage>34</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1139/cjm-2018-0275</pub-id><pub-id pub-id-type="pmid">30248271</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letten</surname> <given-names>AD</given-names></name><name><surname>Baumgartner</surname> <given-names>M</given-names></name><name><surname>Pfrunder-Cardozo</surname> <given-names>KR</given-names></name><name><surname>Levine</surname> <given-names>JM</given-names></name><name><surname>Hall</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Human-associated Microbiota suppress invading Bacteria even under disruption by antibiotics</article-title><source>The ISME Journal</source><volume>15</volume><fpage>2809</fpage><lpage>2812</lpage><pub-id pub-id-type="doi">10.1038/s41396-021-00929-7</pub-id><pub-id pub-id-type="pmid">33712700</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>V</given-names></name><name><surname>Gill</surname> <given-names>S</given-names></name><name><surname>Sauve</surname> <given-names>J</given-names></name><name><surname>Walker</surname> <given-names>K</given-names></name><name><surname>Stumpo</surname> <given-names>C</given-names></name><name><surname>Powis</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Growing a &quot;positive culture&quot; of antimicrobial stewardship in a community hospital</article-title><source>The Canadian Journal of Hospital Pharmacy</source><volume>64</volume><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.4212/cjhp.v64i5.1065</pub-id><pub-id pub-id-type="pmid">22479082</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Samore</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Antimicrobial use and antimicrobial resistance: a population perspective</article-title><source>Emerging Infectious Diseases</source><volume>8</volume><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.3201/eid0804.010312</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozupone</surname> <given-names>CA</given-names></name><name><surname>Stombaugh</surname> <given-names>JI</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name><name><surname>Jansson</surname> <given-names>JK</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Diversity, stability and resilience of the human gut Microbiota</article-title><source>Nature</source><volume>489</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature11550</pub-id><pub-id pub-id-type="pmid">22972295</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luangasanatip</surname> <given-names>N</given-names></name><name><surname>Hongsuwan</surname> <given-names>M</given-names></name><name><surname>Limmathurotsakul</surname> <given-names>D</given-names></name><name><surname>Lubell</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>AS</given-names></name><name><surname>Harbarth</surname> <given-names>S</given-names></name><name><surname>Day</surname> <given-names>NP</given-names></name><name><surname>Graves</surname> <given-names>N</given-names></name><name><surname>Cooper</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis</article-title><source>BMJ</source><volume>351</volume><elocation-id>h3728</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.h3728</pub-id><pub-id pub-id-type="pmid">26220070</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lübbert</surname> <given-names>C</given-names></name><name><surname>Schumacher</surname> <given-names>U</given-names></name><name><surname>Stareprawo</surname> <given-names>S</given-names></name><name><surname>Claus</surname> <given-names>J</given-names></name><name><surname>Heeß-Erler</surname> <given-names>G</given-names></name><name><surname>Fiebig</surname> <given-names>C</given-names></name><name><surname>de With</surname> <given-names>K</given-names></name><name><surname>Wilhelms</surname> <given-names>D</given-names></name><name><surname>Kekulé</surname> <given-names>AS</given-names></name><name><surname>Klöss</surname> <given-names>T</given-names></name><name><surname>Moritz</surname> <given-names>S</given-names></name><collab>University Hospital Halle (Saale)</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Can the antibiotic prescription practice in a hospital be influenced by in-house guidelines? an interventional study at the university hospital halle Germany</article-title><source>Deutsche Medizinische Wochenschrift</source><volume>139</volume><fpage>2578</fpage><lpage>2584</lpage><pub-id pub-id-type="doi">10.1055/s-0034-1387220</pub-id><pub-id pub-id-type="pmid">25271804</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>SV</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The human intestinal microbiome in health and disease</article-title><source>New England Journal of Medicine</source><volume>375</volume><fpage>2369</fpage><lpage>2379</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1600266</pub-id><pub-id pub-id-type="pmid">27974040</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFadden</surname> <given-names>DR</given-names></name><name><surname>Fisman</surname> <given-names>DN</given-names></name><name><surname>Hanage</surname> <given-names>WP</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The relative impact of community and hospital antibiotic use on the selection of Extended-spectrum Beta-lactamase-producing <italic>Escherichia coli</italic></article-title><source>Clinical Infectious Diseases</source><volume>69</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy978</pub-id><pub-id pub-id-type="pmid">30462185</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mach</surname> <given-names>R</given-names></name><name><surname>Vlcek</surname> <given-names>J</given-names></name><name><surname>Prusova</surname> <given-names>M</given-names></name><name><surname>Batka</surname> <given-names>P</given-names></name><name><surname>Rysavy</surname> <given-names>V</given-names></name><name><surname>Kubena</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a czech hospital</article-title><source>Pharmacy World &amp; Science</source><volume>29</volume><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1007/s11096-006-9059-x</pub-id><pub-id pub-id-type="pmid">17610145</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maechler</surname> <given-names>F</given-names></name><name><surname>Schwab</surname> <given-names>F</given-names></name><name><surname>Hansen</surname> <given-names>S</given-names></name><name><surname>Fankhauser</surname> <given-names>C</given-names></name><name><surname>Harbarth</surname> <given-names>S</given-names></name><name><surname>Huttner</surname> <given-names>BD</given-names></name><name><surname>Diaz-Agero</surname> <given-names>C</given-names></name><name><surname>Lopez</surname> <given-names>N</given-names></name><name><surname>Canton</surname> <given-names>R</given-names></name><name><surname>Ruiz-Garbajosa</surname> <given-names>P</given-names></name><name><surname>Blok</surname> <given-names>H</given-names></name><name><surname>Bonten</surname> <given-names>MJ</given-names></name><name><surname>Kloosterman</surname> <given-names>F</given-names></name><name><surname>Schotsman</surname> <given-names>J</given-names></name><name><surname>Cooper</surname> <given-names>BS</given-names></name><name><surname>Behnke</surname> <given-names>M</given-names></name><name><surname>Golembus</surname> <given-names>J</given-names></name><name><surname>Kola</surname> <given-names>A</given-names></name><name><surname>Gastmeier</surname> <given-names>P</given-names></name><collab>R-GNOSIS WP5 study group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing enterobacterales in non-critical care wards: a cluster-randomised crossover trial</article-title><source>The Lancet Infectious Diseases</source><volume>20</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(19)30626-7</pub-id><pub-id pub-id-type="pmid">32087113</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malani</surname> <given-names>AN</given-names></name><name><surname>Richards</surname> <given-names>PG</given-names></name><name><surname>Kapila</surname> <given-names>S</given-names></name><name><surname>Otto</surname> <given-names>MH</given-names></name><name><surname>Czerwinski</surname> <given-names>J</given-names></name><name><surname>Singal</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Clinical and economic outcomes from a community hospital's antimicrobial stewardship program</article-title><source>American Journal of Infection Control</source><volume>41</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2012.02.021</pub-id><pub-id pub-id-type="pmid">22579261</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname> <given-names>S</given-names></name><name><surname>Hogue</surname> <given-names>IB</given-names></name><name><surname>Ray</surname> <given-names>CJ</given-names></name><name><surname>Kirschner</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A methodology for performing global uncertainty and sensitivity analysis in systems biology</article-title><source>Journal of Theoretical Biology</source><volume>254</volume><fpage>178</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2008.04.011</pub-id><pub-id pub-id-type="pmid">18572196</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>AR</given-names></name><name><surname>de Almeida</surname> <given-names>SM</given-names></name><name><surname>Correa</surname> <given-names>L</given-names></name><name><surname>Silva</surname> <given-names>M</given-names></name><name><surname>Martino</surname> <given-names>MD</given-names></name><name><surname>Silva</surname> <given-names>CV</given-names></name><name><surname>Cal</surname> <given-names>RG</given-names></name><name><surname>Edmond</surname> <given-names>MB</given-names></name><name><surname>dos Santos</surname> <given-names>OF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting</article-title><source>American Journal of Infection Control</source><volume>37</volume><fpage>204</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2008.06.008</pub-id><pub-id pub-id-type="pmid">18986735</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>McCormack</surname> <given-names>J</given-names></name><name><surname>Lalji</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><source>Antibiotic Sensitivity Chart</source><ext-link ext-link-type="uri" xlink:href="http://therapeuticseducation.org/sites/therapeuticseducation.org/files/Antibiotic_Sensitivity_December_2015.pdf">http://therapeuticseducation.org/sites/therapeuticseducation.org/files/Antibiotic_Sensitivity_December_2015.pdf</ext-link></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melnyk</surname> <given-names>AH</given-names></name><name><surname>Wong</surname> <given-names>A</given-names></name><name><surname>Kassen</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The fitness costs of antibiotic resistance mutations</article-title><source>Evolutionary Applications</source><volume>8</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1111/eva.12196</pub-id><pub-id pub-id-type="pmid">25861385</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>E</given-names></name><name><surname>Schwab</surname> <given-names>F</given-names></name><name><surname>Pollitt</surname> <given-names>A</given-names></name><name><surname>Bettolo</surname> <given-names>W</given-names></name><name><surname>Schroeren-Boersch</surname> <given-names>B</given-names></name><name><surname>Trautmann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit</article-title><source>Infection</source><volume>38</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1007/s15010-009-9115-2</pub-id><pub-id pub-id-type="pmid">19904488</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mideo</surname> <given-names>N</given-names></name><name><surname>Alizon</surname> <given-names>S</given-names></name><name><surname>Day</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Linking within- and between-host dynamics in the evolutionary epidemiology of infectious diseases</article-title><source>Trends in Ecology &amp; Evolution</source><volume>23</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.tree.2008.05.009</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>BA</given-names></name><name><surname>Chen</surname> <given-names>LF</given-names></name><name><surname>Sexton</surname> <given-names>DJ</given-names></name><name><surname>Anderson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated <italic>Clostridium difficile</italic> Infection and of Healthcare-Associated Infection due to Methicillin-Resistant <italic>Staphylococcus aureus</italic> in Community Hospitals</article-title><source>Infection Control &amp; Hospital Epidemiology</source><volume>32</volume><fpage>387</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1086/659156</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyawaki</surname> <given-names>K</given-names></name><name><surname>Miwa</surname> <given-names>Y</given-names></name><name><surname>Tomono</surname> <given-names>K</given-names></name><name><surname>Kurokawa</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impact of antimicrobial stewardship by infection control team in a japanese teaching hospital</article-title><source>Yakugaku Zasshi</source><volume>130</volume><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1248/yakushi.130.1105</pub-id><pub-id pub-id-type="pmid">20686215</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>DE</given-names></name><name><surname>Oakley</surname> <given-names>JE</given-names></name><name><surname>Crowe</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A web-based tool for eliciting probability distributions from experts</article-title><source>Environmental Modelling &amp; Software</source><volume>52</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.envsoft.2013.10.010</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulberry</surname> <given-names>N</given-names></name><name><surname>Rutherford</surname> <given-names>A</given-names></name><name><surname>Colijn</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systematic comparison of coexistence in models of drug-sensitive and drug-resistant pathogen strains</article-title><source>Theoretical Population Biology</source><volume>133</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.tpb.2019.12.001</pub-id><pub-id pub-id-type="pmid">31887315</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadimpalli</surname> <given-names>G</given-names></name><name><surname>O'Hara</surname> <given-names>LM</given-names></name><name><surname>Pineles</surname> <given-names>L</given-names></name><name><surname>Lebherz</surname> <given-names>K</given-names></name><name><surname>Johnson</surname> <given-names>JK</given-names></name><name><surname>Calfee</surname> <given-names>DP</given-names></name><name><surname>Miller</surname> <given-names>LG</given-names></name><name><surname>Morgan</surname> <given-names>DJ</given-names></name><name><surname>Harris</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patient to healthcare personnel transmission of MRSA in the non-intensive care unit setting</article-title><source>Infection Control &amp; Hospital Epidemiology</source><volume>41</volume><fpage>601</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1017/ice.2020.10</pub-id><pub-id pub-id-type="pmid">32036800</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname> <given-names>NR</given-names></name><name><surname>Atun</surname> <given-names>R</given-names></name><name><surname>Zhu</surname> <given-names>N</given-names></name><name><surname>Kulasabanathan</surname> <given-names>K</given-names></name><name><surname>Silva</surname> <given-names>S</given-names></name><name><surname>Chatterjee</surname> <given-names>A</given-names></name><name><surname>Knight</surname> <given-names>GM</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Estimating the burden of antimicrobial resistance: a systematic literature review</article-title><source>Antimicrobial Resistance &amp; Infection Control</source><volume>7</volume><elocation-id>58</elocation-id><pub-id pub-id-type="doi">10.1186/s13756-018-0336-y</pub-id><pub-id pub-id-type="pmid">29713465</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niewiadomska</surname> <given-names>AM</given-names></name><name><surname>Jayabalasingham</surname> <given-names>B</given-names></name><name><surname>Seidman</surname> <given-names>JC</given-names></name><name><surname>Willem</surname> <given-names>L</given-names></name><name><surname>Grenfell</surname> <given-names>B</given-names></name><name><surname>Spiro</surname> <given-names>D</given-names></name><name><surname>Viboud</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Population-level mathematical modeling of antimicrobial resistance: a systematic review</article-title><source>BMC Medicine</source><volume>17</volume><elocation-id>81</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-019-1314-9</pub-id><pub-id pub-id-type="pmid">31014341</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opatowski</surname> <given-names>L</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Boëlle</surname> <given-names>PY</given-names></name><name><surname>Temime</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Contribution of mathematical modeling to the fight against bacterial antibiotic resistance</article-title><source>Current Opinion in Infectious Diseases</source><volume>24</volume><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1097/QCO.0b013e3283462362</pub-id><pub-id pub-id-type="pmid">21467930</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname> <given-names>S</given-names></name><name><surname>Baumgartner</surname> <given-names>M</given-names></name><name><surname>Hall</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Species interactions drive the spread of ampicillin resistance in human-associated gut Microbiota</article-title><source>Evolution, Medicine, and Public Health</source><volume>9</volume><fpage>256</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1093/emph/eoab020</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Resurrecting the intestinal Microbiota to combat antibiotic-resistant pathogens</article-title><source>Science</source><volume>352</volume><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1126/science.aad9382</pub-id><pub-id pub-id-type="pmid">27126035</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantel</surname> <given-names>A</given-names></name><name><surname>Marchandin</surname> <given-names>H</given-names></name><name><surname>Prère</surname> <given-names>MF</given-names></name><name><surname>Boutet-Dubois</surname> <given-names>A</given-names></name><name><surname>Brieu-Roche</surname> <given-names>N</given-names></name><name><surname>Gaschet</surname> <given-names>A</given-names></name><name><surname>Davin-Regli</surname> <given-names>A</given-names></name><name><surname>Sotto</surname> <given-names>A</given-names></name><name><surname>Lavigne</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern france</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><volume>34</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1007/s10096-014-2298-1</pub-id><pub-id pub-id-type="pmid">25532506</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peto</surname> <given-names>Z</given-names></name><name><surname>Benko</surname> <given-names>R</given-names></name><name><surname>Matuz</surname> <given-names>M</given-names></name><name><surname>Csullog</surname> <given-names>E</given-names></name><name><surname>Molnar</surname> <given-names>A</given-names></name><name><surname>Hajdu</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary</article-title><source>Infection</source><volume>36</volume><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1007/s15010-008-7377-8</pub-id><pub-id pub-id-type="pmid">19011742</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilmis</surname> <given-names>B</given-names></name><name><surname>Cattoir</surname> <given-names>V</given-names></name><name><surname>Lecointe</surname> <given-names>D</given-names></name><name><surname>Limelette</surname> <given-names>A</given-names></name><name><surname>Grall</surname> <given-names>I</given-names></name><name><surname>Mizrahi</surname> <given-names>A</given-names></name><name><surname>Marcade</surname> <given-names>G</given-names></name><name><surname>Poilane</surname> <given-names>I</given-names></name><name><surname>Guillard</surname> <given-names>T</given-names></name><name><surname>Bourgeois Nicolaos</surname> <given-names>N</given-names></name><name><surname>Zahar</surname> <given-names>JR</given-names></name><name><surname>Le Monnier</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study</article-title><source>Journal of Hospital Infection</source><volume>98</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2017.11.022</pub-id><pub-id pub-id-type="pmid">29222035</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilmis</surname> <given-names>B</given-names></name><name><surname>Le Monnier</surname> <given-names>A</given-names></name><name><surname>Zahar</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Gut Microbiota, antibiotic therapy and antimicrobial resistance: a narrative review</article-title><source>Microorganisms</source><volume>8</volume><elocation-id>269</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8020269</pub-id><pub-id pub-id-type="pmid">32079318</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinquier</surname> <given-names>JL</given-names></name><name><surname>Varastet</surname> <given-names>M</given-names></name><name><surname>Meyers</surname> <given-names>D</given-names></name><name><surname>Sayah-Jeanne</surname> <given-names>S</given-names></name><name><surname>Féger</surname> <given-names>C</given-names></name><name><surname>Gaumétou</surname> <given-names>O</given-names></name><name><surname>Corbel</surname> <given-names>T</given-names></name><name><surname>de Gunzburg</surname> <given-names>J</given-names></name><name><surname>Mentré</surname> <given-names>F</given-names></name><name><surname>Ducher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A Colon-Targeted adsorbent (DAV132) does not affect the pharmacokinetics of warfarin or clonazepam in healthy subjects</article-title><source>Clinical Pharmacology in Drug Development</source><volume>10</volume><fpage>908</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1002/cpdd.901</pub-id><pub-id pub-id-type="pmid">33434399</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prescott</surname> <given-names>HC</given-names></name><name><surname>Dickson</surname> <given-names>RP</given-names></name><name><surname>Rogers</surname> <given-names>MA</given-names></name><name><surname>Langa</surname> <given-names>KM</given-names></name><name><surname>Iwashyna</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hospitalization type and subsequent severe sepsis</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>192</volume><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1164/rccm.201503-0483OC</pub-id><pub-id pub-id-type="pmid">26016947</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pressley</surname> <given-names>J</given-names></name><name><surname>D'Agata</surname> <given-names>EM</given-names></name><name><surname>Webb</surname> <given-names>GF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant <italic>Staphylococcus aureus</italic> strains on competitive exclusion</article-title><source>Journal of Theoretical Biology</source><volume>264</volume><fpage>645</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2010.03.036</pub-id><pub-id pub-id-type="pmid">20347850</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafii</surname> <given-names>F</given-names></name><name><surname>Sutherland</surname> <given-names>JB</given-names></name><name><surname>Cerniglia</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effects of treatment with antimicrobial agents on the human colonic microflora</article-title><source>Therapeutics and Clinical Risk Management</source><volume>4</volume><fpage>1343</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.2147/tcrm.s4328</pub-id><pub-id pub-id-type="pmid">19337440</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsay</surname> <given-names>DE</given-names></name><name><surname>Invik</surname> <given-names>J</given-names></name><name><surname>Checkley</surname> <given-names>SL</given-names></name><name><surname>Gow</surname> <given-names>SP</given-names></name><name><surname>Osgood</surname> <given-names>ND</given-names></name><name><surname>Waldner</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review</article-title><source>Epidemiology and Infection</source><volume>146</volume><fpage>2014</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1017/S0950268818002091</pub-id><pub-id pub-id-type="pmid">30062979</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravi</surname> <given-names>A</given-names></name><name><surname>Halstead</surname> <given-names>FD</given-names></name><name><surname>Bamford</surname> <given-names>A</given-names></name><name><surname>Casey</surname> <given-names>A</given-names></name><name><surname>Thomson</surname> <given-names>NM</given-names></name><name><surname>van Schaik</surname> <given-names>W</given-names></name><name><surname>Snelson</surname> <given-names>C</given-names></name><name><surname>Goulden</surname> <given-names>R</given-names></name><name><surname>Foster-Nyarko</surname> <given-names>E</given-names></name><name><surname>Savva</surname> <given-names>GM</given-names></name><name><surname>Whitehouse</surname> <given-names>T</given-names></name><name><surname>Pallen</surname> <given-names>MJ</given-names></name><name><surname>Oppenheim</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Loss of microbial diversity and pathogen domination of the gut Microbiota in critically ill patients</article-title><source>Microbial Genomics</source><volume>5</volume><elocation-id>000293</elocation-id><pub-id pub-id-type="doi">10.1099/mgen.0.000293</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relman</surname> <given-names>DA</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Microbiome as a tool and a target in the effort to address antimicrobial resistance</article-title><source>PNAS</source><volume>115</volume><fpage>12902</fpage><lpage>12910</lpage><pub-id pub-id-type="doi">10.1073/pnas.1717163115</pub-id><pub-id pub-id-type="pmid">30559176</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Baño</surname> <given-names>J</given-names></name><name><surname>Gutiérrez-Gutiérrez</surname> <given-names>B</given-names></name><name><surname>Machuca</surname> <given-names>I</given-names></name><name><surname>Pascual</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Treatment of infections caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae</article-title><source>Clinical Microbiology Reviews</source><volume>31</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.1128/CMR.00079-17</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname> <given-names>JL</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The gut Microbiota shapes intestinal immune responses during health and disease</article-title><source>Nature Reviews Immunology</source><volume>9</volume><fpage>313</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1038/nri2515</pub-id><pub-id pub-id-type="pmid">19343057</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname> <given-names>S</given-names></name><name><surname>Trinchieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microbiota: a key orchestrator of Cancer therapy</article-title><source>Nature Reviews Cancer</source><volume>17</volume><fpage>271</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/nrc.2017.13</pub-id><pub-id pub-id-type="pmid">28303904</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruppé</surname> <given-names>E</given-names></name><name><surname>Ghozlane</surname> <given-names>A</given-names></name><name><surname>Tap</surname> <given-names>J</given-names></name><name><surname>Pons</surname> <given-names>N</given-names></name><name><surname>Alvarez</surname> <given-names>AS</given-names></name><name><surname>Maziers</surname> <given-names>N</given-names></name><name><surname>Cuesta</surname> <given-names>T</given-names></name><name><surname>Hernando-Amado</surname> <given-names>S</given-names></name><name><surname>Clares</surname> <given-names>I</given-names></name><name><surname>Martínez</surname> <given-names>JL</given-names></name><name><surname>Coque</surname> <given-names>TM</given-names></name><name><surname>Baquero</surname> <given-names>F</given-names></name><name><surname>Lanza</surname> <given-names>VF</given-names></name><name><surname>Máiz</surname> <given-names>L</given-names></name><name><surname>Goulenok</surname> <given-names>T</given-names></name><name><surname>de Lastours</surname> <given-names>V</given-names></name><name><surname>Amor</surname> <given-names>N</given-names></name><name><surname>Fantin</surname> <given-names>B</given-names></name><name><surname>Wieder</surname> <given-names>I</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name><name><surname>van Schaik</surname> <given-names>W</given-names></name><name><surname>Rogers</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Willems</surname> <given-names>RJL</given-names></name><name><surname>de Brevern</surname> <given-names>AG</given-names></name><name><surname>Batto</surname> <given-names>JM</given-names></name><name><surname>Blottière</surname> <given-names>HM</given-names></name><name><surname>Léonard</surname> <given-names>P</given-names></name><name><surname>Léjard</surname> <given-names>V</given-names></name><name><surname>Letur</surname> <given-names>A</given-names></name><name><surname>Levenez</surname> <given-names>F</given-names></name><name><surname>Weiszer</surname> <given-names>K</given-names></name><name><surname>Haimet</surname> <given-names>F</given-names></name><name><surname>Doré</surname> <given-names>J</given-names></name><name><surname>Kennedy</surname> <given-names>SP</given-names></name><name><surname>Ehrlich</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Prediction of the intestinal resistome by a three-dimensional structure-based method</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0292-6</pub-id><pub-id pub-id-type="pmid">30478291</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname> <given-names>S</given-names></name><name><surname>Tariq</surname> <given-names>R</given-names></name><name><surname>Tosh</surname> <given-names>PK</given-names></name><name><surname>Pardi</surname> <given-names>DS</given-names></name><name><surname>Khanna</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Faecal Microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review</article-title><source>Clinical Microbiology and Infection</source><volume>25</volume><fpage>958</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2019.04.006</pub-id><pub-id pub-id-type="pmid">30986562</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanvic</surname> <given-names>A</given-names></name><name><surname>Denic</surname> <given-names>L</given-names></name><name><surname>Gaillon</surname> <given-names>S</given-names></name><name><surname>Giry</surname> <given-names>P</given-names></name><name><surname>Andremont</surname> <given-names>A</given-names></name><name><surname>Lucet</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Duration of colonization by methicillin-resistant <italic>Staphylococcus aureus</italic> after hospital discharge and risk factors for prolonged carriage</article-title><source>Clinical Infectious Diseases</source><volume>32</volume><fpage>1393</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1086/320151</pub-id><pub-id pub-id-type="pmid">11317238</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schön</surname> <given-names>T</given-names></name><name><surname>Sandelin</surname> <given-names>LL</given-names></name><name><surname>Bonnedahl</surname> <given-names>J</given-names></name><name><surname>Hedebäck</surname> <given-names>F</given-names></name><name><surname>Wistedt</surname> <given-names>A</given-names></name><name><surname>Brudin</surname> <given-names>L</given-names></name><name><surname>Jarnheimer</surname> <given-names>PÅ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A comparative study of three methods to evaluate an intervention to improve empirical antibiotic therapy for acute bacterial infections in hospitalized patients</article-title><source>Scandinavian Journal of Infectious Diseases</source><volume>43</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.3109/00365548.2010.544326</pub-id><pub-id pub-id-type="pmid">21171827</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname> <given-names>JT</given-names></name><name><surname>Leboucher</surname> <given-names>G</given-names></name><name><surname>Myard-Dury</surname> <given-names>AF</given-names></name><name><surname>Girardo</surname> <given-names>P</given-names></name><name><surname>Luzzati</surname> <given-names>A</given-names></name><name><surname>Mary</surname> <given-names>M</given-names></name><name><surname>Sauzon</surname> <given-names>JF</given-names></name><name><surname>Lafay</surname> <given-names>B</given-names></name><name><surname>Dauwalder</surname> <given-names>O</given-names></name><name><surname>Laurent</surname> <given-names>F</given-names></name><name><surname>Lina</surname> <given-names>G</given-names></name><name><surname>Chidiac</surname> <given-names>C</given-names></name><name><surname>Couray-Targe</surname> <given-names>S</given-names></name><name><surname>Vandenesch</surname> <given-names>F</given-names></name><name><surname>Flandrois</surname> <given-names>JP</given-names></name><name><surname>Rasigade</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Metapopulation ecology links antibiotic resistance, consumption, and patient transfers in a network of hospital wards</article-title><source>eLife</source><volume>9</volume><elocation-id>e54795</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54795</pub-id><pub-id pub-id-type="pmid">33106223</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname> <given-names>LP</given-names></name><name><surname>Bassam</surname> <given-names>H</given-names></name><name><surname>Barnes</surname> <given-names>CP</given-names></name><name><surname>Walker</surname> <given-names>AS</given-names></name><name><surname>Klein</surname> <given-names>N</given-names></name><name><surname>Balloux</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Modelling microbiome recovery after antibiotics using a stability landscape framework</article-title><source>The ISME Journal</source><volume>13</volume><fpage>1845</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1038/s41396-019-0392-1</pub-id><pub-id pub-id-type="pmid">30877283</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenoy</surname> <given-names>ES</given-names></name><name><surname>Paras</surname> <given-names>ML</given-names></name><name><surname>Noubary</surname> <given-names>F</given-names></name><name><surname>Walensky</surname> <given-names>RP</given-names></name><name><surname>Hooper</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Natural history of colonization with methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review</article-title><source>BMC Infectious Diseases</source><volume>14</volume><elocation-id>177</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-14-177</pub-id><pub-id pub-id-type="pmid">24678646</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simor</surname> <given-names>AE</given-names></name><name><surname>Yake</surname> <given-names>SL</given-names></name><name><surname>Tsimidis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Infection due to Clostridium difficile among elderly residents of a long-term-care facility</article-title><source>Clinical Infectious Diseases</source><volume>17</volume><fpage>672</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1093/clinids/17.4.672</pub-id><pub-id pub-id-type="pmid">7903557</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>RL</given-names></name><name><surname>Evans</surname> <given-names>HL</given-names></name><name><surname>Chong</surname> <given-names>TW</given-names></name><name><surname>McElearney</surname> <given-names>ST</given-names></name><name><surname>Hedrick</surname> <given-names>TL</given-names></name><name><surname>Swenson</surname> <given-names>BR</given-names></name><name><surname>Scheld</surname> <given-names>WM</given-names></name><name><surname>Pruett</surname> <given-names>TL</given-names></name><name><surname>Sawyer</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Reduction in rates of methicillin-resistant <italic>Staphylococcus aureus</italic> infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit</article-title><source>Surgical Infections</source><volume>9</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1089/sur.2007.024</pub-id><pub-id pub-id-type="pmid">18759679</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>DRM</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>microbiomeR</data-title><source>Software Heritage</source><version designator="swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f">swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b9466325c11d19e7bc3962c2c4b913dd88d701b8;origin=https://github.com/drmsmith/microbiomeR;visit=swh:1:snp:111f1edd0d2dbcdc7509e028d86125d72f7d7650;anchor=swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f">https://archive.softwareheritage.org/swh:1:dir:b9466325c11d19e7bc3962c2c4b913dd88d701b8;origin=https://github.com/drmsmith/microbiomeR;visit=swh:1:snp:111f1edd0d2dbcdc7509e028d86125d72f7d7650;anchor=swh:1:rev:a3682a24970d79e4f748952ecc49fcdb16adf48f</ext-link></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorbara</surname> <given-names>MT</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them</article-title><source>Mucosal Immunology</source><volume>12</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41385-018-0053-0</pub-id><pub-id pub-id-type="pmid">29988120</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spicknall</surname> <given-names>IH</given-names></name><name><surname>Foxman</surname> <given-names>B</given-names></name><name><surname>Marrs</surname> <given-names>CF</given-names></name><name><surname>Eisenberg</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization</article-title><source>American Journal of Epidemiology</source><volume>178</volume><fpage>508</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1093/aje/kwt017</pub-id><pub-id pub-id-type="pmid">23660797</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname> <given-names>B</given-names></name><name><surname>Maier</surname> <given-names>L</given-names></name><name><surname>Hardt</surname> <given-names>WD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution</article-title><source>Nature Reviews Microbiology</source><volume>11</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2989</pub-id><pub-id pub-id-type="pmid">23474681</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Toussaint</surname> <given-names>NC</given-names></name><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Rätsch</surname> <given-names>G</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Xavier</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ecological modeling from time-series inference: insight into dynamics and stability of intestinal Microbiota</article-title><source>PLOS Computational Biology</source><volume>9</volume><elocation-id>e1003388</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003388</pub-id><pub-id pub-id-type="pmid">24348232</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takesue</surname> <given-names>Y</given-names></name><name><surname>Nakajima</surname> <given-names>K</given-names></name><name><surname>Ichiki</surname> <given-names>K</given-names></name><name><surname>Ishihara</surname> <given-names>M</given-names></name><name><surname>Wada</surname> <given-names>Y</given-names></name><name><surname>Takahashi</surname> <given-names>Y</given-names></name><name><surname>Tsuchida</surname> <given-names>T</given-names></name><name><surname>Ikeuchi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative Bacteria</article-title><source>Journal of Hospital Infection</source><volume>75</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2009.11.022</pub-id><pub-id pub-id-type="pmid">20346536</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>C</given-names></name><name><surname>Vermeulen</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zvonar</surname> <given-names>R</given-names></name><name><surname>Garber</surname> <given-names>G</given-names></name><name><surname>Daneman</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Variability in antibiotic use across Ontario acute care hospitals</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>72</volume><fpage>554</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1093/jac/dkw454</pub-id><pub-id pub-id-type="pmid">27856724</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tedijanto</surname> <given-names>C</given-names></name><name><surname>Olesen</surname> <given-names>SW</given-names></name><name><surname>Grad</surname> <given-names>YH</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora</article-title><source>PNAS</source><volume>115</volume><fpage>E11988</fpage><lpage>E11995</lpage><pub-id pub-id-type="doi">10.1073/pnas.1810840115</pub-id><pub-id pub-id-type="pmid">30559213</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepekule</surname> <given-names>B</given-names></name><name><surname>Uecker</surname> <given-names>H</given-names></name><name><surname>Derungs</surname> <given-names>I</given-names></name><name><surname>Frenoy</surname> <given-names>A</given-names></name><name><surname>Bonhoeffer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modeling antibiotic treatment in hospitals: a systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005745</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005745</pub-id><pub-id pub-id-type="pmid">28915236</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tepekule</surname> <given-names>B</given-names></name><name><surname>Abel Zur Wiesch</surname> <given-names>P</given-names></name><name><surname>Kouyos</surname> <given-names>RD</given-names></name><name><surname>Bonhoeffer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut Microbiota</article-title><source>PNAS</source><volume>116</volume><fpage>23106</fpage><lpage>23116</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912188116</pub-id><pub-id pub-id-type="pmid">31666328</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touat</surname> <given-names>M</given-names></name><name><surname>Opatowski</surname> <given-names>M</given-names></name><name><surname>Brun-Buisson</surname> <given-names>C</given-names></name><name><surname>Cosker</surname> <given-names>K</given-names></name><name><surname>Guillemot</surname> <given-names>D</given-names></name><name><surname>Salomon</surname> <given-names>J</given-names></name><name><surname>Tuppin</surname> <given-names>P</given-names></name><name><surname>de Lagasnerie</surname> <given-names>G</given-names></name><name><surname>Watier</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A payer perspective of the hospital inpatient additional care costs of antimicrobial resistance in France: a matched Case-Control study</article-title><source>Applied Health Economics and Health Policy</source><volume>17</volume><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1007/s40258-018-0451-1</pub-id><pub-id pub-id-type="pmid">30506456</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bunnik</surname> <given-names>BAD</given-names></name><name><surname>Woolhouse</surname> <given-names>MEJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Modelling the impact of curtailing antibiotic usage in food animals on antibiotic resistance in humans</article-title><source>Royal Society Open Science</source><volume>4</volume><elocation-id>161067</elocation-id><pub-id pub-id-type="doi">10.1098/rsos.161067</pub-id><pub-id pub-id-type="pmid">28484624</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Driessche</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reproduction numbers of infectious disease models</article-title><source>Infectious Disease Modelling</source><volume>2</volume><fpage>288</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.idm.2017.06.002</pub-id><pub-id pub-id-type="pmid">29928743</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kleef</surname> <given-names>E</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name><name><surname>Jit</surname> <given-names>M</given-names></name><name><surname>Deeny</surname> <given-names>SR</given-names></name><name><surname>Edmunds</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modelling the transmission of healthcare associated infections: a systematic review</article-title><source>BMC Infectious Diseases</source><volume>13</volume><elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-13-294</pub-id><pub-id pub-id-type="pmid">23809195</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kleef</surname> <given-names>E</given-names></name><name><surname>Deeny</surname> <given-names>SR</given-names></name><name><surname>Jit</surname> <given-names>M</given-names></name><name><surname>Cookson</surname> <given-names>B</given-names></name><name><surname>Goldenberg</surname> <given-names>SD</given-names></name><name><surname>Edmunds</surname> <given-names>WJ</given-names></name><name><surname>Robotham</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy</article-title><source>Vaccine</source><volume>34</volume><fpage>5562</fpage><lpage>5570</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.09.046</pub-id><pub-id pub-id-type="pmid">27727031</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal-Navarro</surname> <given-names>L</given-names></name><name><surname>Pfeiffer</surname> <given-names>C</given-names></name><name><surname>Bouziges</surname> <given-names>N</given-names></name><name><surname>Sotto</surname> <given-names>A</given-names></name><name><surname>Lavigne</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a french university hospital</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>65</volume><fpage>2455</fpage><lpage>2458</lpage><pub-id pub-id-type="doi">10.1093/jac/dkq333</pub-id><pub-id pub-id-type="pmid">20813808</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname> <given-names>CL</given-names></name><name><surname>Chan</surname> <given-names>DS</given-names></name><name><surname>Earnest</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>TS</given-names></name><name><surname>Yeoh</surname> <given-names>SF</given-names></name><name><surname>Lim</surname> <given-names>R</given-names></name><name><surname>Jureen</surname> <given-names>R</given-names></name><name><surname>Fisher</surname> <given-names>D</given-names></name><name><surname>Hsu</surname> <given-names>LY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><volume>31</volume><fpage>583</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1007/s10096-011-1351-6</pub-id><pub-id pub-id-type="pmid">21845470</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zellmer</surname> <given-names>C</given-names></name><name><surname>Sater</surname> <given-names>MRA</given-names></name><name><surname>Huntley</surname> <given-names>MH</given-names></name><name><surname>Osman</surname> <given-names>M</given-names></name><name><surname>Olesen</surname> <given-names>SW</given-names></name><name><surname>Ramakrishna</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Shiga Toxin-Producing <italic>Escherichia coli</italic> transmission via fecal Microbiota transplant</article-title><source>Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America</source><volume>72</volume><fpage>e876</fpage><lpage>e880</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa1486</pub-id><pub-id pub-id-type="pmid">33159210</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Jiang</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Ren</surname> <given-names>H</given-names></name><name><surname>Peng</surname> <given-names>H</given-names></name><name><surname>Lai</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oral antibiotic treatment induces skin Microbiota dysbiosis and influences wound healing</article-title><source>Microbial Ecology</source><volume>69</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1007/s00248-014-0504-4</pub-id><pub-id pub-id-type="pmid">25301498</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>YM</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>JH</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Fan</surname> <given-names>T</given-names></name><name><surname>Shan</surname> <given-names>YY</given-names></name><name><surname>Yao</surname> <given-names>HP</given-names></name><name><surname>Dong</surname> <given-names>YL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a chinese teaching hospital (2009-2013)</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><volume>34</volume><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1007/s10096-014-2293-6</pub-id><pub-id pub-id-type="pmid">25487131</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>zur Wiesch</surname> <given-names>PA</given-names></name><name><surname>Kouyos</surname> <given-names>R</given-names></name><name><surname>Engelstädter</surname> <given-names>J</given-names></name><name><surname>Regoes</surname> <given-names>RR</given-names></name><name><surname>Bonhoeffer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Population biological principles of drug-resistance evolution in infectious diseases</article-title><source>The Lancet Infectious Diseases</source><volume>11</volume><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(10)70264-4</pub-id><pub-id pub-id-type="pmid">21371657</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><sec id="s8" sec-type="appendix"><title>Model and assumptions</title><sec id="s8-1"><title>ODEs</title><p>The final ODE system, which incorporates horizontal gene transfer (HGT) of a transmissible resistance gene R into the mixed microbiome-strain competition model (<xref ref-type="disp-formula" rid="equ6">Equation 6</xref> in the main text), is given by:<disp-formula id="equ9"><label>(A1)</label><mml:math id="m9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>ω</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>ω</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>ω</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>η</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>This system of equations describes epidemiological colonization dynamics of a bacterial pathogen among host classes <italic>H<sub>j,k</sub></italic>, corresponding to patients of pathogen colonization status <italic>H</italic> (<italic>S</italic>, <italic>C<sup>S</sup></italic>, <italic>C<sup>R</sup></italic>), microbiome status <italic>j</italic> (<italic>e</italic>, equilibrium; or <italic>d</italic>, dysbiosis) and microbiome resistance profile <italic>k</italic> (<italic>s</italic>, not bearing R; <italic>r</italic>, bearing R). Equations can be found in an R file and Mathematica notebook available online (<ext-link ext-link-type="uri" xlink:href="https://github.com/drmsmith/microbiomeR">https://github.com/drmsmith/microbiomeR</ext-link>), and modeling assumptions are listed below.</p></sec><sec id="s8-2"><title>Patient demography</title><p>We assume constant population size (N=1), balanced by a daily rate of hospital admission and discharge μ. The number of patients in each compartment is expressed as proportions of the total population. The proportion of patients entering each compartment <italic>j</italic> is given by admission fractions <italic>f<sub>j</sub></italic>. These are interpreted as representing prevalence of different host types in the community, which are assumed to be stable over time and unaffected by hospital dynamics. For simplicity, demography is expressed as Δ<sub>j</sub> for each class <italic>j</italic>, which expand to:<disp-formula id="equ10"><label>(A2)</label><mml:math id="m10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow><mml:mrow><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>where <italic>f<sub>C</sub></italic> is the proportion of patients colonized with the pathogen upon admission, <italic>f<sub>R</sub></italic> is the proportion of colonized patients bearing the focal resistant strain (i.e. the community resistance rate), <italic>f<sub>d</sub></italic> is the proportion of patients undergoing dysbiosis upon hospital admission, and <italic>f<sub>ω</sub></italic> is the proportion of admitted patients with microbiota bearing R.</p></sec><sec id="s8-3"><title>Pathogen epidemiology</title><p>Pathogen colonization can be acquired through dynamic patient-to-patient <italic>transmission</italic> via the dynamic force of infection λ, which is defined as the product of the pathogen’s intrinsic transmission rate (β) and the prevalence of patients colonized at a particular time <italic>t</italic>. For each strain P<sup>j</sup>, with <italic>j</italic> in {S, R}, this is given by<disp-formula id="equ11"><label>(A3)</label><mml:math id="m11"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>β</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:msubsup><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>In hospital environments, pathogen colonization incidence also results from <italic>endogenous acquisition</italic> (α). This subsumes alternative routes of acquisition not resulting from direct patient-to-patient transmission, and can include processes like translocation and within-host outgrowth of a subdominant/non-detectable/non-transmissible colony (into a dominant/detectable/transmissible colony) (<xref ref-type="bibr" rid="bib4">Archambaud et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Bootsma et al., 2007</xref>; <xref ref-type="bibr" rid="bib53">Duval et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref>). This reflects the tenet that ‘everything is everywhere, but the environment selects’ (<xref ref-type="bibr" rid="bib45">de Wit and Bouvier, 2006</xref>). We assume that pathogen colonization is not acquired endogenously among patients undergoing antibiotic treatment capable of clearing that pathogen, such that for each strain P<sup>j</sup>,<disp-formula id="equ12"><label>(A4)</label><mml:math id="m12"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mi>'</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>)</mml:mo></mml:math></disp-formula>where α’ is the baseline rate in untreated patients. For the hospital simulation study (below), available literature estimates for endogenous acquisition rates were not strain-specific. These were generated by scaling species-specific rates by the baseline prevalence of each strain in the community, or<disp-formula id="equ13"><label>(A5)</label><mml:math id="m13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Pathogen colonization is naturally cleared by the host at rate γ. To reflect potential metabolic costs associated with bearing antibiotic resistance genes (<xref ref-type="bibr" rid="bib102">Melnyk et al., 2015</xref>), we assumed that C<sup>R</sup> (colonization with the resistant strain) is naturally cleared at a faster rate than C<sup>S</sup> (colonization with the sensitive strain), such that γ<sub>S</sub> &lt; γ<sub>R</sub>. This is given by<disp-formula id="equ14"><label>(A6)</label><mml:math id="m14"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where <italic>c</italic> is interpreted as the fitness cost of bearing R.</p></sec><sec id="s8-4"><title>Antibiotic resistance</title><p>Pathogen colonization is cleared by antibiotics according to strain-specific rates of effective antibiotic treatment, given by<disp-formula id="equ15"><label>(A7)</label><mml:math id="m15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Antibiotic exposure prevalence <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> is applied independently of colonization status to reflect high estimated rates of bystander selection for ARB, which predominantly colonize patients asymptomatically, are rarely detected and only opportunistically cause disease (<xref ref-type="bibr" rid="bib145">Tedijanto et al., 2018</xref>). Among patients exposed to effective antibiotic therapy, pathogen colonization is cleared at a constant rate θ<sub>C</sub>. The proportion of antibiotics that are ineffective is given by the antibiotic resistance level <italic>r<sub>j</sub></italic>, which is a proportion reflecting the pathogen’s innate resistance to the antibiotics to which it is exposed, ranging from complete antibiotic sensitivity (<italic>r<sub>j</sub></italic> = 0) to complete resistance (<italic>r<sub>j</sub></italic> = 1), For model application, effective antibiotic treatment is considered at the level of antibiotic class, with rates for each class varying across strains and species (see main text <xref ref-type="disp-formula" rid="equ8">Equation 8</xref>).</p></sec><sec id="s8-5"><title>Microbiome dynamics</title><p>Patient microbiota are considered in terms of their population dynamic stability, and are assumed either to be at stable equilibrium or undergoing temporary dysbiosis (population dynamic disequilibrium). Microbiome stability is disrupted via antibiotic treatment according to<disp-formula id="equ16"><label>(A8)</label><mml:math id="m16"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>For model application, rates of antibiotic-induced microbiome dysbiosis are also considered at the level of antibiotic class (see main text <xref ref-type="disp-formula" rid="equ7">Equation 7</xref>). Microbiome stability recovers at rate δ, but only among patients not actively undergoing antibiotic treatment, such that<disp-formula id="equ17"><label>(A9)</label><mml:math id="m17"><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>δ</mml:mi><mml:mi>'</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where δ ‘is the baseline rate in untreated hosts. Further, during model application we assume that microbiota can still recover among patients exposed to aminoglycosides and tetracyclines, the antibiotic classes inducing microbiome dysbiosis at the lowest rate (k=3, see Materials and methods), such that<disp-formula id="equ18"><label>(A10)</label><mml:math id="m18"><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>δ</mml:mi><mml:mi>'</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mo>×</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>)</mml:mo></mml:math></disp-formula></p></sec><sec id="s8-6"><title>Microbiome-pathogen competition</title><p>We assume that the host microbiome and the focal pathogen compete ecologically within the host, such that host microbiota limit pathogen transmission, persistence and endogenous acquisition. We propose three examples of microbiome-pathogen competition – colonization resistance (ε), resource competition (η), and ecological release (ϕ) – and conceptualize how they affect pathogen colonization processes, and by extension how microbiome dysbiosis predisposes patients to pathogen colonization (see <xref ref-type="fig" rid="fig2">Figure 2</xref> in the main text). Interactions are given by<disp-formula id="equ19"><label>(1)</label><mml:math id="m19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mi>ε</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ε</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>β</mml:mi></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>η</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>η</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>γ</mml:mi></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:mi>ϕ</mml:mi><mml:mo>×</mml:mo><mml:mi>α</mml:mi></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>where, respectively, ε reduces the transmission rate to patients with stable microbiota, η reduces the clearance rate among patients undergoing dysbiosis, and ϕ favours endogenous acquisition among patients undergoing dysbiosis. We assume that microbiome-pathogen interactions are species- and not strain-specific, that is that ε, η and ϕ apply equally to P<sup>S</sup> and P<sup>R</sup>.</p></sec><sec id="s8-7"><title>Horizontal gene transfer</title><p>HGT is conceptualized as two-way within-host transfer of the focal resistance gene R, either from an R-bearing pathogen strain P<sup>R</sup> to co-colonizing microbiota, or from R-bearing microbiota to a co-colonizing drug-sensitive pathogen strain P<sup>S</sup>. For simplicity, we assumed (i) a symmetric rate of HGT (χ) from each donor, (ii) no loss of resistance upon donation, (iii) no accumulation of resistance (e.g. plasmid copy number dependence), (iv) that all patients bear microbiota capable of receiving and transferring R, (v) that dysbiosis can accelerate the rate of transfer (χ<sub>d</sub> ≥ χ<sub>e</sub>), (vi) no impact of R on rates of microbiome dysbiosis and recovery, (vii) that a proportion <italic>f<sub>ω</sub></italic> of patients are admitted to hospital with microbiota bearing R, and lastly (viii) that microbiota of a proportion ω of patients can spontaneously acquire R subsequent to dysbiosis. The latter assumption was made to reflect increased expression of antibiotic resistance genes among host microbiota following antibiotic therapy, and can be interpreted as a corollary to endogenous pathogen acquisition (<xref ref-type="bibr" rid="bib129">Ruppé et al., 2019</xref>).</p></sec><sec id="s8-8"><title>Public health interventions</title><p>Three public health interventions τ were incorporated into Appendix <xref ref-type="disp-formula" rid="equ9">Equation A1</xref> for subsequent model application. First, contact precautions were assumed to represent physical or behavioral barriers that block opportunities for transmission, reducing transmission rates by the same fraction τ<sub>ipc</sub> across all pathogens relative to baseline. This is given by<disp-formula id="equ20"><label>(A12)</label><mml:math id="m20"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>×</mml:mo><mml:mi>β</mml:mi></mml:math></disp-formula></p><p>Second, antibiotic stewardship programmes were assumed to alter antibiotic consumption patterns in the hospital. Two main types were considered: antibiotic reduction, which limits overall antibiotic prescribing by a fraction τ<sub>asp</sub>, given by<disp-formula id="equ21"><label>(A13)</label><mml:math id="m21"><mml:msub><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>×</mml:mo><mml:mi mathvariant="normal">a</mml:mi></mml:math></disp-formula>and antibiotic restriction, which adjusts the distribution of antibiotic classes consumed in the hospital. We considered two types of restriction, the first favouring classically narrow-spectrum antibiotics (e.g. macrolides) over broad-spectrum (e.g. quinolones), and the second favouring antibiotics that cause dysbiosis at very low or low rates (k={3,2}) over those causing dysbiosis at medium or high rates (k={1,0}). For both, the proportion of antibiotics in the restricted group (<italic>p<sub>restrict</sub></italic>) was reduced by the same fraction τ<sub>asp</sub> without adjusting the distribution of antibiotics consumed within that group, given by<disp-formula id="equ22"><label>(A14)</label><mml:math id="m22"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mo>|</mml:mo><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula>and the proportion of non-restricted antibiotics was increased symmetrically. With this structure, τ<sub>asp</sub> alters antibiotic consumption for the same proportion of hospital patients across all three stewardship interventions. In all simulations, p<sub>restrict</sub> &gt; τ<sub>asp</sub>.</p><p>Third, microbiome recovery therapy was assumed to trigger recovery at rate 0.5 day<sup>−1</sup> and was apportioned to the fraction τ<sub>pbt</sub> of patients, such that the overall rate of microbiome recovery when including these interventions (δ<sub>pbt</sub>) is given by<disp-formula id="equ23"><label>(A15)</label><mml:math id="m23"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>b</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:mn>0.5</mml:mn><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>b</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>For simplicity, different values assumed for intervention parameters (τ<sub>ipc</sub>, τ<sub>asp</sub>, τ<sub>pbt</sub>) are interpreted as different levels of compliance to the respective interventions.</p></sec></sec><sec id="s9" sec-type="appendix"><title>Part 1: Model evaluation and parameterization</title><sec id="s9-1"><title>R<sub>0</sub> expressions</title><p><italic>R</italic><sub>0</sub> was calculated for P<sup>R</sup> across <xref ref-type="disp-formula" rid="equ19 equ3 equ4 equ6">Equations 1, 3, 4 and 6</xref> from the main text (see Mathematica notebook), and was interpreted as the expected number of secondary patients colonized by an index patient in a fully susceptible (uncolonized) hospital population (i.e. at <italic>disease-free equilibrium</italic>, DFE, as indicated by the equilibrium symbol ^ above state variables). To reflect this epidemiological context, we made two additional assumptions specifically for <italic>R</italic><sub>0</sub> calculations: no C<sup>R</sup> input from the community (<italic>f<sub>R</sub></italic>=0), and that the rate of endogenous acquisition α<sub>R</sub> scales linearly with current colonization prevalence C<sup>R</sup>. <italic>R</italic><sub>0</sub> expressions were derived following <xref ref-type="bibr" rid="bib150">van den Driessche, 2017</xref>.</p><p>For the susceptible-colonized model,<disp-formula id="equ24"><label>(A16)</label><mml:math id="m24"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mfrac><mml:mrow><mml:mi>β</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, such that pathogens with higher rates of transmission (β) and endogenous acquisition (α<sub>R</sub>) have higher <italic>R</italic><sub>0</sub>, while those with higher rates of natural clearance (γ<sub>R</sub>) have lower <italic>R</italic><sub>0</sub>. Higher rates of effective antibiotic treatment (σ<sub>R</sub>) and patient admission and discharge (μ) also reduce <italic>R</italic><sub>0</sub>.</p><p>For the strain competition model, we derive <italic>R</italic><sub>0</sub> for P<sup>R</sup> assuming that P<sup>S</sup> is at endemic equilibrium with input from the community (<italic>f<sub>C</sub></italic> &gt; 0, <italic>f<sub>R</sub></italic> = 0). In this context, the same <italic>R</italic><sub>0</sub> expression was found as for the susceptible-colonized model (Appendix <xref ref-type="disp-formula" rid="equ24">Equation A16</xref>), except <italic>R</italic><sub>0</sub> is reduced because of a lower equilibrium prevalence of susceptible hosts when P<sup>S</sup> is endemic (<inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>). DFE were not found analytically for models with strain competition and were solved numerically (details below).</p><p>For the microbiome model, <italic>R</italic><sub>0</sub> was calculated using next-generation theory as the spectral radius of the next-generation matrix (NGM),<disp-formula id="equ25"><label>(A17)</label><mml:math id="m25"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>ρ</mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="bold">N</mml:mi><mml:mi mathvariant="bold">G</mml:mi><mml:mi mathvariant="bold">M</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where NGM is the product of the transmission matrix <bold>F</bold> (describing the rates at which existing colonies cause colonization in new hosts) and the inverse transition matrix <bold>V</bold> (describing the rates at which colonized hosts shift between colonized classes or are removed). These are given by<disp-formula id="equ26"><label>(A18)</label><mml:math id="m26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="bold">F</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mtable columnalign="center center" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ε</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ε</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>ϕ</mml:mi><mml:mo>+</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>ϕ</mml:mi><mml:mo>+</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula>and<disp-formula id="equ27"><label>(A19)</label><mml:math id="m27"><mml:mi mathvariant="bold">V</mml:mi><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mtd><mml:mtd><mml:mo>-</mml:mo><mml:mi>δ</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:msub><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>η</mml:mi><mml:mo>)</mml:mo><mml:mo>×</mml:mo><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math></disp-formula>which give<disp-formula id="equ28"><label>(A20)</label><mml:math id="m28"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ε</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>η</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>ϕ</mml:mi><mml:mo>+</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>η</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>η</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula>where the two terms in the numerator correspond to pathogen acquisition, respectively, in hosts with a stable microbiome and in those undergoing dysbiosis. Antibiotic-induced dysbiosis (σ<sub>m</sub>) and treatment (σ<sub>R</sub>) are found in both numerator and denominator.</p><p>When assuming no microbiome-pathogen interactions (ε = 0, η = 0, ϕ = 1), DFE is<disp-formula id="equ29"><label>(A21)</label><mml:math id="m29"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mi>μ</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:mi>δ</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula>and <italic>R</italic><sub>0</sub> reduces to the same expression as given by the susceptible-colonized model<disp-formula id="equ30"><label>(A22)</label><mml:math id="m30"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>β</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>With two strains, as in the microbiome-strain competition model, the same <italic>R</italic><sub>0</sub> expression is found for P<sup>R</sup> as the single-strain model, but when P<sup>S</sup> is endemic,<disp-formula id="equ31"><label>(A23)</label><mml:math id="m31"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></disp-formula>so strain competition dampens <italic>R</italic><sub>0</sub> relative to the single-strain microbiome competition model. <italic>R</italic><sub>0</sub> expressions are evaluated numerically in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref> and <xref ref-type="fig" rid="app1fig3">3</xref>.</p></sec><sec id="s9-2"><title>Epidemiological outcomes</title><sec id="s9-2-1"><title>Colonization prevalence</title><p>Colonization prevalence was defined as the proportion of hospital patients colonized (C<sup>R</sup>) by the focal drug-resistant strain (P<sup>R</sup>) at endemic equilibrium:<disp-formula id="equ32"><label>(A24)</label><mml:math id="m32"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Colonization prevalence of the drug-sensitive strain P<sup>S</sup> was also calculated:<disp-formula id="equ33"><label>(A25)</label><mml:math id="m33"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>C</mml:mi><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mover><mml:mi>C</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>These were found by substituting a corresponding vector of numerical parameter values Ω and solving ODE systems through numerical integration. Solutions were found using the lsoda method of the function <italic>ode</italic> from the package <italic>deSolve</italic> in R (version 3.6.0). For evaluation of the theoretical pathogen (part 1), solutions were corroborated using the function NSolve in Mathematica.</p></sec><sec id="s9-2-2"><title>Resistance rate</title><p>The resistance rate was defined as the proportion of patients colonized with the focal resistant strain P<sup>R</sup> relative to the sensitive strain P<sup>S</sup>, calculated using equilibrium prevalence values as C<sup>R</sup>/(C<sup>S</sup> + C<sup>R</sup>).</p></sec><sec id="s9-2-3"><title>Colonization incidence</title><p>Nosocomial colonization incidence was defined as the daily rate of colonization acquisition within the hospital, calculated separately for each route of acquisition. For P<sup>R</sup>, incidence rates corresponding to transmission (<italic>inc<sub>β</sub></italic>), endogenous acquisition (<italic>inc<sub>α</sub></italic>) and HGT (<italic>inc<sub>χ</sub></italic>) were calculated as<disp-formula id="equ34"><label>(A26)</label><mml:math id="m34"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>α</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>χ</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mtd><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>We evaluated incidence at dynamic equilibrium by solving ODE systems numerically for each Ω, then using resulting equilibria as initial values for subsequent numerical integration to calculate incidence from time <italic>t</italic> to <italic>t</italic> +1.</p></sec></sec><sec id="s9-3"><title>Parameter space for P<sup>R</sup> colonization</title><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Parameter values and ranges for the generic pathogen P<sup>R</sup> evaluated over five different colonization models (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3</xref> and <xref ref-type="fig" rid="fig4">4</xref>, and <xref ref-type="fig" rid="app1fig1">Appendix 1—figures 1</xref>–<xref ref-type="fig" rid="app1fig7">7</xref>).</title><p>For endogenous acquisition and microbiome recovery, rates presented are assumed rates in untreated hosts, represented by the’ (prime) symbol. Model 1: susceptible-colonized model; Model 2: strain competition model; Model 3: microbiome competition model; Model 4: microbiome-strain competition model; Model 5: microbiome-strain competition model with HGT.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="bottom">Symbol</th><th rowspan="2" valign="bottom">Parameter</th><th rowspan="2" valign="bottom">Unit</th><th rowspan="2" valign="bottom">Value {Range}</th><th colspan="5" valign="bottom">Model</th></tr><tr><th valign="bottom">1</th><th valign="bottom">2</th><th valign="bottom">3</th><th valign="bottom">4</th><th valign="bottom">5</th></tr></thead><tbody><tr><td colspan="9" valign="top">Pathogen colonization</td></tr><tr><td valign="top"> β</td><td valign="top">Transmission rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.2</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> α’</td><td valign="top">Endogenous acquisition rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.01</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> γ</td><td valign="top">natural clearance rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.03</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> c</td><td valign="top">Fitness cost of resistance</td><td valign="top">/</td><td valign="top">1</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td colspan="9" valign="top">Patient demography</td></tr><tr><td valign="top"> μ</td><td valign="top">Admission / discharge rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.1</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>f<sub>C</sub></italic></td><td valign="top">Admission fraction (colonized)</td><td valign="top">/</td><td valign="top">0.1</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>f<sub>R</sub></italic></td><td valign="top">Admission fraction (bearing resistant strain)</td><td valign="top">/</td><td valign="top">0.5</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>f<sub>d</sub></italic></td><td valign="top">Admission fraction (dysbiosis)</td><td valign="top">/</td><td valign="top">0</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>f<sub>ω</sub></italic></td><td valign="top">Admission fraction (microbiota bearing resistance gene)</td><td valign="top">/</td><td valign="top">0</td><td/><td/><td/><td/><td>X</td></tr><tr><td colspan="9" valign="top">Antibiotics</td></tr><tr><td valign="top"> <inline-formula><mml:math id="inf14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula></td><td valign="top">Antibiotic exposure prevalence</td><td valign="top">/</td><td valign="top">0.2 {0–1}</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>r<sub>R</sub></italic></td><td valign="top">Antibiotic resistance level (P<sup>R</sup>)</td><td valign="top">/</td><td valign="top">0.8 {0–1}</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> <italic>r<sub>S</sub></italic></td><td valign="top">Antibiotic resistance level (P<sup>S</sup>)</td><td valign="top">/</td><td valign="top">0</td><td/><td>X</td><td/><td>X</td><td>X</td></tr><tr><td valign="top"> θ<sub>c</sub></td><td valign="top">Antibiotic-induced pathogen clearance rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.2</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> θ<sub>m</sub></td><td valign="top">Antibiotic-induced microbiome dysbiosis rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td colspan="9" valign="top">Microbiome ecology</td></tr><tr><td valign="top"> ε</td><td valign="top">Colonization resistance</td><td valign="top">/</td><td valign="top">0.5 {0.2–0.8}</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> η</td><td valign="top">Resource competition</td><td valign="top">/</td><td valign="top">0.5 {0.2–0.8}</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> ϕ</td><td valign="top">Ecological release</td><td valign="top">/</td><td valign="top">5 {2–8}</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> χ<sub>e</sub></td><td valign="top">HGT rate (equilibrium)</td><td valign="top">day<sup>−1</sup></td><td valign="top">{0, 0.01, 0.1}</td><td/><td/><td/><td/><td>X</td></tr><tr><td valign="top"> χ<sub>d</sub></td><td valign="top">HGT rate (dysbiosis)</td><td valign="top">day<sup>−1</sup></td><td valign="top">χ<sub>e</sub> × 10</td><td/><td/><td/><td/><td>X</td></tr><tr><td valign="top"> δ’</td><td valign="top">Microbiome recovery rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">0.143</td><td/><td/><td>X</td><td>X</td><td>X</td></tr><tr><td valign="top"> ω</td><td valign="top">Proportion of patients acquiring the resistance gene among microbiota following antibiotic exposure</td><td valign="top">/</td><td valign="top">0.01</td><td/><td/><td/><td/><td>X</td></tr></tbody></table></table-wrap></sec></sec><sec id="s10" sec-type="appendix"><title>Part 1: Supplementary results</title><p>Here, we expand on results for Part one from the main text. For both strain competition and microbiome competition models, C<sup>R</sup> increases monotonically with antibiotic use under the assumption of complete antibiotic resistance (<italic>r<sub>R</sub></italic> = 1) (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>). In <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>, we evaluate <italic>R</italic><sub>0</sub> in the context of each microbiome-pathogen interaction separately, and in concert, over a range of assumed values. This demonstrates how colonization resistance dampens pathogen <italic>R</italic><sub>0</sub>, while resource competition and ecological release augment it. Taken together, strong microbiome-pathogen interactions can protect patients from P<sup>R</sup> colonization in some conditions (e.g. at low <inline-formula><mml:math id="inf15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> and <italic>r<sub>R</sub></italic>), while predisposing them to P<sup>R</sup> colonization in others (high <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> and <italic>r<sub>R</sub></italic>). In <xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3</xref>, we demonstrate numerically that introducing a drug-sensitive strain P<sup>S</sup> to the microbiome model reduces <italic>R</italic><sub>0</sub> of P<sup>R</sup>. In <xref ref-type="fig" rid="app1fig4">Appendix 1—figure 4</xref>, we again demonstrate how the strength of a pathogen’s microbiome interactions (ε, η, ϕ) and the level of antibiotic resistance for P<sup>R</sup> (<italic>r<sub>R</sub></italic>) drive epidemiological consequences of antibiotic use, here disentangling the role of antibiotic-induced pathogen clearance (θ<sub>c</sub>) from antibiotic-induced microbiome dysbiosis (θ<sub>m</sub>). In <xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5</xref>, we simulate dynamic responses of P<sup>R</sup> to public health interventions. First, dynamic equilibria were found, from which ODEs were integrated for an additional 365 days, evaluating C<sup>R</sup> and the resistance rate over time in the context of each microbiome-pathogen interaction (separately and in concert). We introduced theoretical interventions at days 90 (halving <italic>r<sub>R</sub></italic> from 0.8 to 0.4), 180 (halving θ<sub>m</sub> from 1.0 to 0.5), and 270 (halving <inline-formula><mml:math id="inf17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> from 0.2 to 0.1), demonstrating that an otherwise identical pathogen can experience diverse, and sometimes opposing responses to public health interventions in the context of different microbiome-pathogen interactions and epidemiological outcomes.</p><p>In <xref ref-type="fig" rid="app1fig6">Appendix 1—figure 6</xref>, we show how HGT impacts P<sup>R</sup> colonization incidence, in contrast to prevalence and resistance rate as presented in <xref ref-type="fig" rid="fig4">Figure 4</xref> in the main text. In <xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref>, we demonstrate effects of HGT on pathogen colonization outcomes. First, we vary key epidemiological parameters over broad ranges to show how the absolute impact of HGT depends on how other parameters mediate colonization dynamics (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7A</xref>). Second, we show how increasing the rate of HGT in hosts undergoing dysbiosis (χ<sub>d</sub>), while holding the rate constant in hosts with stable microbiota (χ<sub>e</sub>), augments HGT’s impact but does not substantively shift the level of antibiotic exposure that maximizes C<sup>R</sup> (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7B</xref>). Third, we demonstrate how effects of HGT depend on characteristics of the resistance gene being transmitted (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7C</xref>). For instance, a metabolically costly but highly drug-resistant gene R (c = 2, r<sub>R</sub> = 0.8) is potentially disadvantageous for the pathogen species as a whole at low antibiotic use (reducing total pathogen prevalence) but advantageous at high antibiotic use (increasing total prevalence).</p><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>Antibiotic selection for the epidemiological spread of an antibiotic-resistant bacterial pathogen P<sup>R</sup> with full resistance to all antibiotics (<italic>r<sub>R</sub></italic> = 1; for the middle panel, <italic>r<sub>S</sub></italic> = 0).</title><p>As in <xref ref-type="fig" rid="fig1">Figure 1</xref> in the main text, we compare results from the susceptible-colonized model (left), strain competition model (middle) and microbiome competition model (right). There are no selection trade-offs here because antibiotics have no epidemiological ‘benefit’, i.e. no ability to clear P<sup>R</sup>. See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig1-v2.tif"/></fig><fig id="app1fig2" position="float"><label>Appendix 1—figure 2.</label><caption><title>Different microbiome-pathogen interactions of different strengths (figure sub-titles) mediate how antibiotic use (<inline-formula><mml:math id="inf18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, x-axis) and resistance (<italic>r<sub>R</sub></italic>, y-axis) drive <italic>R</italic><sub>0</sub> for P<sup>R</sup> (z-axis, color).</title><p>White contour lines indicate <italic>R</italic><sub>0</sub>=1, and each successive black contour line represents an incremental change of 0.2. Microbiome-pathogen interactions are included separately (columns 1, 2, 3) and together (column 4), and their strengths are varied from weak (top row) to medium (middle row) to strong (bottom row) using values from <xref ref-type="fig" rid="fig2">Figure 2</xref> in the main text. See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig2-v2.tif"/></fig><fig id="app1fig3" position="float"><label>Appendix 1—figure 3.</label><caption><title>Introducing strain competition to the microbiome competition model reduces <italic>R</italic><sub>0</sub> for P<sup>R</sup>.</title><p>Over the whole parameter space, the focal strain P<sup>R</sup> of a two-strain microbiome competition model (right) has a lower <italic>R</italic><sub>0</sub> than the same pathogen evaluated in the absence of strain competition (left). We assume the competing strain P<sup>S</sup> is at endemic equilibrium and is completely sensitive to antibiotics (<italic>r<sub>S</sub></italic>=0). White contour lines indicate <italic>R</italic><sub>0</sub>=1, and each successive black contour line represents an incremental change of 0.2. See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig3-v2.tif"/></fig><fig id="app1fig4" position="float"><label>Appendix 1—figure 4.</label><caption><title>Antibiotic selection for the spread of an antibiotic-resistant pathogen strain P<sup>R</sup> depends on the strength of its interactions with microbiota (rows) and its level of resistance to antibiotics <italic>r<sub>R</sub></italic> (columns).</title><p>We assume complete antibiotic sensitivity for P<sup>S</sup> (<italic>r<sub>S</sub></italic> = 0), and low, medium, and high interactions strengths correspond to values in <xref ref-type="fig" rid="fig2">Figure 2</xref> in the main text, and columns in <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref> ({ε = 0.2, η = 0.2, ϕ = 2}, {ε = 0.5, η = 0.5, ϕ = 5} and {ε = 0.8, η = 0.8, ϕ = 8}, respectively). See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig4-v2.tif"/></fig><fig id="app1fig5" position="float"><label>Appendix 1—figure 5.</label><caption><title>Antibiotic prescribing interventions have mixed impacts on P<sup>R</sup> colonization dynamics, depending on the microbiome interactions in effect (colors) and the epidemiological outcomes measured (top: colonization prevalence; bottom: the resistance rate).</title><p>ODEs were integrated numerically for the baseline pathogen P<sup>R</sup>, introducing successive interventions at 3, 6, and 9 months. Interventions represent changes to parameter values corresponding to presumed changes in antibiotic consumption: for intervention 1, P<sup>R</sup>’s resistance level <italic>r<sub>R</sub></italic> was halved from 0.8 to 0.4; for intervention 2, the rate of antibiotic-induced microbiome dysbiosis θ<sub>m</sub> was halved from 1 to 0.5; and for intervention 3, the baseline antibiotic exposure prevalence <inline-formula><mml:math id="inf19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> was halved from 0.2 to 0.1. See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig5-v2.tif"/></fig><fig id="app1fig6" position="float"><label>Appendix 1—figure 6.</label><caption><title>Impacts of horizontal gene transfer (HGT) on steady-state daily colonization incidence of P<sup>R</sup>.</title><p>The relative impact of HGT depends on the gene’s rate of transfer (χ, line type), antibiotic exposure prevalence (<inline-formula><mml:math id="inf20"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, x-axis), competitive interactions between pathogen strains and host microbiota (colors: purple=combined strain and microbiome competition; orange=strain competition only), and the level of resistance conferred by the gene (<italic>r<sub>R</sub></italic>, columns). Assumptions match those for <xref ref-type="fig" rid="fig4">Figure 4</xref> in the main text. See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig6-v2.tif"/></fig><fig id="app1fig7" position="float"><label>Appendix 1—figure 7.</label><caption><title>Impacts of HGT on pathogen colonization dynamics are tied to other parameters that mediate the prevalence of competing pathogen strains.</title><p>(<bold>A</bold>) The absolute difference in P<sup>R</sup> colonization prevalence when including HGT (dashed and dotted lines) compared to prevalence in the absence of HGT (solid horizontal line) depends on assumed values of other parameters (panels) that drive colonization dynamics. For brevity, ω is described as the plasmid acquisition rate, and <italic>f<sub>ω</sub></italic> as the plasmid admission fraction. (<bold>B</bold>) Assuming a higher rate of HGT in patients undergoing dysbiosis (χ<sub>d</sub>) than in patients with stable microbiota (χ<sub>e</sub>) has a modest impact on C<sup>R</sup>. Here, χ<sub>e</sub> is held constant at χ<sub>e</sub>=0.05, such that changes in the fraction χ<sub>d</sub>/χ<sub>e</sub> result from corresponding increases in χ<sub>d</sub>. (<bold>C</bold>) Impacts of HGT on total pathogen prevalence (C<sup>S</sup> + C<sup>R</sup>) depend on how selectively (dis)advantageous the resistance gene R is for the pathogen bearing it. Here, we show total prevalence (both strains) as proportional to a model assuming the same parameter values but excluding HGT (dashed horizontal line). Colors represent different fitness costs of resistance <italic>c</italic>, demonstrating that HGT not only changes the relative frequency of competing strains, but can feed forward to alter total prevalence of all strains, tending to increase total prevalence when R has little metabolic cost (low c), but decrease prevalence when R is costly (high c). See <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> for all parameter values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig7-v2.tif"/></fig></sec><sec id="s11" sec-type="appendix"><title>Part 2: Model application, species characterization, and parameterization</title><sec id="s11-1"><title>Host and pathogen parameterization</title><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Parameters and probability distributions for baseline hospital and host parameters applied across all ARB.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Symbol</th><th valign="top">Parameter</th><th valign="top">Unit</th><th valign="top">Distribution</th><th valign="top">Reference</th><th valign="top">Reference setting</th><th valign="top">Notes</th></tr></thead><tbody><tr><td valign="top">μ</td><td valign="top">Admission / discharge rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1 / Normal (8, 2.55)</td><td valign="top"><xref ref-type="bibr" rid="bib148">Touat et al., 2019</xref></td><td valign="top">French hospitals</td><td valign="top">/</td></tr><tr><td valign="top"><italic>f<sub>d</sub></italic></td><td valign="top">Admission fraction (dysbiosis)</td><td valign="top">/</td><td valign="top">Normal (0.0756, 0.0190)</td><td valign="top"><xref ref-type="bibr" rid="bib17">Bernier et al., 2014</xref></td><td valign="top">French community</td><td valign="top">Taken as proportion of the French community exposed to antibiotics in previous 28 days, extrapolating weekly reimbursed antibiotic prescriptions/1000 inhabitants (18.9, 9.6–28.3) to 4 weeks and assuming independent prescriptions = 75.6 (38.4–113.2) prescriptions/1000 inhabitants</td></tr><tr><td valign="top"><inline-formula><mml:math id="inf21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula></td><td valign="top">Antibiotic exposure prevalence</td><td valign="top">/</td><td valign="top">Normal (0.195, 0.0195)</td><td valign="top"><xref ref-type="bibr" rid="bib3">Alfandari et al., 2015</xref></td><td valign="top">314 French hospitals</td><td valign="top">/</td></tr><tr><td valign="top"><italic>r<sub>i,j</sub></italic></td><td valign="top">Antibiotic resistance level</td><td valign="top">/</td><td valign="top">if sensitive, 0; if resistant, 1; if intermediate sensitivity, <italic>r<sub>i,j</sub></italic> ~ Uniform (0,1)</td><td valign="top"/><td valign="top"/><td valign="top">For all strains <italic>i</italic>, the resistance level to each antibiotic class <italic>j</italic> depends on whether the strain is classified as sensitive, resistant, or of intermediate sensitivity in its assumed antibiogram</td></tr><tr><td valign="top">θ<sub>c</sub></td><td valign="top">Antibiotic-induced pathogen clearance rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1 / Uniform (1, 10)</td><td valign="top"><xref ref-type="bibr" rid="bib146">Tepekule et al., 2017</xref></td><td valign="top">Simulation study</td><td valign="top">/</td></tr><tr><td valign="top">θ<sub>m</sub></td><td valign="top">Antibiotic-induced microbiome dysbiosis rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1 / Normal (2, 0.4)</td><td valign="top"><xref ref-type="bibr" rid="bib18">Bhalodi et al., 2019</xref></td><td valign="top">Mixed</td><td valign="top">Circumstantial evidence of same-day microbiome disruption following antibiotic therapy; assumed an average minimum 12 hr to disruption</td></tr><tr><td valign="top">δ’</td><td valign="top">Microbiome recovery rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1 / Normal (28, 10.71)</td><td valign="top"><xref ref-type="bibr" rid="bib28">Burdet et al., 2019</xref>; <xref ref-type="bibr" rid="bib122">Rafii et al., 2008</xref></td><td valign="top">Mixed; French hospital</td><td valign="top">Across studies in a review of antibiotic-induced microbiome disruption, intestinal microflora were observed to ‘return to normal’ 1–49 days after antibiotic cessation; in a French hospital, two measures of microbiome diversity were observed to ‘return to normal’ after 16–21 days.</td></tr></tbody></table></table-wrap><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Parameters and probability distributions for <italic>C. difficile</italic>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Symbol</th><th valign="top">Parameter</th><th valign="top">Unit</th><th valign="top">Distribution</th><th valign="top">Reference</th><th valign="top">Reference setting</th><th valign="top">Notes</th></tr></thead><tbody><tr><td valign="top">β</td><td valign="top">Transmission rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">Normal (0.00555, 0.000944)</td><td valign="top"><xref ref-type="bibr" rid="bib152">van Kleef et al., 2016</xref></td><td valign="top">English hospitals (modeling study)</td><td valign="top">Mean of point estimates of the daily probability of transmission from colonized patients (0.0037) and infected patients (0.0074)</td></tr><tr><td valign="top">α’</td><td valign="top">Endogenous acquisition rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">Normal (0.0000253, 0.0000114)</td><td valign="top"><xref ref-type="bibr" rid="bib52">Durham et al., 2016</xref></td><td valign="top">USA hospitals (modeling study)</td><td valign="top">Proxy measure: the estimated daily rate of progression from colonization to infection in hospital patients, divided by the relative risk of progression in patients exposed to antibiotics</td></tr><tr><td valign="top">γ</td><td valign="top">Natural clearance rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">Normal (0.0119, 0.00170)</td><td valign="top"><xref ref-type="bibr" rid="bib136">Simor et al., 1993</xref></td><td valign="top">Canadian care home</td><td valign="top">Fit longitudinal colonization data using exponential decay model</td></tr><tr><td valign="top"><italic>f<sub>C</sub></italic></td><td valign="top">Admission fraction (colonized)</td><td valign="top">/</td><td valign="top">Binomial (229, 0.048) / 229</td><td valign="top"><xref ref-type="bibr" rid="bib12">Barbut, 1996</xref></td><td valign="top">11 French hospitals</td><td valign="top">Stool prevalence among asymptomatic patients</td></tr><tr><td valign="top"><italic>r</italic></td><td valign="top">Antibiotic resistance level</td><td valign="top">/</td><td valign="top">median 94.3%, (range 93.3–95.4%)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td valign="top">ε</td><td valign="top">Colonization resistance</td><td valign="top">/</td><td valign="top">1–1 / Cauchy (52.85, 1.62)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr><tr><td valign="top">η</td><td valign="top">Resource competition</td><td valign="top">/</td><td valign="top">(1/γ)/(1/γ + Cauchy (121.11, 4.85))</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr><tr><td valign="top">ϕ</td><td valign="top">Ecological release</td><td valign="top">/</td><td valign="top">Cauchy (39.22 0.922)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr></tbody></table></table-wrap><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Parameters and probability distributions for <italic>S. aureus</italic>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Symbol</th><th valign="top">Parameter</th><th valign="top">Unit</th><th valign="top">Distribution</th><th valign="top">Reference</th><th valign="top">Reference setting</th><th valign="top">Notes</th></tr></thead><tbody><tr><td valign="top">β</td><td valign="top">Transmission rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">Normal (0.057, 0.0057)</td><td valign="top"><xref ref-type="bibr" rid="bib47">Di Ruscio et al., 2019</xref></td><td valign="top">Norwegian hospitals (modeling study)</td><td valign="top">/</td></tr><tr><td valign="top">α’</td><td valign="top">Endogenous acquisition rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">Normal (0.0016, 0.0008)</td><td valign="top"><xref ref-type="bibr" rid="bib35">Coello et al., 1997</xref>; <xref ref-type="bibr" rid="bib47">Di Ruscio et al., 2019</xref></td><td valign="top">Spanish hospital</td><td valign="top">Proxy measure: the estimated daily rate of progression from colonization to infection in hospital patients</td></tr><tr><td valign="top">γ</td><td valign="top">Natural clearance rate</td><td valign="top">day<sup>−1</sup></td><td valign="top">1 / Normal (287, 17.9)</td><td valign="top"><xref ref-type="bibr" rid="bib135">Shenoy et al., 2014</xref></td><td valign="top">Mixed</td><td valign="top">/</td></tr><tr><td valign="top"><italic>c</italic></td><td valign="top">Fitness cost of resistance</td><td valign="top">/</td><td valign="top">Normal (0.2, 0.02)</td><td valign="top"><xref ref-type="bibr" rid="bib83">Kouyos et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Laurent et al., 2001</xref></td><td valign="top">French hospitals</td><td valign="top">Growth cultures showed 20% fitness benefit to MSSA over MRSA strains</td></tr><tr><td valign="top"><italic>f<sub>C</sub></italic></td><td valign="top">Admission fraction (colonized)</td><td valign="top">/</td><td valign="top">Normal (0.0757, 0.00364)</td><td valign="top"><xref ref-type="bibr" rid="bib38">Cravo Oliveira Hashiguchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Scanvic et al., 2001</xref></td><td valign="top">French hospitals</td><td valign="top">Estimated as the proportion of patients arriving to a French hospital with MRSA colonization, divided by the estimated proportion of <italic>S. aureus</italic> strains that are methicillin-resistant in France</td></tr><tr><td valign="top"><italic>f<sub>R</sub></italic></td><td valign="top">Admission fraction (bearing resistant strain)</td><td valign="top">/</td><td valign="top">Normal (0.16, 0.016)</td><td valign="top"><xref ref-type="bibr" rid="bib38">Cravo Oliveira Hashiguchi et al., 2019</xref></td><td valign="top">France</td><td valign="top">/</td></tr><tr><td valign="top"><italic>r<sub>S</sub></italic></td><td valign="top">Antibiotic resistance level (MSSA)</td><td valign="top">/</td><td valign="top">median 33.1% (range 17.2–48.9%)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td valign="top"><italic>r<sub>R</sub></italic></td><td valign="top">Antibiotic resistance level (MRSA)</td><td valign="top">/</td><td valign="top">median 94.5% (range 90.8–98.2%)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td valign="top">ε</td><td valign="top">Colonization resistance</td><td valign="top">/</td><td valign="top">1–1 / Cauchy (2.21, 0.15)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr><tr><td valign="top">η</td><td valign="top">Resource competition</td><td valign="top">/</td><td valign="top">(1/γ) / (1/γ + Cauchy (73.09, 3.09))</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr><tr><td valign="top">ϕ</td><td valign="top">Ecological release</td><td valign="top">/</td><td valign="top">Cauchy (2.97, 0.28)</td><td valign="top">estimated</td><td valign="top">/</td><td valign="top">From expert opinion</td></tr></tbody></table></table-wrap><table-wrap id="app1table5" position="float"><label>Appendix 1—table 5.</label><caption><title>Parameters and probability distributions for <italic>E. coli</italic>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Symbol</th><th>Parameter</th><th>Unit</th><th>Distribution</th><th>Reference</th><th>Reference setting</th><th>Notes</th></tr></thead><tbody><tr><td>β</td><td>Transmission rate</td><td>day<sup>−1</sup></td><td>Normal (0.0078, 0.00334)</td><td><xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>13 European ICUs</td><td>/</td></tr><tr><td>α’</td><td>Endogenous acquisition rate</td><td>day<sup>−1</sup></td><td>Normal (0.0024, 0.000663)</td><td><xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>13 European ICUs</td><td>/</td></tr><tr><td>γ</td><td>Natural clearance rate</td><td>day<sup>−1</sup></td><td>Normal (0.00269, 0.000216)</td><td><xref ref-type="bibr" rid="bib11">Bar-Yoseph et al., 2016</xref></td><td>Mixed</td><td>Fit longitudinal colonization data using exponential decay model</td></tr><tr><td><italic>c</italic></td><td>Fitness cost of resistance</td><td>/</td><td>Normal (0.2, 0.02)</td><td>/</td><td>/</td><td>In absence of data for ESBL resistance, used same distribution as for MRSA</td></tr><tr><td><italic>f<sub>C</sub></italic></td><td>Admission fraction (colonized)</td><td>/</td><td>Normal (0.275, 0.0140)</td><td><xref ref-type="bibr" rid="bib54">Ebrahimi et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>Mixed</td><td>Estimated as the proportion of patients arriving to 13 European ICUs with ESBL-EC carriage, divided by the estimated proportion of <italic>E. coli</italic> that are ESBL-producing in a Hungarian hospital</td></tr><tr><td><italic>f<sub>R</sub></italic></td><td>Admission fraction (bearing resistant strain)</td><td>/</td><td>Normal (0.119, 0.0413)</td><td><xref ref-type="bibr" rid="bib54">Ebrahimi et al., 2016</xref></td><td>Hungarian hospital</td><td>Proportion of fecal <italic>E. coli</italic> that were ESBL-producing from a non-outbreak setting</td></tr><tr><td><italic>f<sub>ω</sub></italic></td><td>Admission fraction (microbiota bearing ESBL gene)</td><td/><td>Binomial(857, 0.0665)/857</td><td><xref ref-type="bibr" rid="bib117">Pilmis et al., 2018</xref>; <xref ref-type="bibr" rid="bib153">Vidal-Navarro et al., 2010</xref></td><td>2 French hospitals</td><td>Estimated by pooling 857 samples from two studies reporting fecal carriage of ESBL-producing species other than <italic>E. coli</italic></td></tr><tr><td><italic>r<sub>S</sub></italic></td><td>Antibiotic resistance level (EC)</td><td>/</td><td>median 23.1% (range 9.6–36.5%)</td><td>Estimated</td><td>/</td><td>Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td><italic>r<sub>R</sub></italic></td><td>Antibiotic resistance level (ESBL-EC)</td><td>/</td><td>median 84.9% (range 77.4–92.2%)</td><td>Estimated</td><td>/</td><td>Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td>ε</td><td>Colonization resistance</td><td>/</td><td>1–1/Cauchy (6.06, 0.64)</td><td>Estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>η</td><td>Resource competition</td><td>/</td><td>(1/γ)/(1/γ + Cauchy(76.38, 5.35))</td><td>Estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>ϕ</td><td>Ecological release</td><td>/</td><td>Cauchy(11.80, 0.80)</td><td>Estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>χ<sub>e</sub></td><td>HGT rate (equilibrium)</td><td>day<sup>−1</sup></td><td>χ<sub>d</sub>/Log-Normal (1.36, 0.81)</td><td>Estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>χ<sub>d</sub></td><td>HGT rate (dysbiosis)</td><td>day<sup>−1</sup></td><td>-log(1-Weibull (0.94, 0.11)) /10</td><td>Estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>ω</td><td>Proportion of patients whose microbiota acquire ESBL gene following antibiotic exposure</td><td>/</td><td>Binomial(132, 18/132)/132 × 0.382</td><td><xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>; <xref ref-type="bibr" rid="bib11">Bar-Yoseph et al., 2016</xref></td><td>Mixed</td><td>The proportion of patients in a meta-analysis who, subsequent to treatment, express resistance to the antibiotic with which treated (18/132), multiplied by the proportion of ESBLs among antibiotics consumed in French hospitals (38.2%)</td></tr></tbody></table></table-wrap><table-wrap id="app1table6" position="float"><label>Appendix 1—table 6.</label><caption><title>Parameters and probability distributions for <italic>K. pneumoniae</italic>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Symbol</th><th>Parameter</th><th>Unit</th><th>Distribution</th><th>Reference</th><th>Reference setting</th><th>Notes</th></tr></thead><tbody><tr><td>β</td><td>Transmission rate</td><td>day<sup>−1</sup></td><td>Normal (0.029, 0.00842)</td><td><xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>13 European ICUs</td><td>Estimate for non-<italic>E. coli</italic> Enterobacteriaceae</td></tr><tr><td>α’</td><td>Endogenous acquisition rate</td><td>day<sup>−1</sup></td><td>Normal (0.0048, 0.00133)</td><td><xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>13 European ICUs</td><td>Estimate for non-<italic>E. coli</italic> Enterobacteriaceae</td></tr><tr><td>γ</td><td>Natural clearance rate</td><td>day<sup>−1</sup></td><td>Normal (0.00267, 0.000324)</td><td><xref ref-type="bibr" rid="bib11">Bar-Yoseph et al., 2016</xref></td><td>Meta-analysis</td><td>Fit longitudinal colonization data using exponential decay model</td></tr><tr><td><italic>c</italic></td><td>Fitness cost of resistance</td><td>/</td><td>Normal (0.2, 0.02)</td><td>/</td><td>/</td><td>In absence of data for CP resistance, used same distribution as for MRSA</td></tr><tr><td><italic>f<sub>C</sub></italic></td><td>Admission fraction (colonized)</td><td>/</td><td>Binomial (11420, (928 / 11420)) / 11420</td><td><xref ref-type="bibr" rid="bib38">Cravo Oliveira Hashiguchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Gurieva et al., 2018</xref></td><td>Mixed</td><td>The proportion of patients arriving to 13 European ICUs with CP-KP carriage, divided by the estimated proportion of <italic>K. pneumoniae</italic> that produce carbapenemase in France</td></tr><tr><td><italic>f<sub>R</sub></italic></td><td>Admission fraction (bearing resistant strain)</td><td>/</td><td>Normal (0.01,0.001)</td><td><xref ref-type="bibr" rid="bib38">Cravo Oliveira Hashiguchi et al., 2019</xref></td><td>France</td><td>/</td></tr><tr><td><italic>f<sub>ω</sub></italic></td><td>Admission fraction (microbiota bearing CP gene)</td><td/><td>Binomial(1135, 0.00441) / 1135</td><td><xref ref-type="bibr" rid="bib115">Pantel et al., 2015</xref></td><td>7 French hospitals</td><td>Rectal carriage of carbapenemase-producing bacteria</td></tr><tr><td><italic>r<sub>S</sub></italic></td><td>Antibiotic resistance level (KP)</td><td>/</td><td>median 23.1% (range 9.6–36.5%)</td><td>estimated</td><td>/</td><td>Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td><italic>r<sub>R</sub></italic></td><td>Antibiotic resistance level (CP-KP)</td><td>/</td><td>median 91.7% (range 89.7–93.7%)</td><td>estimated</td><td>/</td><td>Cumulative resistance level across simulated antibiotic consumption data and assumed antibiograms</td></tr><tr><td>ε</td><td>Colonization resistance</td><td>/</td><td>1–1 / Cauchy (17.16, 0.97)</td><td>estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>η</td><td>Resource competition</td><td>/</td><td>(1/γ) / (1/γ + Cauchy (74.93, 4.03))</td><td>estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>ϕ</td><td>Ecological release</td><td>/</td><td>Cauchy (36.63, 0.82)</td><td>estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>χ<sub>e</sub></td><td>HGT rate (equilibrium)</td><td>day<sup>−1</sup></td><td>χ<sub>d</sub> / Gamma (2.01,0.36)</td><td>estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>χ<sub>d</sub></td><td>HGT rate (dysbiosis)</td><td>day<sup>−1</sup></td><td>-log(1-Gamma(0.54, 3.67))/10</td><td>estimated</td><td>/</td><td>From expert opinion</td></tr><tr><td>ω</td><td>Proportion of patients whose microbiota acquire CP gene following antibiotic exposure</td><td/><td>Binomial (132, 0.1363) / 132 × 0.0151</td><td>estimated from <xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>; <xref ref-type="bibr" rid="bib11">Bar-Yoseph et al., 2016</xref></td><td>Mixed</td><td>The proportion of patients in a meta-analysis who, subsequent to treatment, express resistance to the antibiotic with which treated (18/132), multiplied by the proportion of carbapenems among antibiotics consumed in French hospitals (1.5%)</td></tr></tbody></table></table-wrap></sec><sec id="s11-2"><title>Expert elicitation</title><sec id="s11-2-1"><title>Protocol</title><p>Expert elicitation is a scientific consensus methodology involving the estimation of unknown parameter values from subject-matter experts. We developed an expert elicitation protocol, using published recommendations for elicitation of clinical parameters,(<xref ref-type="bibr" rid="bib73">Johnson et al., 2010</xref>) to characterize the role of microbiome dysbiosis in driving hospital colonization dynamics across the ARB included in this study (provided separately). First, the scientific context of the study was introduced, including the potential epidemiological relevance of microbiome-pathogen interactions, and potential roles for intraspecific strain competition and microbiome dysbiosis in explaining how antibiotics select for resistance. Second, the MATCH uncertainty elicitation tool and ‘chips and bins’ method were introduced, allowing experts to build distributions visually in the form of histograms to quantify parameter values and associated uncertainty. (<xref ref-type="bibr" rid="bib107">Morris et al., 2014</xref>) Third, potential cognitive biases were reviewed and tips for reliable parameter estimation were provided. Finally, experts were asked to respond to questions and quantify their beliefs and uncertainty about how microbiome dysbiosis among hospital patients affects pathogen colonization processes (acquisition, clearance, growth and horizontal gene transfer). It was stressed that the goal of the elicitation was not to characterize precise numerical estimates of particular mechanistic interactions, but rather to quantify the relative impact of microbiome dysbiosis on different colonization outcomes in the hospital setting. Experts were initially identified through a review of authors of relevant publications in the field. At the end of each interview, experts were further asked to refer us to additional experts in the form of snowball sampling. Elicitation results are reported anonymously, but all experts agreed to their acknowledgment in this article.</p></sec></sec><sec id="s11-3"><title>Results and interpretation</title><p>Of 23 invited experts, ten ultimately participated in elicitation interviews (response rate 43.5%). Their specialties include bacteriology, internal medicine, intensive care, infectious disease epidemiology and clinical microbiology. Model parameters, the clinical parameters that experts were asked to estimate, and assumed links between them are provided in <xref ref-type="table" rid="app1table7">Appendix 1—table 7</xref>. First, experts were asked about the relevance of intraspecific strain competition for the nosocomial epidemiology of each pathogen. Then, for key colonization parameters (β, α, γ, χ), experts were asked whether hospital patients experiencing antibiotic-induced dysbiosis are more or less likely to experience the corresponding colonization outcome than patients not experiencing dysbiosis (<xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref>). If yes, they were asked to quantify the relative impact of dysbiosis on that outcome <italic>i</italic> for each ARB <italic>j</italic> as a histogram (estimated using MATCH) given by a vector <italic>x<sub>i,j,k</sub></italic> for each expert <italic>k</italic>. Experts made estimates for each ARB consecutively, such that parameters for each ARB were estimated relative to other included ARB.</p><p>Raw data for expert distributions are provided in <xref ref-type="fig" rid="app1fig9">Appendix 1—figure 9</xref>. Experts differed substantially in estimated ranges of different parameters, but Friedman’s tests using medians of each parameter distribution suggested that the species rank order was conserved across experts, with <italic>C. difficile</italic> generally having the strongest estimated microbiome-pathogen interaction coefficients, and MRSA the weakest. To conserve species rank order when combining expert estimates <italic>x<sub>i,j,k</sub></italic> to form pooled histograms, distributions were re-centred by the mean relative distance <italic>z<sub>i,j</sub></italic> between each <italic>j</italic> and the reference ARB (taken as MRSA) over all experts <italic>k</italic> (<xref ref-type="fig" rid="app1fig10">Appendix 1—figure 10</xref>). For <italic>C. difficile</italic> and MRSA, HGT was excluded from simulations and pooled distributions were not re-centred. Each expert distribution was weighted equally, contributing to 10% of the final pooled distribution for each species and parameter. Pooled histograms were fit to six candidate distributions (normal, log-normal, Weibull, Cauchy, exponential and gamma), and the final distribution was selected as the fitted distribution giving the lowest Akaike Information Criterion (using the function fitdist from the R package fitdistrplus). Final fitted distributions for each parameter and ARB are given in <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref>–<xref ref-type="table" rid="app1table6">6</xref>, and for select parameters in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p><p>Among other observations, experts highlighted (i) uncertainty about an influence of strain competition on hospital colonization dynamics for all ARB, with the majority of experts believing strain competition was irrelevant for <italic>C. difficile</italic> but at least partially relevant for other ARB, (ii) unanimous certainty about a role for antibiotic-induced microbiome dysbiosis as a driver of colonization for <italic>C. difficile</italic>, ESBL-EC and CP-KP, with somewhat less certainty for MRSA, and (iii) certainty about a role for horizontal gene transfer (HGT) for ESBL-EC and CP-KP (<xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref>).</p><table-wrap id="app1table7" position="float"><label>Appendix 1—table 7.</label><caption><title>Relationship between model parameters and the clinical parameters estimated by experts.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3" valign="bottom">Model parameter</th><th colspan="2" valign="bottom">Clinical parameter</th><th rowspan="2" valign="top">Assumed relationship between model and clinical parameters</th></tr><tr><th valign="bottom">Name</th><th valign="bottom">Symbol</th><th colspan="2" valign="bottom">Description</th><th valign="bottom">Symbol</th></tr></thead><tbody><tr><td valign="top">Colonization resistance</td><td colspan="2" valign="top">ε</td><td valign="top">Relative risk of acquiring colonization among patients experiencing microbiome dysbiosis</td><td valign="top">RR<sub>β</sub></td><td valign="top"><inline-formula><mml:math id="inf22"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>ε</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">R</mml:mi></mml:mrow><mml:mi>β</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula></td></tr><tr><td valign="top">Resource competition</td><td colspan="2" valign="top">η</td><td valign="top">Excess duration of colonization among patients experiencing microbiome dysbiosis</td><td valign="top"><italic>d</italic></td><td valign="top"><inline-formula><mml:math id="inf23"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>η</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mfrac><mml:mn>1</mml:mn><mml:mi>γ</mml:mi></mml:mfrac><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>γ</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula></td></tr><tr><td valign="top">Ecological release</td><td colspan="2" valign="top">ϕ</td><td valign="top">Relative risk of pathogen outgrowth among patients experiencing microbiome dysbiosis</td><td valign="top">RR<sub>α</sub></td><td valign="top"><inline-formula><mml:math id="inf24"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>ϕ</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">R</mml:mi><mml:msub><mml:mi mathvariant="normal">R</mml:mi><mml:mi>α</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></td></tr><tr><td valign="top">HGT rate (dysbiosis)</td><td colspan="2" valign="top">χ<sub>d</sub></td><td valign="top">Proportion of antibiotic-exposed patients colonized with the specified species that acquire the specified resistance via HGT during their hospital stay</td><td valign="top">pχ<sub>d</sub></td><td valign="top"><inline-formula><mml:math id="inf25"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>μ</mml:mi></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula></td></tr><tr><td valign="top">HGT rate (equilibrium)</td><td colspan="2" valign="top">χ<sub>e</sub></td><td valign="top">Relative risk of acquiring the specified resistance via HGT among patients experiencing microbiome dysbiosis</td><td valign="top">RRχ</td><td valign="top"><inline-formula><mml:math id="inf26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">R</mml:mi></mml:mrow><mml:mi>χ</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>χ</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula></td></tr></tbody></table></table-wrap><fig id="app1fig8" position="float"><label>Appendix 1—figure 8.</label><caption><title>Expert belief about which mechanisms drive epidemiological dynamics of bacterial pathogens.</title><p>(<bold>A</bold>) Expert belief in whether or not intraspecific strain competition influences nosocomial colonization dynamics for each pathogen. (<bold>B</bold>) Expert belief in whether or not each of the given colonization processes is affected by microbiome dysbiosis, and for HGT, whether or not this process is relevant in clinical settings. CD: <italic>Clostridioides difficile</italic>; SA: <italic>Staphylococcus aureus</italic>; EC: <italic>Escherichia coli</italic>; KP: <italic>Klebsiella pneumoniae</italic>; HGT: horizontal gene transfer.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig8-v2.tif"/></fig><fig id="app1fig9" position="float"><label>Appendix 1—figure 9.</label><caption><title>Expert elicitation results (raw data): expert belief and uncertainty about the impact of microbiome dysbiosis on nosocomial colonization dynamics of included bacterial pathogens (colors).</title><p>Rows A through E represent, respectively, responses to questions two through six from the expert elicitation (protocol provided separately). Distributions were generated during expert interviews using the MATCH Uncertainty Elicitation Tool with the chips and bins method (<xref ref-type="bibr" rid="bib107">Morris et al., 2014</xref>) Experts are anonymized and represented by different columns. Vertical bars represent medians of each distribution to visualize the rank order for each pathogen as estimated by each expert. p-values represent results of Friedman’s tests for distribution medians, considering species as groups and experts as blocks for each question; when p&lt;0.05, the species rank order across experts is interpreted as non-random.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig9-v2.tif"/></fig><fig id="app1fig10" position="float"><label>Appendix 1—figure 10.</label><caption><title>Expert elicitation results (re-centred data): expert belief and uncertainty about the impact of microbiome dysbiosis on nosocomial colonization dynamics of included bacterial pathogens (colors).</title><p>Rows A through E represent, respectively, responses to questions two through six from the expert elicitation protocol (provided separately).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig10-v2.tif"/></fig></sec><sec id="s11-4"><title>Antibiotic exposure data</title><table-wrap id="app1table8" position="float"><label>Appendix 1—table 8.</label><caption><title>Antibiotic classes, their contribution to total hospital antibiotic consumption, their spectrum, and their relative rate of inducing microbiome dysbiosis.</title><p>Consumption data come from the French ANSM and are supplemented with data from Baggs et al. (<xref ref-type="bibr" rid="bib2">Agence nationale de sécurité du médicament et des produits de santé, 2017</xref>; <xref ref-type="bibr" rid="bib9">Baggs et al., 2016</xref>). The literature was used to classify antibiotic classes in terms of their spectrum, (<xref ref-type="bibr" rid="bib1">Abbara et al., 2020</xref>; <xref ref-type="bibr" rid="bib144">Tan et al., 2017</xref>) and relative rate of causing microbiome dysbiosis. (<xref ref-type="bibr" rid="bib10">Baggs et al., 2018</xref>; <xref ref-type="bibr" rid="bib25">Brown et al., 2013</xref>) The percentage column does not total to 100 due to rounding error.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Antibiotic class</th><th valign="bottom">ACT code</th><th valign="bottom">% of consumption</th><th valign="bottom">Spectrum</th><th valign="bottom">Rate of inducing microbiome dysbiosis</th></tr></thead><tbody><tr><td>Amoxicillin and beta-lactamase inhibitor</td><td>J01CR02</td><td>32.4</td><td>Broad</td><td>High</td></tr><tr><td>Penicillins with extended spectrum</td><td>J01CA</td><td>21.9</td><td>Narrow</td><td>Medium</td></tr><tr><td>Quinolones</td><td>J01M</td><td>11.0</td><td>Broad</td><td>High</td></tr><tr><td>C3G</td><td>J01DD</td><td>8.2</td><td>Broad</td><td>Very high</td></tr><tr><td>C1G</td><td>J01DB</td><td>3.7</td><td>Narrow</td><td>High</td></tr><tr><td>Macrolides</td><td>J01FA</td><td>3.4</td><td>Narrow</td><td>Medium</td></tr><tr><td>Imidazole</td><td>J01XD</td><td>2.9</td><td>Narrow</td><td>Medium</td></tr><tr><td>Piperacillin and beta-lactamase inhibitor</td><td>J01CR05</td><td>2.3</td><td>Broad</td><td>High</td></tr><tr><td>Aminoglycosides</td><td>J01G</td><td>2.3</td><td>Narrow</td><td>Low</td></tr><tr><td>Tetracyclines</td><td>J01A</td><td>2.0</td><td>Narrow</td><td>Low</td></tr><tr><td>Sulfonamides, trimethoprim</td><td>J01E</td><td>1.8</td><td>Narrow</td><td>Medium</td></tr><tr><td>Glycopeptides</td><td>J01XA</td><td>1.8</td><td>Narrow</td><td>Very high</td></tr><tr><td>Lincosamides</td><td>J01FF</td><td>1.6</td><td>Broad</td><td>Very high</td></tr><tr><td>Carbapenems</td><td>J01DH</td><td>1.5</td><td>Broad</td><td>High</td></tr><tr><td>Penicillins (other)</td><td>J01C_other</td><td>1.4</td><td>Narrow</td><td>Medium</td></tr><tr><td>C2G</td><td>J01DC</td><td>0.9</td><td>Narrow</td><td>High</td></tr><tr><td>C4G</td><td>J01DE</td><td>0.6</td><td>Broad</td><td>Very high</td></tr><tr><td>Other</td><td>Other</td><td>2.1</td><td>Narrow</td><td>Medium</td></tr></tbody></table></table-wrap></sec></sec><sec id="s12" sec-type="appendix"><title>Part 2: Supplementary results</title><sec id="s12-1"><title>Baseline colonization dynamics</title><fig id="app1fig11" position="float"><label>Appendix 1—figure 11.</label><caption><title>Baseline steady-state pathogen colonization outcomes for single-species simulations excluding the microbiome (ε = 0, η = 0, ϕ = 1, χ = 0).</title><p>Compared to microbiome simulations (<xref ref-type="fig" rid="fig6">Figure 6</xref> in the main text), pathogens are less prevalent (<bold>A</bold>), and incidence is more than halved for all ARB except MRSA (<bold>C</bold>). However, resistance rates are largely unchanged (<bold>B</bold>). Points (<bold>A and B</bold>) and bars (<bold>C</bold>) represent medians, and error bars represent 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig11-v2.tif"/></fig><fig id="app1fig12" position="float"><label>Appendix 1—figure 12.</label><caption><title>Change in ARB colonization outcomes in the hospital relative to the community (log<sub>10</sub> scale), comparing single-species and microbiome simulations.</title><p>(<bold>A</bold>) The ratio of colonization prevalence among hospital patients relative to baseline colonization prevalence in the community. (<bold>B</bold>) The ratio of resistance rates in the hospital relative to baseline resistance rates in the community. Points represent medians and error bars represent 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig12-v2.tif"/></fig><fig id="app1fig13" position="float"><label>Appendix 1—figure 13.</label><caption><title>Different ARB spread in different ways, and the importance of different routes depends on potential microbiome interactions.</title><p>Each shaded region represents the median estimated proportion of acquisition events explained by each acquisition route over 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig13-v2.tif"/></fig><fig id="app1fig14" position="float"><label>Appendix 1—figure 14.</label><caption><title>Multivariate sensitivity analysis describing partial rank correlation coefficients (PRCCs) between model parameters and two epidemiological outcomes evaluated at population dynamic equilibrium: in panel A, colonization prevalence of the focal strain P<sup>R</sup>; in panel B, the pathogen resistance rate.</title><p>For all pathogens, prevalence was positively associated with prior colonization upon hospital admission (<italic>f<sub>C</sub></italic> for <italic>C. difficile</italic>, <italic>f<sub>R</sub></italic> for MRSA, ESBL-EC and CP-KP) and ecological release (ϕ), and negatively associated with a higher rate of discharge and admission, i.e. shorter duration of hospitalisation (μ). Across ARB, higher rates of antibiotic-induced dysbiosis (θ<sub>m</sub>) and microbiome recovery (δ) were generally positively and negatively associated with prevalence, respectively. Conversely, microbiome parameters were minimally associated with resistance rates, with the exception of the HGT rate among patients undergoing dysbiosis (χ<sub>d</sub>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig14-v2.tif"/></fig></sec><sec id="s12-2"><title>Intervention evaluation</title><fig id="app1fig15" position="float"><label>Appendix 1—figure 15.</label><caption><title>Compared to pathogen incidence (<xref ref-type="fig" rid="fig7">Figure 7</xref>), dynamic responses of pathogen resistance rates to public health interventions were similar across single-species and microbiome simulations (left panels, contact precautions; middle, antibiotic stewardship; right, microbiome recovery interventions).</title><p>Top panels show results from simulations using ‘single-species models’ that only account for the focal pathogen species (including intraspecific strain competition for MRSA, ESBL-EC and CP-KP); bottom panels show simulation results when models also include microbiome-pathogen interactions and antibiotic-induced microbiome dysbiosis. For each intervention, three levels of intervention compliance (shading) are simulated. Points correspond to medians, and bars to 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig15-v2.tif"/></fig><fig id="app1fig16" position="float"><label>Appendix 1—figure 16.</label><caption><title>Interventions act on different routes of acquisition.</title><p>Intervention efficacy (x-axis) for reducing colonization incidence via different routes of colonization acquisition (colors) for different interventions (columns) and ARB (rows). Unlike contact precautions, which only reduced incidence via transmission, antibiotic stewardship and microbiome recovery interventions reduced colonization incidence through all considered routes. Points correspond to medians, and bars to 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig16-v2.tif"/></fig><fig id="app1fig17" position="float"><label>Appendix 1—figure 17.</label><caption><title>Intervention efficacy for three considered types of antibiotic stewardship: (<bold>i</bold>) reducing overall antibiotic prescribing, (ii) restricting broad-spectrum antibiotics in favour of narrow-spectrum antibiotics, and (iii) restricting antibiotics categorized as inducing microbiome dysbiosis at high or very high rates in favour of those that induce dysbiosis at medium or low rates.</title><p>In microbiome simulations, restricting antibiotics that induce dysbiosis at a high rate was approximately as effective as reducing overall antibiotic prescribing. In single-species simulations, all stewardship interventions were of limited to negligible efficacy. Points correspond to medians, and bars to 95% uncertainty intervals across 10,000 Monte Carlo simulations.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig17-v2.tif"/></fig></sec><sec id="s12-3"><title>Meta-analysis of hospital antibiotic stewardship interventions</title><p>To assess consistency of intervention outcomes with the literature, we compared antibiotic stewardship results to a systematic review and meta-analysis of hospital antibiotic stewardship interventions initially conducted by <xref ref-type="bibr" rid="bib16">Baur et al., 2017.</xref> They included interventional studies published worldwide from Jan 1960 to May 2016 describing incidence of bacterial colonization or infection among hospital inpatients. Stewardship interventions were heterogeneous and included audits, antibiotic restriction, antibiotic cycling, antibiotic mixing, feedback, guideline implementation and education. The authors found no evidence of publication bias or small study effects.</p><p>Their analysis included 32 studies over 9 million patient-days, though stewardship interventions were co-implemented with other infection control measures (e.g. hand hygiene, patient isolation) in 31% of studies. When limited to stewardship, patients were still significantly less likely to experience colonization and infection (IRR=0.81, 0.67–0.97), but species-specific estimates were not made. When excluding studies that included non-stewardship interventions, ten studies remained for MRSA, (<xref ref-type="bibr" rid="bib5">Arda et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Frank et al., 1997</xref>; <xref ref-type="bibr" rid="bib96">Mach et al., 2007</xref>; <xref ref-type="bibr" rid="bib100">Marra et al., 2009</xref>; <xref ref-type="bibr" rid="bib103">Meyer et al., 2010</xref>; <xref ref-type="bibr" rid="bib106">Miyawaki et al., 2010</xref>; <xref ref-type="bibr" rid="bib116">Peto et al., 2008</xref>; <xref ref-type="bibr" rid="bib137">Smith et al., 2008</xref>; <xref ref-type="bibr" rid="bib154">Yeo et al., 2012</xref>; <xref ref-type="bibr" rid="bib157">Zou et al., 2015</xref>) seven for <italic>C. difficile</italic>, (<xref ref-type="bibr" rid="bib23">Borde et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Dubrovskaya et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Frank et al., 1997</xref>; <xref ref-type="bibr" rid="bib89">Leung et al., 2011</xref>; <xref ref-type="bibr" rid="bib93">Lübbert et al., 2014</xref>; <xref ref-type="bibr" rid="bib98">Malani et al., 2013</xref>; <xref ref-type="bibr" rid="bib132">Schön et al., 2011</xref>) two for ESBL-<italic>E. coli</italic>, (<xref ref-type="bibr" rid="bib5">Arda et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Chong et al., 2013</xref>) and one for CP-<italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="bib5">Arda et al., 2007</xref>) For ESBL-<italic>E.</italic> coli, we further included studies of ESBL-producing Enterobacteriaceae and Gram-negative bacteria (<xref ref-type="bibr" rid="bib63">Grohs et al., 2014</xref>; <xref ref-type="bibr" rid="bib143">Takesue et al., 2010</xref>) Using their published data and methodology, we calculated incidence risk ratios (IRR) using the standard inverse-variance method, and pooled IRRs across species using mixed-effects meta-analysis models (R package <italic>metafor</italic>). Results for each study and pooled results for each pathogen are presented in <xref ref-type="fig" rid="app1fig18">Appendix 1—figure 18</xref>.</p><fig id="app1fig18" position="float"><label>Appendix 1—figure 18.</label><caption><title>Incidence rate ratios (IRRs) for ARB colonization and infection among hospital inpatients exposed to antibiotic stewardship interventions.</title><p>IRRs were calculated using data presented in <xref ref-type="bibr" rid="bib16">Baur et al., 2017</xref> Results are stratified by four pathogens: (<bold>a</bold>) <italic>C. difficile</italic>, (<bold>b</bold>) methicillin-resistant <italic>S. aureus</italic>, (<bold>c</bold>) ESBL-producing <italic>E. coli</italic> (and here also including ESBL-producing Enterobacteriaceae or Gram-negative bacteria), and (<bold>d</bold>) carbapenemase-producing <italic>K. pneumoniae</italic>. Points represent means and bars represent 95% confidence intervals.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68764-app1-fig18-v2.tif"/></fig></sec></sec></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68764.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Knight</surname><given-names>Gwenan M</given-names></name><role>Reviewing Editor</role><aff><institution>London School of Hygiene and Tropical Medicine</institution><country>United Kingdom</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>van Kleef</surname><given-names>Esther</given-names> </name><role>Reviewer</role><aff><institution>Institute of Tropical Medicine</institution><country>Belgium</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Wright</surname><given-names>Erik S</given-names></name><role>Reviewer</role><aff><institution>University of Pittsburgh</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper provides a mathematical modelling framework for a stepwise incorporation of ecological complexity up to the effects of host microbiome on the spread of antibiotic-resistance. This provides a key first step in our understanding of the heterogeneous impact of the host microbiome on the spread of resistance, as demonstrated by the author's application of the model to four key pathogens.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: modelling insights for infection control&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and George Perry as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Esther van Kleef (Reviewer #1); Erik S Wright (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers agreed that the approach is thoughtful, and the analysis performed is well complemented by simulations using relevant parameters in healthcare settings in hospitals. The big problem with this area, which is stressed by the authors, is the lack of information to support parameter choice. Despite being stressed, it was often not completely clear how and why parameters were chosen. Further clarity is required to support publication of this work which does offer a rational framework for linking the epidemiology and the microbiome, with an important hypothesis for antibiotic resistance.</p><p>Essential revisions:</p><p>The main revisions required are</p><p>– A restructuring of the methods to provide greater clarity of model structures and justification of parameter choices (is there no data? why was this chosen if so?). The driving force behind this should be the reproducibility of the work and the exploration of the results based on the parameter choices.</p><p>– A rewriting of the introduction and discussion to include more context of prior modelling work as well as to provide justification for the focus of the work</p><p>– In line with (1), all reviewers were in agreement that this work needs a clear single model description: a formal description of the model framework in one place. This could be in the supplementary, but it needs to be a well referenced place.</p><p>1) In general, the model the authors use is highly parameterized. There is a worry about circular reasoning when modelling. Parameters are derived from observations, then a model is constructed to recapitulate this observation. Then similar observations are used to show the model's validity. How did the authors ensure this type of bias was not incorporated into their modelling? This can become a bigger issue with more highly parameterized models, and that is why simpler models are preferable. Another approach is to use cross-validation, although we are not sure how that would work here.</p><p>Abstract</p><p>2) The Abstract is vague and somewhat convoluted as written. It did not do the best job of selling the paper and does not convey any specific information.</p><p>Introduction</p><p>3) The authors need to tailor this to their specific question: where is the knowledge gap? We recommend that the authors think carefully about the statements they are making and consider revising the Introduction to include a more thorough analysis of prior modelling work, which is largely absent from the Introduction.</p><p>4) The study focuses on four particular pathogens, however, no motivation of why they are chosen is provided, nor the relevance of their analysis in a more general overview is discussed. The authors could expand on how their results could be extended to other contexts/species in which the role of microbiome on resistance is also relevant. This could also be included in the discussion.</p><p>5) The authors conclude that disruption of the microbiome on an individual level (due to antibiotics) can result in selection for AMR on a population level. In a way, the work is, at least in part, a model-based implementation of the theoretical perspective of Lipsitch and Samore 2002 EID doi: 10.3201/eid0804.010312 (which describes how antibiotic effects on an individual, within-host level, can affect population level transmission dynamics). Could the comparison to Lipsitch and Samore and the novelty of the improved data-driven approach (although still limited) be further discussed?</p><p>6) Antibiotic stewardship is treated a single entity, whereas in reality there are countless types of stewardship interventions and a concomitant variety of outcomes. Comparing the model's results directly to an analysis of previous stewardship interventions and attempting to show alignment does not make sense to me. How were these stewardship interventions reflective of the model? Why would we expect agreement or disagreement a priori? The fact that there was agreement with the model was somewhat concerning given the complexity of many stewardship interventions.</p><p>Methods</p><p>7) In attempting to replicate this study, it became intractably difficult to recreate the ODEs because the equations and variables are interspersed throughout the main text and supplementary appendix. For example, in Figure 1e the authors mention differences in resistance levels (γ) and not transmission rate (λ, related to β as in Equation (3)), the value of which could not be found anywhere in the text. Similarly, where is patient demography (Δ) incorporated into equations 3 or 4? There are certainly answers to these questions, but it would have been helpful to have the model more clearly presented in a central location. Finding the parameters and making sense of them was extremely challenging, if not infeasible. Therefore, we were unable to replicate the results to any extent.</p><p>8) It is unclear how the authors arrived at their parameter values throughout the manuscript. For example, colonization resistance (epsilon) as it is formulated is not compelling, and where did the value of this parameter come from? It is listed in Table S5 as being drawn from a Cauchy distribution. Why? Where did these numbers come from? Some of the parameters seem justified by literature, but the rest are perhaps debatable. This might be inevitable with a complex model, but the authors should minimally provide a robustness analysis to each of their less-supported parameter choices. What would be the outcome if the sampled distributions had been wider (e.g., if the true value had been different by an order of magnitude)?</p><p>9) The inclusion of the 'r' parameter, allowing for partial resistance in the resistant strain, is interesting (and innovative for modelling frameworks to our knowledge). Nonetheless, it is not clear why the authors use a baseline of r = 0.8 to illustrate the trade-off between antibiotic induced clearance and selection for Cr (Figure 1F), whereas in figure 2, the authors use r=0.4, i.e. higher levels of sensitivity in Cr. I suppose with a lower r, strain coexistence is more likely, and thus higher likelihood of Horizontal Gene Transfer (HGT) (?), but it would be, for consistency and comparison of the different within-host dynamics, more transparent to use the same baseline parameter values, unless the authors can provide a good reason why different values of r are assumed at baseline between Figure 1 and Figure 2B?</p><p>10) The model presented in Eq. (1) needs a better introduction. Is this a new model or based on other models previously studied? This is explained later in the text citing references (30) and (31), but we recommend to introduce them earlier. It would be also good to point the reader earlier in the main text to the first sections of the supplement for a better understanding of the model assumptions and parameters employed.</p><p>11) Also, should the parameters be more consistently labelled across frameworks? For example, we recommend writing λ(N,C), or something similar, in all the equations to explicitly state it depends on these parameters. The way it is written gives the impression that λ is a constant parameter.</p><p>12) The r vs resistance rate (Cr/Cr+Cs) caused some confusion. This as a resistance rate of Cr = 0.8 but an r = 0.4 could actually mean that 0.8*0.4 = 0.08 of pathogens carried are fully resistant against the antibiotic, while this is 0.64 when r=0.8. Can the same baseline values for r be used in Figure 1 and Figure 2 or the differences justified?</p><p>13) Furthermore, in figure 1F: this is representing a one strain model. Is the Ce+Cd strain similar to the Cr? Can this be clarified?</p><p>14) In line with this. In Figure S3, R0 seems to represent the R0 of Cr. However, for Figure 1H and 1I, how should R0 be interpreted respectively? And for Figure S2? Please clarify how similar Cr (Figure 1H) and the one strain modelled (which could be similar to the Cr strain of Figure 1H) for figure 1I are</p><p>15) Figure 2A, the minimum resistance rate is 0.35 (see legend, and this appeared the case when no antibiotic induced clearance nor antibiotic induced microbiome disruption). This seems rather high. In particular as in Figure 2B, minimum levels of less than 0.1 are shown. Could the authors explain where this discrepancy is coming from and to what extend these high baseline resistance rates are representative?</p><p>16) For parameterisation of the models for the different pathogens, estimates from literature, notably existing modelling studies are chosen. However, these estimates, at least for C. difficile and MRSA, are coming from models that don't incorporate endogenous acquisition explicitly (for the Enterobacterieacia, model estimates from Gurieva are used, which do use a modelling framework incorporating an exo- and endogenous acquisition). Therefore, the acquisition rates may be overestimated for these gram-positives, in particular for C. diff the endogenous acquisition, which is listed as the main acquisition route (pp 14 line 330).</p><p>This may affect the estimated intervention effectiveness (in particular for antibiotic stewardship (less effective) and contact precautions (more effective)) under assumptions of the microbiome model. Could the authors use more realistic estimates (not sure models with explicit exo- and endogenous acquisition exist for MRSA and C. diff), or at least, reflect on how different values of α and β affect the model results?</p><p>17) It would be helpful to explicitly say how the simulations were performed, i.e., mention that the ODEs where integrated. My first impression was that the authors performed stochastic simulations using the processes illustrated in panels A, B, C from Figure 1. This is probably an issue that only mathematical modellers would have, but could the authors please add this clarification.</p><p>Discussion</p><p>18) The model is described by a set of differential equations. This means the model ignores stochasticity of the population size dynamics of each strain. The authors could expand a bit more on the assumptions of the model and why fluctuations are ignored.</p><p>19) Also, spatial structure is particularly important when taking into account interactions between microbiome and pathogens, but it is also neglected in the model. It would be useful if the authors could discuss this as well.</p><p>20) The results shown often focus on steady-state quantities (such as colonisation prevalence), but the temporal evolution of the model is not discussed. It would be interesting if the authors could investigate the timescale of the different interactions taken into account, and how relevant they may be in the healthcare settings they investigate. Is the temporal evolution of the model any relevant for their conclusions?</p><p>21) Can the authors please add examples of the hypothetical microbiome recovery interventions they have in mind? Are the authors thinking of things like faecal transplantation? Please add, also to provide more practical interpretation of the work.</p><p><italic>Reviewer #1:</italic></p><p>The authors use a theoretical dynamic transmission modelling framework, incorporating both between and within-host dynamics of antimicrobial resistant (AMR) pathogens, to stress the importance of the microbiome in the transmission dynamics of bacterial species. The work considered five different colonisation models, comprising different variations of 'traditional' epidemiological models, which, according to the authors, often do not include within-host microbiome-pathogen interactions, and add such interactions. With regards to the latter, three different within-host microbiome-pathogen interactions, as well as horizontal gene transfer are considered, and their effect on population transmission as well as interventions, evaluated.</p><p>The authors have done an extensive amount of work, and have done a great job in documenting all the model assumptions, data used and methods employed. Also, visualisations and illustrations are nice and informative.</p><p>However, the main difficulty with incorporating within-host dynamics of AMR pathogens in a human-to-human transmission modelling framework is the lack of data to inform key parameters. The authors stress this limitation is also part of their work. The authors emphasise that they aimed to show in theory the importance of microbiome-pathogen interactions, and have conducted an expert elicitation to partly inform parameters representing these dynamics.</p><p>The authors conclude that disruption of the microbiome on an individual level (due to antibiotics) can result in selection for AMR on a population level. In a way, the work is, at least in part, a model-based implementation of the theoretical perspective of Lipsitch and Samore 2002 EID doi: 10.3201/eid0804.010312 (which similar to here, describes how antibiotic effects on an individual, within-host level, can affect population level transmission dynamics). Therefore, I am somewhere inclined to think, are the main points made by the authors new? As this work here does, similar to this earlier work, not provide a data-driven approach (although tries to some extend). On the other hand, the work does, in contrast to Lipsitch and Samore, provide a framework for how to model these interactions, and illustrate to some extend which parameter values require what data, as well as which dynamics are most likely at play for which pathogens. Moreover, what is new, is that the authors try to illustrate how such interactions may affect the effectiveness of interventions, which is an interesting and, to the best of my knowledge, a novel component. My comments are largely requests for clarification.</p><p><italic>Reviewer #2:</italic></p><p>Here the authors tackle the important challenge of incorporating the microbiome into a traditional susceptible-colonized transmission model. The microbiome acts as a third party in infections, with roles in supplying or suppressing antibiotic resistance. The authors found that microbiome interventions hold the promise of avoiding antibiotic resistance dissemination. This theoretical work encourages continued research into how the microbiome could be used to mitigate antibiotic resistance. However, I am skeptical of the translatability of the model's predictions to real infections. The model is heavily parameterized, without clear reasoning for some parameter choices. The work's greatest contribution, in my opinion, is that it offers a rational framework for how the microbiome could be incorporated into epidemiology, and provides an intriguing hypothesis that the microbiome could play a substantial role in combating antibiotic resistance.</p><p>I would like to say the authors clearly did a good job of conceptualizing infections and resistance dissemination. This was a substantial body of work and the manuscript was interesting to read. My biggest concern is that some of the results intuitively reflect parameters of the model, suggesting they might be artifacts of the approach rather than independent results.</p><p><italic>Reviewer #3:</italic></p><p>This manuscript by Smith et al. proposes a novel mathematical framework that contributes to the understanding of the role of microbiome on the resistance colonisation of bacterial pathogen populations exposed to antibiotics. The model proposed incorporates microbiome competition and takes into account dysbiosis effects on the population dynamics. Extended versions of this model that incorporates strain-microbiome competition and horizontal gene transfer contributions are also presented. The model is simple to understand and takes into account important considerations in healthcare settings usually ignored in the literature. The simulations performed use parameters of four pathogens obtained carefully from a panel of experts. The fact they used these parameters makes the implications of their analysis quite relevant in clinical infections. Different assumptions on the interactions of each of the pathogens are incorporated in the model, and different public health interventions are analysed. The study performed is quite complete and supports the authors objectives. Their work demonstrate how relevant is the accounting for microbiome interactions for the understanding of antibiotics incidence on antibiotic resistance. This is particularly relevant for future work on mathematical modelling of resistance.</p><p>Even though the work presented is well supported by the analysis performed, there are certain aspects regarding the model that need to expanded. In particular:</p><p>1) The study focuses on four particular pathogens, however, no motivation of why they are chosen is provided, nor the relevance of their analysis in a more general overview is discussed. The authors could expand on how their results could be extended to other contexts/species in which the role of microbiome on resistance is also relevant.</p><p>2) The model is described by a set of differential equations. This means the model ignores stochasticity of the population size dynamics of each strain. The authors could expand a bit more on the assumptions of the model and why fluctuations are ignored. Also, spatial structure is particularly important when taking into account interactions between microbiome and pathogens, but it is also neglected in the model. It would be useful if the authors could discuss this as well.</p><p>3) The results shown often focus on steady-state quantities (such as colonisation prevalence), but the temporal evolution of the model is not discussed. It would be interesting if the authors could investigate the timescale of the different interactions taken into account, and how relevant they may be in the healthcare settings they investigate. Is the temporal evolution of the model any relevant for their conclusions?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68764.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The main revisions required are</p><p>– A restructuring of the methods to provide greater clarity of model structures and justification of parameter choices (is there no data? why was this chosen if so?). The driving force behind this should be the reproducibility of the work and the exploration of the results based on the parameter choices.</p></disp-quote><p>We have significantly restructured the paper to provide greater clarity of model structures and parameter choices. Changes include:</p><p>– Explicitly separating the work into two parts: Part 1, Development of a novel ODE modelling framework, evaluated using a generic nosocomial pathogen denoted P<sup>R</sup>; and Part 2, Model application to high-risk nosocomial pathogens with species-specific parameterization. This distinction is made clear from the end of the introduction.</p><p>– Part 1 now begins with a leading paragraph introducing the methods used and outcomes evaluated, with immediate reference to the Methods for more technical detail, and to the Supplement for the final model framework.</p><p>– The Methods section now begins by clearly explaining that the final model combines the 4 models described in the main text (bacterial colonization; strain competition; microbiome competition; strain-microbiome competition), and directs readers to the final model 5 incorporating HGT in supplementary equation S1.</p><p>– Model parameterization, including our use of expert elicitation to approximate microbiome-pathogen interaction coefficients, is expanded and more clearly presented from the end of the introduction, and when introducing Part 2 of the Model and Results section, with additional detail provided in the third paragraph of the Methods section, and with full context and methodological detail in the supplement (Appendix section 4.2, page 21), including raw elicitation data (Appendix figures 8-9) and final re-centred data (Appendix figure 10).</p><p>To support reproducibility of the work, in addition to the Mathematica notebook provided previously, R code has now been made available online at https://github.com/drmsmith/microbiomeR. Code includes all ODEs, functions used to calculate model results, parameter values for the generic pathogen P<sup>R</sup>, and reproduces figures from Part 1 of this work.</p><disp-quote content-type="editor-comment"><p>– A rewriting of the introduction and discussion to include more context of prior modelling work as well as to provide justification for the focus of the work</p></disp-quote><p>In the previous introduction paragraph describing existing modelling work, we now clearly state that antibiotic-induced microbiome dysbiosis is a long-standing hypothesis for the spread of resistance (and not our own), dating to at least Lipsitch and Samore 2002 <italic>EID</italic>.</p><p>“Disruption of the host microbiome is a long-standing theory explaining how antibiotics select for the spread of resistance at both the individual and population levels,(34) but most epidemiological models consider just one species of bacteria at a time, under the traditional assumption that antibiotic selection for resistance results from intraspecific competition between co-circulating strains.” (35–37)</p><p>We have included a new introductory paragraph describing contemporary modelling studies in the field of antibiotic resistance epidemiology. We stress the importance of within-host ecological competition among co-colonizing bacteria explored in contemporary work, e.g; Davies <italic>et al.</italic> 2019 <italic>Nature Ecol Evol</italic>.</p><p>“Accounting for other forms of complexity in epidemiological models – from treatment intensity, to age-assortative contact behaviour, to hospital referral networks, to animal-human interactions, to genetic linkage between resistance and non-resistance genes – has helped to unravel the many, disparate forces that contribute to drive the spread of resistance.(42–47) Nevertheless, within-host competition between co-colonizing bacteria is a key mechanism of selection for antibiotic resistance dissemination, and an active area of research at the forefront of resistance modelling.”</p><p>“For instance, the ‘mixed-carriage’ model by Davies <italic>et al.</italic> demonstrates how intraspecific competition results in negative frequency-dependent selection for either of two competing strains, and provides a satisfying mechanistic explanation for widespread strain coexistence at the population level.(49) However, contemporary work has stopped short of evaluating consequences of between-species competition on resistance epidemiology. Yet for many ARB, including emerging high-priority multidrug-resistant bacteria like extended-spectrum β-lactamase (ESBL) producing <italic>Enterobacteriaceae</italic>, interactions with the host microbiome may be important mediators of nosocomial colonization dynamics.”</p><p>Additional detail has also been provided in the Discussion to better contextualize our work, including:</p><p>– A sentence in the first paragraph broadly contextualizing our work:</p><p>“We present a modelling framework that includes within-host ecological costs of antibiotic use in the form of microbiome dysbiosis, incorporating a leading hypothesis for antibiotic selection into classical models of resistance epidemiology.”</p><p>– The new paragraph on microbiome recovery interventions now references relevant modelling work in this context: two within-host modelling papers newly released since initial submission of our work (Guittar et al. Am Nat 2021 doi: 10.1086/714527; Guk et al. Clin Pharmacol Ther 2021 doi: 10.1002/cpt.1977).</p><p>“Modelling has been used previously to evaluate impacts of such microbiome-oriented interventions at the within-host level,(74,75) but knock-on impacts on ARB transmission dynamics and epidemiological burden have not been evaluated previously.”</p><p>– The paragraph comparing modelling results to the literature now makes clear reference to which results come from modelling vs. clinical studies.</p><p>– The paragraph discussing alternative means of modeling antibiotic selection in previous work now makes a clear link to our work:</p><p>“These strategies reflect widespread recognition that antibiotic use favours ARB acquisition, through erosion of colonization resistance or other supposed mechanisms, and independent of potential competition with other strains. The present work formalizes examples of the microbiome-pathogen interactions that underlie these assumptions, demonstrating their relevance to various epidemiological outcomes, distinguishing them from strain-based selection, and providing a framework for their application.”</p><p>– In the first limitations paragraph, we provide examples of alternative modelling methods commonly used in the literature, and reference alternative factors not considered here (e.g. space, behaviour), but which have been found to drive antibiotic resistance dynamics in other modelling work:</p><p>“This study has a number of limitations. First, hospitals and healthcare settings are heterogeneous environments with non-random contact patterns and relatively small population sizes. Stochastic, individual-based models accounting for these factors reproduce more realistic nosocomial transmission dynamics than deterministic ODE simulations, allowing for local extinction events, super-spreaders, and other inherently random epidemiological phenomena. Nonetheless, our goal was to study how ecological mechanisms impact average epidemiological outcomes in the context of different model assumptions and parameter uncertainty, and in this context ODE modelling was the more appropriate tool, particularly for widely endemic ARB like <italic>C. difficile</italic>, MRSA and ESBL-EC. Still, further insights could certainly be gained by accounting for additional complexity and stochastic heterogeneity in future work, from within-host spatial organization,(91) to patient and staff contact behaviour,(92) to inter-institutional or inter-ward meta-population dynamics.(93) These distinctions may be particularly important for rare or non-endemic ARB (e.g. CP-KP in some regions).”</p><p>To provide further justification for the focus of the work, the introduction has been expanded:</p><p>– In intro paragraph 2, we provide a more clear description of relationships between antibiotic consumption, microbiome dysbiosis, and consequences for susceptibility to colonization (foreshadowing model content):</p><p>“Microbiome dysbiosis is associated with reduced abundance and diversity of commensal bacteria, impaired host immune responses, and loss of colonization resistance, altogether increasing host susceptibility to ARB colonization.(18–20) Antibiotic-induced dysbiosis may further result in elevated expression of antibiotic resistance genes, increased rates of horizontal transfer of such genes, and ecological release, whereby subdominant ARB are released from competition via clearance of drug-sensitive bacteria, growing out into dominant colonies.(21–24)”</p><p>– In intro paragraph 4, we more clearly define the research gap we have aimed to fill:</p><p>“However, contemporary work has stopped short of evaluating consequences of between-species competition on resistance epidemiology. Yet for many ARB, including emerging high-priority multidrug-resistant bacteria like extended-spectrum β-lactamase (ESBL) producing <italic>Enterobacteriaceae</italic>, interactions with the host microbiome may be important mediators of nosocomial colonization dynamics.(18,50,51)”</p><disp-quote content-type="editor-comment"><p>– In line with (1), all reviewers were in agreement that this work needs a clear single model description: a formal description of the model framework in one place. This could be in the supplementary, but it needs to be a well referenced place.</p></disp-quote><p>– A single model description is now provided from the beginning of the supplementary appendix (Appendix page 2), and is referenced throughout the main text, including at the end of the first paragraph of the Model and Results section; upon introduction of HGT at the end of part 1; and in first paragraph of the Methods, where we state:</p><p>“The final model, comprising pathogen colonization (equation 1), intraspecific strain competition (equation 3), microbiome-pathogen competition (equation 4), and horizontal gene transfer (HGT), is given alongside all assumptions in the supplementary appendix (equation S1).”</p><p>– This entailed a complete reformulation of the supplementary appendix, which is now presented in a simplified format (see Table of Contents on Appendix page 1) as follows:</p><p>– Model and assumptions (including final 12-compartment ODE system and describing all underlying modelling choices and assumptions).</p><p>– Part 1: Model evaluation and parameterization (including calculations for all outcomes evaluated).</p><p>– Part 1: Supplementary results.</p><p>– Part 2: Model application, species characterization and parameterization (including expert elicitation and parameter estimates from the literature).</p><p>– Part 2: Supplementary results.</p><disp-quote content-type="editor-comment"><p>1) In general, the model the authors use is highly parameterized. There is a worry about circular reasoning when modelling. Parameters are derived from observations, then a model is constructed to recapitulate this observation. Then similar observations are used to show the model's validity. How did the authors ensure this type of bias was not incorporated into their modelling? This can become a bigger issue with more highly parameterized models, and that is why simpler models are preferable. Another approach is to use cross-validation, although we are not sure how that would work here.</p><p>Abstract</p><p>2) The Abstract is vague and somewhat convoluted as written. It did not do the best job of selling the paper and does not convey any specific information.</p></disp-quote><p>We agree that simple models are preferable, and that our final model (equation S1) combines a large number of assumptions into a single ODE system (although still fewer than a typical agent-based approach). This was our primary motivation for decomposing the final 12-compartment model into individual sub-models and presenting these gradually through Part 1, in order to evaluate each component ecological interaction separately and understand its impacts on resistance epidemiology.</p><p>– By parameterizing all models identically to the same generic pathogen P<sup>R</sup>, by conducting identical univariate and bivariate analyses across models, and by evaluating a range of epidemiological outcomes, we believe that we have isolated and demonstrated epidemiological impacts of different ecological mechanisms that we have considered, and justified their inclusion in our final modelling framework (Figures 1, 2, 3)</p><p>By “Parameters are derived from observations, then a model is constructed to recapitulate this observation”, we presume that the reviewers refer to parameters like pathogen prevalence and resistance rates, which are simultaneously model input parameters (community burden) and epidemiological outputs (simulated hospital dynamics). We don’t disagree with the interpretation that there is inherently “circularity” here where model inputs drive outputs. However, we stress that such sink dynamics are a truism for healthcare institutions (see e.g. Blanquart et al. 2019 Evol App https://doi.org/10.1111/eva.12753): baseline prevalence and resistance rates for asymptomatic colonizers like MRSA and Enterobacteria inevitably reflect burden in the surrounding community.</p><p>– This is also why colonization incidence was evaluated as the primary outcome for evaluation of public health interventions, as this outcome reflects model dynamics but does not have a corresponding input parameter.</p><p>– We now better distinguish between interpretation of these input and output parameters in the caption for Figure 5:</p><p>“Dashed lines (model inputs) represent assumed community prevalence, i.e. the proportion of patients already colonized upon hospital admission (see Tables S3-S6). Solid lines represent simulated prevalence within the hospital, as resulting from both importation from the community and within-hospital epidemiology.”</p><p>For part 2, we stress our use of multivariate sensitivity analysis (PRCC) to understand the impacts of parameter uncertainty on model outcomes, and our analysis of “single-species” vs. “microbiome” simulations to understand impacts of microbiome parameters on model outcomes</p><p>Title [editor request, included here by authors]:</p><disp-quote content-type="editor-comment"><p>Could you please edit your title so the second part gives clear indication of the study design under investigation, if appropriate, and avoiding abbreviations where possible. The remainder of the title should read as a single, concise sentence containing no dashes or question-answer, and avoiding abbreviations where possible.</p></disp-quote><p>We propose the following title:</p><p>“Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: a modelling study applied to nosocomial pathogen control”</p><disp-quote content-type="editor-comment"><p>Introduction</p><p>3) The authors need to tailor this to their specific question: where is the knowledge gap? We recommend that the authors think carefully about the statements they are making and consider revising the Introduction to include a more thorough analysis of prior modelling work, which is largely absent from the Introduction.</p></disp-quote><p>A more thorough analysis of previous modelling work is now provided as the fourth paragraph of the introduction. In the context of this paragraph, we present the following knowledge gap.</p><p>“Accounting for other forms of complexity in epidemiological models – from treatment intensity, to age-assortative contact behaviour, to hospital referral networks, to animal-human interactions, to genetic linkage between resistance and non-resistance genes – has helped to unravel the many, disparate forces that contribute to drive the spread of resistance.(42–47) Nevertheless, within-host competition between co-colonizing bacteria is a key mechanism of selection for antibiotic resistance dissemination, and an active area of research at the forefront of resistance modelling.(34,36,48) For instance, the ‘mixed-carriage’ model by Davies et al. demonstrates how intraspecific competition results in negative frequency-dependent selection for either of two competing strains, and provides a satisfying mechanistic explanation for widespread strain coexistence at the population level.(49) However, contemporary work has stopped short of evaluating consequences of between-species competition on resistance epidemiology. Yet for many ARB, including emerging high-priority multidrug-resistant bacteria like extended-spectrum β-lactamase (ESBL) producing <italic>Enterobacteriaceae</italic>, interactions with the host microbiome may be important mediators of nosocomial colonization dynamics.”</p><disp-quote content-type="editor-comment"><p>4) The study focuses on four particular pathogens, however, no motivation of why they are chosen is provided, nor the relevance of their analysis in a more general overview is discussed. The authors could expand on how their results could be extended to other contexts/species in which the role of microbiome on resistance is also relevant. This could also be included in the discussion.</p></disp-quote><p>We thank the reviewer for this helpful comment which we have taken into account in several instances:</p><p>In the introduction, in addition to previous reference to <italic>C. difficile</italic>, we now reference the emerging threat of ESBL-<italic>Enterobacteriaceae</italic> when introducing the knowledge gap motivating this work (see previous comment).</p><p>In the discussion, second paragraph:</p><p>– Additional context for these species as key drivers of nosocomial infection:</p><p>“MRSA, <italic>C. difficile</italic> and ESBL-producing <italic>Enterobacteriaceae</italic> are leading causes of antibiotic-resistant and healthcare-associated infection, while carbapenemase-producing <italic>Enterobacteriaceae</italic> represent emerging threats of particular concern due to limited therapeutic options for effective treatment of invasive infection.” (4,63–65)</p><p>“Antibiotic stewardship is a core component of public health efforts to limit the emergence and spread of these ARB in clinical settings,(66) and an important focus of antibiotic resistance modelling.”</p><p>– Relevance for other species and settings:</p><p>“Our simulations were limited to a select few ARB, but our framework and findings likely have relevance for other bacteria known to interact with the microbiome, including vancomycin-resistant Enterococci and other multidrug-resistant <italic>Enterobacteriaceae</italic>,(23,76) and could be further extended to explore impacts of the microbiome on resistance dynamics and intervention efficacy beyond healthcare settings.”</p><disp-quote content-type="editor-comment"><p>5) The authors conclude that disruption of the microbiome on an individual level (due to antibiotics) can result in selection for AMR on a population level. In a way, the work is, at least in part, a model-based implementation of the theoretical perspective of Lipsitch and Samore 2002 EID doi: 10.3201/eid0804.010312 (which describes how antibiotic effects on an individual, within-host level, can affect population level transmission dynamics). Could the comparison to Lipsitch and Samore and the novelty of the improved data-driven approach (although still limited) be further discussed?</p></disp-quote><p>We agree that our work implements a long-standing hypothesis previously described in the perspective by written by Lipsitch and Samore 2002 <italic>EID</italic>. This is now emphasized first in the introduction:</p><p>“Disruption of the host microbiome is a long-standing theory explaining how antibiotics select for the spread of resistance at both the individual and population levels,(34) but most epidemiological models consider just one species of bacteria at a time, under the traditional assumption that antibiotic selection for resistance results from intraspecific competition between co-circulating strains.”</p><p>In the Model and Results, as previously:</p><p>“….intraspecific strain competition is not the only mechanism by which antibiotic consumption can drive ARB spread,(34) and may have limited relevance for certain species, settings, timescales and epidemiological indicators.”</p><p>And anew in the first paragraph of the discussion</p><p>“We present a modelling framework that includes within-host ecological costs of antibiotic use in the form of microbiome dysbiosis, incorporating a leading hypothesis for antibiotic selection into classical models of resistance epidemiology.”</p><p>We also highlight the following passage from Lipsitch and Samore, which supports the present work:</p><p>“The use of mathematical models, and more generally the attempt to predict the relative merits of different interventions, will depend on an improved understanding of the mechanisms of antibiotic selection in particular organisms.”</p><p>The novelty of our approach is further emphasized in the discussion, when comparing our approach to previous models assuming increased susceptibility to colonization/infection among antibiotic-exposed individuals:</p><p>“These strategies reflect widespread recognition that antibiotic use favours ARB acquisition, through erosion of colonization resistance or other supposed mechanisms, and independent of potential competition with other strains. The present work formalizes examples of the microbiome-pathogen interactions that underlie these assumptions, demonstrating their relevance to various epidemiological outcomes, distinguishing them from strain-based selection, and providing a framework for their application.”</p><p>In the second limitations paragraph of the discussion, we now highlight that, despite clear data limitations, our expert elicitation-driven approach provided useful proxy measures that allowed us to characterize the species-specific ecology of different ARB:</p><p>“Finally, the nature of microbiome-pathogen interactions and their epidemiological consequences remain poorly understood and largely unquantified. We show in theory why these interactions matter at the population level, but empirical data were unavailable to inform their parameterization. Instead, we translated microbiome-pathogen competition coefficients into clinical parameters, designed a structured expert elicitation protocol and conducted interviews allowing subject-matter experts to quantify their beliefs. Although these estimates are subject to substantial bias and uncertainty, they facilitated species-specific characterization of the epidemiological impact of microbiome dysbiosis, and represent useful proxy measures in the absence of clinical data.”</p><p>And in the penultimate paragraph we further discuss our approach and findings in the context of limited data, including perspectives for future empirical work:</p><p>“Despite data limitations, epidemiological conclusions from Monte Carlo simulations were largely consistent with empirical findings (discussed above), suggesting that final parameter distributions were reasonable approximations. Uncertainty in parameter inputs translated to uncertainty in model outputs and reflects the knowledge gaps underlying our simulations (Figure S14). This is exemplified by HGT and its highly uncertain role in driving colonization incidence; to date, HGT modelling has largely been limited to within-host dynamics, and impacts on epidemiological dynamics are only just beginning to come to light.(51,57,94) Increasing availability and synthesis of high-quality within-host microbiological data will help to further characterize epidemiological impacts of microbiome-pathogen interactions. Studies are needed that describe ecological impacts of antibiotic exposure on microbiome population structure across control and treatment groups, with longitudinal follow-up evaluating subsequent nosocomial ARB colonization risk. In the absence of clinical data, insights from experiments and within-host models nonetheless suggest that antibiotic disruption of microbiome-pathogen competition is a key driver of selection for resistance.” (95–100).</p><disp-quote content-type="editor-comment"><p>6) Antibiotic stewardship is treated a single entity, whereas in reality there are countless types of stewardship interventions and a concomitant variety of outcomes. Comparing the model's results directly to an analysis of previous stewardship interventions and attempting to show alignment does not make sense to me. How were these stewardship interventions reflective of the model? Why would we expect agreement or disagreement a priori? The fact that there was agreement with the model was somewhat concerning given the complexity of many stewardship interventions.</p></disp-quote><p>– We totally agree that stewardship interventions are highly heterogeneous and thank the reviewer for raising this point. Heterogeneity likely drives high uncertainty in efficacy estimates from the meta-analysis by <italic>Baur</italic> et al., which groups interventions together as a single entity. Despite this high heterogeneity, stewardship interventions – whether reducing rates of antibiotic consumption, favouring lower-spectrum antibiotics, decreasing treatment duration, or otherwise limiting patient exposure to unnecessary antibiotics – should in theory all reduce population-level antibiotic-induced dysbiosis (and hence reduce microbiome-induced selection for resistance)</p><p>– Owing to our ODE-based approach, we were unable to reproduce highly granular stewardship interventions that reflect real-world heterogeneity, but we nonetheless simulated 3 types of stewardship, and found similar efficacy estimates (1 – IRR) for each (Appendix figure 17), which were also concordant with pooled estimates from the meta-analysis</p><p>– We agree that visualizing validation of model results to published results from Baur et al. was perhaps not appropriate, and have removed those estimates from Figure 6. Instead, we make comparison to their findings in the discussion:</p><p>“By contrast, simulated antibiotic stewardship interventions were broadly effective for reducing incidence across all included ARB. This is consistent with findings from a meta-analysis of clinical trials evaluating the efficacy of hospital antibiotic stewardship interventions for reducing incidence of ARB colonization and infection,(66) which we updated to exclude studies co-implementing stewardship with alternative interventions (Figure S18). In comparison to our findings, estimates from the meta-analysis were associated with greater uncertainty across more heterogeneous interventions, but predicted the same rank order of efficacy across included ARB, and similar mean efficacy for <italic>C. difficile</italic> (19% from n=7 studies, vs. 18% under intermediate compliance in our simulations), ESBL-EC (18% from n=4 studies, vs. 15%) and MRSA (12% from n=10 studies, vs. 10%), but higher efficacy for CP-KP (54% from n=1 study, vs. 20%).”</p><disp-quote content-type="editor-comment"><p>Methods7 In attempting to replicate this study, it became intractably difficult to recreate the ODEs because the equations and variables are interspersed throughout the main text and supplementary appendix. For example, in Figure 1e the authors mention differences in resistance levels (γ) and not transmission rate (λ, related to β as in Equation (3)), the value of which could not be found anywhere in the text. Similarly, where is patient demography (Δ) incorporated into equations 3 or 4? There are certainly answers to these questions, but it would have been helpful to have the model more clearly presented in a central location. Finding the parameters and making sense of them was extremely challenging, if not infeasible. Therefore, we were unable to replicate the results to any extent.</p></disp-quote><p>We appreciate that some aspects of our model were unclear to reviewers and regret any confusion caused. We have taken a number of steps to improve the clarity of our modelling assumptions and to improve reproducibility of our work:</p><p>– We provide equations for each of the analyzed sub-models in the manuscript (the strain-microbiome competition was previously in the supplement), more explicitly reference them in the text (equations 1, 3, 4 and 6, respectively), and include δ (demography) terms throughout</p><p>The final complete model and all of its underlying assumptions – the ‘framework’ – is now provided at the beginning of the supplement, delineating all assumptions, composite parameters and strain-specific differences. This final framework is referenced on multiple occasions in the manuscript, including:</p><p>– In the first paragraph of Methods and Results:</p><p>“See Methods for technical details, and the supplementary appendix for the complete modelling framework and assumptions (equation S1).”</p><p>– After introduction of HGT, to clarify where the final model including HGT can be found:</p><p>“(See final model and assumptions, Appendix equations 1 – 11.)”</p><p>– At the beginning of the methods, to clarify our approach of building subsequent sub-models together to produce our final framework:</p><p>“We evaluated ODE systems describing colonization dynamics of bacterial pathogens in the healthcare setting. The final model, comprising pathogen colonization (equation 1), intraspecific strain competition (equation 3), microbiome-pathogen competition (equation 4), and horizontal gene transfer (HGT), is given alongside all assumptions in the supplementary appendix (equation S1).”</p><p>In addition to the previously available Mathematica code, R code has been made available for the 5 ODE systems at https://github.com/drmsmith/microbiomeR, as referenced in the Methods:</p><p>“(See the supplementary appendix for technical details, and R and Mathematica files available online at https://github.com/drmsmith/microbiomeR.)”</p><p>In the caption for Figure 1E we have defined strain-specific differences in force of infection, as suggested:</p><p>“For E, P<sup>S</sup> and P<sup>R</sup> circulate simultaneously, assuming strain-specific differences in antibiotic resistance (<italic>r<sub>S</sub></italic> = 0, <italic>r<sub>R</sub></italic> = 0.8), natural clearance (γ<sub>S</sub> = 0.03 day<sup>-1</sup>, γ<sub>R</sub> = 0.06 day<sup>-1</sup>) and transmission (λ<sub>S</sub> = β × C<sup>S</sup>/N, λ<sub>R</sub> = β × C<sup>R</sup>/N).”</p><disp-quote content-type="editor-comment"><p>8) It is unclear how the authors arrived at their parameter values throughout the manuscript. For example, colonization resistance (epsilon) as it is formulated is not compelling, and where did the value of this parameter come from? It is listed in Table S5 as being drawn from a Cauchy distribution. Why? Where did these numbers come from? Some of the parameters seem justified by literature, but the rest are perhaps debatable. This might be inevitable with a complex model, but the authors should minimally provide a robustness analysis to each of their less-supported parameter choices. What would be the outcome if the sampled distributions had been wider (e.g., if the true value had been different by an order of magnitude)?</p></disp-quote><p>We thank the reviewer for raising this important point and have taken a number of steps to address it. First, by explicitly splitting the work into 2 parts, we hope that it is now more clear that in Part 1 we evaluate impacts of different within-host ecological interactions on a generic nosocomial pathogen P<sup>R</sup> – hence with arbitrary parameter values, but using univariate and bivariate analysis to explore the epidemiology of this theoretical pathogen across wide parameter space – and that in Part 2 we tailored our model to particular ARB using species-specific parameter estimates from the literature and expert opinion</p><p>For consistency, we have introduced concepts of <italic>colonization resistance</italic> and <italic>ecological release</italic> – both well-established in cited literature – earlier in the manuscript:</p><p>“The microbiome can also protect against colonization with infectious bacterial pathogens, a phenomenon known as colonization resistance, limiting their capacities to establish colonies, grow, persist and transmit.”</p><p>“Antibiotic-induced dysbiosis may further result in elevated expression of antibiotic resistance genes, increased rates of horizontal transfer of resistance genes, and ecological release, whereby subdominant ARB are released from competition via clearance of drug-sensitive bacteria, growing out into dominant colonies.”</p><p>We now also discuss limitations of our conceptualization of these interactions in our modelling framework:</p><p>“More broadly, our characterizations of microbiome-pathogen interactions are conceptual, and were mapped mechanistically to particular colonization processes (transmission, clearance, endogenous acquisition), but we note that in other contexts terms like <italic>colonization resistance, resource competition</italic> and <italic>ecological release</italic> may map to specific biochemical processes that could affect epidemiological parameters in different ways.”</p><p>We have taken a number of steps to more clearly describe parameterization of microbiome-pathogen interaction coefficients and our use of expert elicitation:</p><p>– The protocol document for our expert elicitation exercise is provided as a separate supplementary file, an exact copy of which was used by experts during interviews.</p><p>– Use of expert elicitation to inform model parameters is now referenced as early as the introduction:</p><p>“Expert elicitation interviews were conducted to characterize the clinical relevance of microbiome dysbiosis for each species, and to qualify and quantify interaction coefficients with uncertainty.”</p><p>– In the Model and Results section of the manuscript, we more clearly reference the expert elicitation and what it was used for, with reference to Methods and relevant sections of the supplement:</p><p>“Data from the literature were used to parameterize the model to each pathogen (Figure 4, Tables S2 – S6). Literature estimates for microbiome-pathogen interaction coefficients are scarce, and the species-specific relevance of different within-host interactions (intraspecific strain competition, microbiome competition, HGT) in the hospital environment are not well-defined. To characterize ecological interactions for each species and inform model structure, we conducted interviews with a panel of subject-matter experts in medical microbiology and antibiotic resistance epidemiology (details in Methods). Based on their beliefs, all pathogens were assumed to compete with microbiota; MRSA, ESBL-EC and CP-KP were further assumed to compete intra-specifically with non-focal strains, for simplicity characterized as methicillin-sensitive <italic>S. aureus</italic> (MSSA), <italic>E. coli</italic> (EC) and <italic>K. pneumoniae</italic> (KP); and both ESBL resistance and carbapenem resistance were assumed to be borne by plasmids capable of horizontal transfer between patient microbiota and, respectively, EC and KP (Figure 4A). To quantify species-specific strengths of microbiome-pathogen interactions, within-host ecological parameters were translated into clinical parameters (Table S7), and experts were asked to quantify these using standardized expert elicitation methodology (Figures 4B, S8 – S10).”</p><p>– In the Methods, description of the expert elicitation has been condensed into one succinct paragraph for clarity, while full methodological details have been provided in the corresponding section of the supplement (Appendix section 4.2, page 21), where we:</p><p>– Describe expert elicitation and our protocol.</p><p>– Describe elicitation results and their interpretation. Here we also detail how final pooled distributions were found (including the Cauchy distribution listed in Table S5 and referenced by the reviewer):</p><p>“Raw data for expert distributions are provided in Figure S9. Experts differed substantially in estimated ranges of different parameters, but Friedman’s tests using medians of each parameter distribution suggested that the species rank order was conserved across experts, with <italic>C. difficile</italic> generally having the strongest estimated microbiome-pathogen interaction coefficients, and MRSA the weakest. To conserve species rank order when combining expert estimates <italic>x<sub>i,j,k</sub></italic> to form pooled histograms, distributions were re-centred by the mean relative distance <italic>z<sub>i,j</sub></italic> between each <italic>j</italic> and the reference ARB (taken as MRSA) over all experts <italic>k</italic> (Figure S10). For <italic>C. difficile</italic> and MRSA, HGT was excluded from simulations and pooled distributions were not re-centred. Each expert distribution was weighted equally, contributing to 10% of the final pooled distribution for each species and parameter. Pooled histograms were fit to six candidate distributions (normal, log-normal, Weibull, Cauchy, exponential and γ), and the final distribution was selected as the fitted distribution giving the lowest Akaike Information Criterion (using the function fitdist from the R package fitdistrplus). Final fitted distributions for each parameter and ARB are given in Tables S3-S6, and for select parameters in Figure 4.”</p><p>– Provide Table S7, as previously, which translates the clinical parameters experts estimated into microbiome-pathogen interaction coefficients.</p><p>– Provide Figure S8, as previously, showing expert opinion about the clinical relevance of different clinical parameters for different species.</p><p>– Provide Figure S9, the raw data resulting from the expert elicitation, i.e. the distributions created by each expert for each microbiome-pathogen interaction for each species.</p><p>– Provide Figure S10, final re-centred data used to generate pooled distributions while maintaining species rank order.</p><p>We agree that alternative model parameterization for each species would change modelling results and conclusions, but stress that the goals of Part 2 – evaluation of species-specific colonization dynamics and intervention efficacy – necessitates species-specific parameterization, which we estimated to the best of our ability given available data, while:</p><p>– accounting for parameter uncertainty;</p><p>– conducting multivariate sensitivity analysis with PRCC to quantify impacts of parameter uncertainty on model outcomes;</p><p>– conducting simulations without microbiome interactions, to show their impact on outcomes.</p><p>A key result of these analyses is that alternative species-specific model parameterization leads to different modelling results and estimates for intervention efficacy, and that these are further impacted by including microbiome-pathogen interactions. We believe that additional analysis arbitrarily adjusting parameter distributions would not be appropriate:</p><p>– Widening distributions for all parameters should produce approximately the same median results with inflated uncertainty across outcomes.</p><p>– Univariate widening of parameter distributions is unnecessary given PRCC results (Appendix figure 14, page 30), which already convey which parameters have greatest impact on outcomes, and hence which parameters should most increase or decrease resistance if adjusting the value.</p><p>– Arbitrarily adjusting certain parameters goes against the stated goal of species-specific characterization. For example, it would be possible to run simulations with a high transmission rate for <italic>E. coli</italic> or low microbiome-pathogen interaction coefficients for <italic>C. difficile</italic>, and outcomes would certainly change substantially. But these simulations would no longer represent these pathogens, and it is not clear to us that worthwhile insights would be gained that are not already demonstrated by PRCC results, by comparisons between the four included ARB, and by ‘single-species’ vs. ‘microbiome’ simulations</p><p>We nonetheless agree that imperfect parameterization is a key limitation to this study, and dedicate a new paragraph to discuss this, highlighting limited availability of several parameters in the literature, uncertain generalizability of results across settings, sensitivity of model conclusions to assumed parameters, the conceptual nature of our characterization of microbiome-pathogen interactions, and the gut-specific nature of our microbiome dysbiosis scale (which could potentially bias results for predominantly skin-residing <italic>S. aureus</italic>).</p><p>Finally, for completeness, we re-ran our multivariate sensitivity analysis conducted previously (Latin Hypercube Sampling + PRCC) for an additional outcome: the pathogen resistance rate (Appendix figure 14B, page 30). Findings for both outcomes are now presented together in the Model and Results section:</p><p>“In multivariate sensitivity analysis, community prevalence (<italic>f<sub>C</sub></italic> for <italic>C. difficile</italic>, <italic>f<sub>R</sub></italic> for others) and rates of endogenous acquisition (α<sub>R</sub>) had overall the strongest positive impacts (highest PRCCs) on hospital prevalence across ARB, while rates of hospital admission/discharge (μ) and microbiome recovery (δ) had the strongest negative impacts (lowest PRCCs; Figure S14A). For resistance rates, parameters with the strongest positive impacts (highest PRCCs) were community prevalence (<italic>f<sub>R</sub></italic>), the rate of endogenous acquisition (α<sub>R</sub>) and the rate of antibiotic-induced pathogen clearance (σ<sub>C</sub>). Parameters with the strongest negative impacts (lowest PRCCs) were rates of hospital admission/discharge (μ) and endogenous acquisition of competing drug-sensitive strains (α<sub>S</sub>) (Figure S14B). Across ARB, prevalence estimates, but not resistance rates, were generally sensitive to microbiome parameters.”</p><disp-quote content-type="editor-comment"><p>9) The inclusion of the 'r' parameter, allowing for partial resistance in the resistant strain, is interesting (and innovative for modelling frameworks to our knowledge). Nonetheless, it is not clear why the authors use a baseline of r = 0.8 to illustrate the trade-off between antibiotic induced clearance and selection for Cr (Figure 1F), whereas in figure 2, the authors use r=0.4, i.e. higher levels of sensitivity in Cr. I suppose with a lower r, strain coexistence is more likely, and thus higher likelihood of Horizontal Gene Transfer (HGT) (?), but it would be, for consistency and comparison of the different within-host dynamics, more transparent to use the same baseline parameter values, unless the authors can provide a good reason why different values of r are assumed at baseline between Figure 1 and Figure 2B?</p></disp-quote><p>We thank you for raising this and agree that identical parameter values across plots for Part 1 makes for more consistent and transparent results. We have now reproduced all Figures using the same default parameter set (Appendix table 1 on page 11, results also provided in R code), such that all results for Part 1 now represent the same generic pathogen P<sup>R</sup> (adjusting only the parameters explicitly made to vary for univariate or bivariate analysis in each figure). In particular, the previous Figure 2B has been expanded into a new Figure 3, which includes the default value of <italic>r<sub>R</sub></italic>=0.8, as well as results for lesser resistance levels (<italic>r<sub>R</sub></italic> = 0.2, 0.5) to demonstrate how different epidemiological outcomes (pathogen prevalence and resistance rate) vary with this important parameter.</p><disp-quote content-type="editor-comment"><p>10) The model presented in Eq. (1) needs a better introduction. Is this a new model or based on other models previously studied? This is explained later in the text citing references (30) and (31), but we recommend to introduce them earlier. It would be also good to point the reader earlier in the main text to the first sections of the supplement for a better understanding of the model assumptions and parameters employed.</p></disp-quote><p>This model is adapted from classic colonization models of antibiotic-resistant bacteria – the first example to our knowledge being Austin and Anderson <italic>Proc Biol Sci</italic> 1997 – with the key difference being our novel approach to modelling antibiotic treatment. We now introduce this model in this context, including the following:</p><p>“We start with a Susceptible-Colonized transmission model (Figure 1A) representing a population of N hospitalized patients as either susceptible to colonization (S) or colonized (C<sup>R</sup>) by P<sup>R</sup>, the focal strain or species: <italic>[equations]</italic> This model is adapted from classic colonization models of antibiotic-resistant bacteria,(51) includes no ecological interactions with non-focal bacteria, and reflects a suite of common assumptions relevant to the healthcare setting, including: …”</p><p>And subsequently highlighting how we model antibiotic exposure and its impacts on pathogen clearance:</p><p>“Modelling the latter as a continuous proportion reflects that bacteria are not necessarily fully drug-sensitive (<italic>r<sub>R</sub></italic> = 0) nor -resistant (<italic>r<sub>R</sub></italic> = 1), but can range in their sensitivity to different antibiotics (0 ≤ <italic>r<sub>R</sub></italic> ≤ 1). The resistance level <italic>r<sub>R</sub></italic> is thus a model input interpreted as an overall measure of the pathogen’s innate degree of resistance to the particular antibiotics to which it is exposed.”</p><p>Finally, we place this first model in the context of subsequent models</p><p>“Following models build upon these assumptions, representing the same pathogen P<sup>R</sup>, but altering its ecological interactions with other bacteria from one model to the next. Models were evaluated over the same generic parameter space, to isolate impacts of model structure on epidemiological outcomes in the context of antibiotic use (see parameters in Table S1).”</p><disp-quote content-type="editor-comment"><p>11) Also, should the parameters be more consistently labelled across frameworks? For example, we recommend writing λ(N,C), or something similar, in all the equations to explicitly state it depends on these parameters. The way it is written gives the impression that λ is a constant parameter.</p><p>13) Furthermore, in figure 1F: this is representing a one strain model. Is the Ce+Cd strain similar to the Cr? Can this be clarified?</p><p>14) In line with this. In Figure S3, R0 seems to represent the R0 of Cr. However, for Figure 1H and 1I, how should R0 be interpreted respectively? And for Figure S2? Please clarify how similar Cr (Figure 1H) and the one strain modelled (which could be similar to the Cr strain of Figure 1H) for figure 1I are</p></disp-quote><p>We respond to these 3 comments simultaneously: yes, the focal antibiotic-resistant pathogen (previously denoted C in model 1, C<sup>R</sup> in model 2 and C<sub>e</sub>+C<sub>d</sub> in model 3) is identical, and we understand the previous confusion. We thank the reviewer for raising these points and we have consequently made changes to clarify notation</p><p>We have rewritten the manuscript to explicitly distinguish between the pathogen in question and patient colonization with that pathogen: drug-sensitive and -resistant pathogen strains are denoted P<sup>S</sup> and P<sup>R</sup>, respectively, while patient colonization with those strains is denoted C<sup>S</sup> and C<sup>R</sup></p><p>All ODE systems are rewritten to describe dynamics of C<sup>R</sup>, i.e. all systems describe colonization with the same focal antibiotic-resistant pathogen P<sup>R</sup>. Epidemiological parameters for P<sup>R</sup> are always denoted by subscript R (e.g. α<sub>R</sub>). Where strain competition is also included, ODE systems include C<sup>S</sup> (representing patient colonization with the strain P<sup>S</sup>), with epidemiological parameters for P<sup>S</sup> denoted by subscript S (e.g. α<sub>S</sub>)</p><p>We now make the reader aware of these notations several times early in the paper. For instance we:</p><p>– Introduce P<sup>R</sup> from the first sentence of the Model and Results:</p><p>“We propose a series of five models describing colonization dynamics of a focal antibiotic-resistant bacterial <italic>pathogen</italic>, denoted P<sup>R</sup>, among hospital inpatients in an acute care setting. Each model accounts for different within-host ecological interactions between P<sup>R</sup> and other bacteria.”</p><p>– Distinguish between P<sup>R</sup> and C<sup>R</sup> upon introduction of the first model:</p><p>“We start with a Susceptible-Colonized transmission model (Figure 1A) representing a population of N hospitalized patients as either susceptible to colonization (S) or colonized (C<sup>R</sup>) by P<sup>R</sup>, the focal strain or species:”</p><p>– Distinguish between P<sup>S</sup> and P<sup>R</sup> upon introduction of strain competition:</p><p>“… selection results from intraspecific competition between two or more drug-sensitive strains P<sup>S</sup> and drug-resistant strains P<sup>R</sup>.”</p><p>– And again upon introduction of the strain competition model:</p><p>“A simple two-strain ‘exclusive colonization’ model (Figure 1B) can be written as: [equations] where patients can be colonized (C<sup>S</sup>, C<sup>R</sup>) by either strain (P<sup>S</sup>, P<sup>R</sup>).”</p><p>– And so on throughout the manuscript.</p><p>We further make explicit that we are always evaluating the same P<sup>R</sup> across models using the same parameter set, changing only its within-host interactions with other bacteria across models:</p><p>“Following models build upon these assumptions, representing the same pathogen P<sup>R</sup>, but altering its ecological interactions with other bacteria from one model to the next. Models were evaluated over the same generic parameter space, to isolate impacts of model structure on epidemiological outcomes in the context of antibiotic use (see parameters in Table S1).”</p><p>We have updated model diagrams in Figure 1 to represent these changes</p><p>We understand that not all readers may be familiar with the classic force of infection term λ, but in the final model λ already has up to 2 subscripts (λ<sub>S,ε</sub>). We believe that adding more (e.g. λ<sub>S,ε,C,N</sub>) could unnecessarily complexify model interpretation. Instead, we have proposed clear definitions of λ in 3 instances:</p><p>– as previously, upon introduction of model 1;</p><p>“(iii) a dynamic rate of colonization acquisition λ<sub>R</sub>=β⨉C<sup>R</sup>/N, for host-to-host transmission.”</p><p>– as suggested by reviewers, in the caption for Figure 1 for the strain competition model:</p><p>“For E, P<sup>S</sup> and P<sup>R</sup> circulate simultaneously, assuming strain-specific differences in antibiotic resistance (<italic>r<sub>S</sub></italic> = 0, <italic>r<sub>R</sub></italic> = 0.8), natural clearance (γ<sub>S</sub> = 0.03 day<sup>-1</sup>, γ<sub>R</sub> = 0.06 day<sup>-1</sup>) and transmission (λ<sub>S</sub> = β × C<sup>S</sup>/N, λ<sub>R</sub> = β × C<sup>R</sup>/N).”</p><p>– in the supplement, as the final generalized expression for any strain <italic>j.</italic> (Appendix equation 3 page 3)</p><disp-quote content-type="editor-comment"><p>12) The r vs resistance rate (Cr/Cr+Cs) caused some confusion. This as a resistance rate of Cr = 0.8 but an r = 0.4 could actually mean that 0.8*0.4 = 0.08 of pathogens carried are fully resistant against the antibiotic, while this is 0.64 when r=0.8. Can the same baseline values for r be used in Figure 1 and Figure 2 or the differences justified?</p></disp-quote><p>We regret the confusion. The same baseline value <italic>r<sub>R</sub></italic>=0.8 is now used throughout.</p><p>To clarify interpretation of the parameter <italic>r<sub>R</sub></italic> (and <italic>r<sub>S</sub></italic>), the following text has been added upon its introduction in the first model:</p><p>“…and <italic>r<sub>R</sub></italic> is the antibiotic resistance level (the proportion of antibiotics that are ineffective against P<sup>R</sup>). Modelling the latter as a continuous proportion reflects that bacteria are not necessarily fully drug-sensitive (<italic>r<sub>R</sub></italic> = 0) nor -resistant (<italic>r<sub>R</sub></italic> = 1), but can range in their sensitivity to different antibiotics (0 ≤ <italic>r<sub>R</sub></italic> ≤ 1). The resistance level <italic>r<sub>R</sub></italic> is thus a model input interpreted as an overall measure of the pathogen’s innate degree of resistance to the particular antibiotics to which it is exposed.”</p><p>And we have also more clearly defined the resistance rate in the first paragraph of Model and Results:</p><p>“Across models, three primary epidemiological outcomes are calculated at steady-state equilibrium: P<sup>R</sup> prevalence (the proportion of patients colonized), P<sup>R</sup> incidence (the daily rate of colonization acquisition within the hospital), and the pathogen resistance rate (the proportion of patients colonized with the focal antibiotic-resistant strain P<sup>R</sup> relative to a competing drug-sensitive strain P<sup>S</sup>).”</p><p>We have kept the initial name used for the <italic>r<sub>R</sub></italic> parameter: the antibiotic resistance level. This name was chosen to avoid confusion with alternative possible names like the antibiotic resistance rate/proportion/frequency/share (which are used elsewhere to describe the share of strains of a species – or the share of clinical isolates – that are drug-resistant, as above). However, we understand that interpretation of this novel parameter may not be obvious and we propose the following alternatives to the reviewers and editors: antibiotic resistance coverage, antibiotic resistibility, antibiotic resistance degree, innate antibiotic resistance level/degree.</p><p>– It is not clear to us that any of these alternatives improve understanding, but our goal is to maximize clarity and interpretability of this important parameter, and we welcome any feedback and are happy to update it, if so desired by the editorial team.</p><disp-quote content-type="editor-comment"><p>15) Figure 2A, the minimum resistance rate is 0.35 (see legend, and this appeared the case when no antibiotic induced clearance nor antibiotic induced microbiome disruption). This seems rather high. In particular as in Figure 2B, minimum levels of less than 0.1 are shown. Could the authors explain where this discrepancy is coming from and to what extend these high baseline resistance rates are representative?</p></disp-quote><p>For ease of interpretation for the generic pathogen P<sup>R</sup> in part 1, in our baseline parameter set (Table S1) we now assume that 50% of colonized individuals admitted from the community are colonized with the resistant strain (<italic>f<sub>R</sub></italic> = 0.5): when the steady-state resistance rate exceeds 50%, it can easily be understood that the hospital has provided a competitive advantage to the resistant strain despite assumed costs of resistance. We agree that this is a higher resistance rate than many real-world pathogens, examples of which are provided in Part 2 (see for e.g. Figure 5B).</p><p>In the previous Figure 2B, minimum levels of C<sup>R</sup> prevalence were &lt;0.1 (not the resistance rate, which was not shown), but we acknowledge that this may have been confusing as the adjacent Figure 2A presented both resistance rate and prevalence. We have now separated these figures: Figure 2A is presented as Figure 2; and Figure 2B has been expanded into a new Figure 3, which includes both prevalence and resistance rates to avoid potential misinterpretation, and to demonstrate asymmetry in these outcomes. We further demonstrate how outcomes related to HGT depend on the antibiotic resistance level <italic>r<sub>R</sub></italic> (columns). We have also added translucent grey bars to this figure representing assumed community P<sup>R</sup> colonization prevalence (<italic>f<sub>C</sub></italic> × <italic>f<sub>R</sub></italic>) and resistance rate (<italic>f<sub>R</sub></italic>), to help the reader to contextualize results against baseline assumptions.</p><disp-quote content-type="editor-comment"><p>16) For parameterisation of the models for the different pathogens, estimates from literature, notably existing modelling studies are chosen. However, these estimates, at least for C. difficile and MRSA, are coming from models that don't incorporate endogenous acquisition explicitly (for the Enterobacterieacia, model estimates from Gurieva are used, which do use a modelling framework incorporating an exo- and endogenous acquisition). Therefore, the acquisition rates may be overestimated for these gram-positives, in particular for C. diff the endogenous acquisition, which is listed as the main acquisition route (pp 14 line 330).</p><p>This may affect the estimated intervention effectiveness (in particular for antibiotic stewardship (less effective) and contact precautions (more effective)) under assumptions of the microbiome model. Could the authors use more realistic estimates (not sure models with explicit exo- and endogenous acquisition exist for MRSA and C. diff), or at least, reflect on how different values of α and β affect the model results?</p></disp-quote><p>Unfortunately, we are also unaware of models with explicit exo-endo estimates for the gram-positives, but we now dedicate substantial discussion to this limitation and discuss relevance to PRCC results from our sensitivity analysis:</p><p>“Third, Monte Carlo simulations were limited by the availability of species-specific model parameters from the literature, in some instances necessitating use of previous modelling results, approximations, or estimates from small studies in specific locations, making the generalizability of results unclear. For instance, Khader <italic>et al.</italic> estimated a four-fold difference in MRSA transmission rates between hospitals and nursing homes.(79) Such differences could have a substantial impact on dynamics and estimated intervention efficacy, with higher transmission rates favouring use of contact precautions, and higher rates of endogenous acquisition favouring antibiotic stewardship (in the context of a high ecological release coefficient). Uncertainty in endogenous acquisition rates may be particularly important: in multivariate sensitivity analyses, this parameter emerged as a key driver of both colonization prevalence and resistance rates across ARB (Figure S14).”</p><disp-quote content-type="editor-comment"><p>17) It would be helpful to explicitly say how the simulations were performed, i.e., mention that the ODEs where integrated. My first impression was that the authors performed stochastic simulations using the processes illustrated in panels A, B, C from Figure 1. This is probably an issue that only mathematical modellers would have, but could the authors please add this clarification.</p></disp-quote><p>We agree that more details on the modelling and simulations were missing and thank the reviewer for raising that point. This is now made explicit in the new introductory paragraph to the Methods and Results section:</p><p>“Models are described using systems of ordinary differential equations (ODEs) and are evaluated deterministically by numerical integration. Across models, three primary epidemiological outcomes are calculated at steady-state equilibrium: P<sup>R</sup> prevalence (the proportion of patients colonized), P<sup>R</sup> incidence (the daily rate of colonization acquisition within the hospital), and the pathogen resistance rate (the proportion of patients colonized with the antibiotic-resistant strain P<sup>R</sup> relative to a drug-sensitive strain P<sup>S</sup>). We also derive and evaluate the basic reproduction number <italic>R</italic><sub>0</sub>, an indicator of pathogen epidemicity representing the average number of patients expected to acquire a novel pathogen from an initial index patient. See Methods for technical details, and the supplementary appendix for the complete modelling framework and assumptions (equation S1).”</p><p>In the caption for Figure 1:</p><p>“For all models, ODEs are integrated numerically using the same parameter values representing a generic nosocomial pathogen P<sup>R</sup> (see Table S1).”</p><p>And again, in the methods:</p><p>“ODEs were integrated numerically to calculate steady-state epidemiological outcomes for nosocomial P<sup>R</sup> colonization: colonization prevalence (the sum of all compartments C<sup>R</sup>), colonization incidence (the daily rate of C<sup>R</sup> acquisition), and the resistance rate (C<sup>R</sup>/(C<sup>S</sup> + C<sup>R</sup>)). (See the supplementary appendix for technical details, and R and Mathematica files available online at <ext-link ext-link-type="uri" xlink:href="https://github.com/drmsmith/microbiomeR">https://github.com/drmsmith/microbiomeR</ext-link>.) For each model, outcomes were evaluated over the same parameter space representing a generic pathogen P<sup>R</sup> (parameters in Table S1), while varying specific parameters through univariate and bivariate analysis to assess their impacts on dynamic equilibria in the context of different modelling assumptions.”</p><disp-quote content-type="editor-comment"><p>Discussion</p><p>18) The model is described by a set of differential equations. This means the model ignores stochasticity of the population size dynamics of each strain. The authors could expand a bit more on the assumptions of the model and why fluctuations are ignored.</p></disp-quote><p>We have expanded upon these limitations as suggested, nuancing our statements with the intended goals of this study:</p><p>“This study has a number of limitations. First, hospitals and healthcare settings are heterogeneous environments with non-random contact patterns and relatively small population sizes. Stochastic, individual-based models accounting for these factors reproduce more realistic nosocomial transmission dynamics than deterministic ODE simulations, allowing for local extinction events, super-spreaders, and other inherently random epidemiological phenomena. Nonetheless, our goal was to study how ecological mechanisms impact average epidemiological outcomes in the context of different model assumptions and parameter uncertainty, and in this context ODE modelling was the more appropriate tool, particularly for widely endemic ARB like <italic>C. difficile</italic>, MRSA and ESBL-EC. Still, further insights could certainly be gained by accounting for additional complexity and stochastic heterogeneity in future work, from within-host spatial organization,(91) to patient and staff contact behaviour,(92) to inter-institutional or inter-ward meta-population dynamics.(93) These distinctions may be particularly important for rare or non-endemic ARB (e.g. CP-KP in some regions).”</p><disp-quote content-type="editor-comment"><p>19) Also, spatial structure is particularly important when taking into account interactions between microbiome and pathogens, but it is also neglected in the model. It would be useful if the authors could discuss this as well.</p></disp-quote><p>Importance of spatial structure to resistance dynamics is now referenced in the introduction:</p><p>“Accounting for additional forms of complexity in epidemiological models – from treatment intensity, to age-assortative contact behaviour, to hospital referral networks, to animal-human interactions, to genetic linkage between resistance and non-resistance genes – has helped to unravel the many, disparate forces that contribute to drive the spread of resistance.”</p><p>and in the discussion:</p><p>“Still, further insights could certainly be gained by accounting for additional complexity and stochastic heterogeneity in future work, from within-host spatial organization,(91) to patient and staff contact behaviour,(92) to inter-institutional or inter-ward meta-population dynamics.(93) These distinctions may be particularly important for rare or non-endemic ARB (e.g. CP-KP in some regions).”</p><disp-quote content-type="editor-comment"><p>20) The results shown often focus on steady-state quantities (such as colonisation prevalence), but the temporal evolution of the model is not discussed. It would be interesting if the authors could investigate the timescale of the different interactions taken into account, and how relevant they may be in the healthcare settings they investigate. Is the temporal evolution of the model any relevant for their conclusions?</p></disp-quote><p>We include a new supplementary figure which evaluates P<sup>R</sup> prevalence and resistance rate over time for the generic pathogen P<sup>R</sup> evaluated in part 1, separating and then combining each microbiome-pathogen interaction to assess their impacts on dynamics (Appendix Figure 5). We included three public health interventions, implemented at days 90, 180 and 270, to explore how pathogen responses to interventions vary with time. Associated code is provided in the R file. We include the following text in the main text with regards to these findings:</p><p>“Different microbiome-pathogen interactions also underlie distinct dynamic responses to theoretical public health interventions. For the same generic pathogen P<sup>R</sup>, antibiotic stewardship interventions generally, but do not always prevent colonization, with predictions depending on the ecological interactions in effect (e.g. strain competition, microbiome competition), the impact of the intervention (e.g. reduced microbiome disruption, reduced overall prescribing), and the epidemiological outcome considered (e.g. colonization prevalence, resistance rate) (Figure S5).”</p><p>As well as the following text in the supplement:</p><p>“In Figure S5, we simulate dynamic responses of P<sup>R</sup> to public health interventions. First, dynamic equilibria were found, from which ODEs were integrated for an additional 365 days, evaluating C<sup>R</sup> and the resistance rate over time in the context of each microbiome-pathogen interaction (separately and in concert). We introduced theoretical interventions at days 90 (halving <italic>r<sub>R</sub></italic> from 0.8 to 0.4), 180 (halving θ<sub>m</sub> from 1.0 to 0.5), and 270 (halving <italic>a</italic> from 0.2 to 0.1), demonstrating that an otherwise identical pathogen can experience diverse, and sometimes opposing responses to public health interventions in the context of different microbiome-pathogen interactions and epidemiological outcomes.”</p><p>Systems generally returned to equilibria after 1 to 3 months. However, we avoid over-interpretation of timescales and lags in the manuscript, owing to limitations to using deterministic ODE modelling for predictive modelling in the hospital setting (see comments 18 and 19).</p><disp-quote content-type="editor-comment"><p>21) Can the authors please add examples of the hypothetical microbiome recovery interventions they have in mind? Are the authors thinking of things like faecal transplantation? Please add, also to provide more practical interpretation of the work.</p></disp-quote><p>We now include a statement in the introduction more clearly referencing these interventions:</p><p>– From a clinical perspective, this motivates a need for public health interventions that minimize or reverse harm to patient microbiota, from antibiotic stewardship, to faecal microbiota transplantation, to microbiome protective therapies. (28,29).</p><p>And devote a new discussion paragraph to discuss these interventions and relevance for our modelling framework and findings.</p><p>– Findings also suggest promise for interventions that effectively restore microbiome stability and associated colonization resistance as a means to control ARB spread. Fecal microbiota transplantation is already used to treat recurrent <italic>C. difficile</italic> infection, and is under investigation for multidrug-resistant <italic>Enterobacteriaceae</italic> decolonization.(67–69) However, its appropriateness for dysbiosis recovery in the absence of other clinical indications is unclear. Transplantation requires rigorous donor screening and close longitudinal follow-up, and cases of donor stool contaminated with toxicogenic and multidrug-resistant bacteria highlight non-negligible risks.(70,71) Alternative microbiome protective therapies now exist, like DAV132, a novel activated-charcoal product currently undergoing clinical trials. When co-administered with antibiotics by the oral route, DAV132 has been shown to absorb antibiotic residues in the colon and preserve the richness and composition of intestinal microbiota, while maintaining systemic antibiotic exposure.(28,72,73) Modelling has been used previously to evaluate impacts of such microbiome-oriented interventions at the within-host level,(74,75) but knock-on impacts on ARB transmission dynamics and epidemiological burden have not been evaluated previously. Our simulations were limited to a select few ARB, but our framework and findings likely have relevance for other bacteria known to interact with the microbiome, including vancomycin-resistant Enterococci and other multidrug-resistant <italic>Enterobacteriaceae</italic>,(23,76) and could be further extended to explore impacts of the microbiome on resistance dynamics and intervention efficacy beyond healthcare settings.</p></body></sub-article></article>